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“Summary and Task of the Thesis” 
 
Most of the work mentioned here has already been published in reputed journals. This 
thesis can be summarized as follows: 
The task of my thesis was to study palladium(0)-catalyzed Suzuki cross-coupling reactions 
of various types of bis(triflates) of benzophenones and benzoates. The triflates are readily available 
from the corresponding hydroxy compounds. The issue of site-selectivity plays an important role in 
my thesis. In this context, steric and electronic parameters have been investigated. 
 
The palladium(0)-catalyzed Suzuki cross-coupling reaction of the bis(triflates) of 2′,4-
dihydroxybenzophenones afforded 2′,4-diarylbenzophenones. The reactions proceeded with very 
good site-selectivity. The first attack takes place at carbon atom C-4. The site-selectivity of 
palladium(0)-catalyzed reactions of bis(triflates) is controlled by electronic and steric parameters. 
The oxidative addition of palladium usually occurs first at the most electron deficient and sterically 
less hindered carbon atom. Therefore, the site-selective formation of mono-adducts can be 
explained by the fact that carbon atom C-4 is more electrons deficient and less sterically hindered 
than C-2′. One electron-withdrawing benzoyl group is located ortho to C-2′. In contrast, both an 
electron-withdrawing benzoyl group and an electron-withdrawing ester group are located para and 


































The Suzuki-Miyaura cross-coupling reaction of the bis(triflate) of 2,4′-dihydroxy 
benzophenone afforded 2,4′-diarylbenzophenones. The reactions again proceeded with very good 
site-selectivity in favour of carbon atom C-4′ which is less sterically hindered than C-2. 
1.0 eq ArB(OH)2








1.0 eq Ar2B(OH)2  
 
The Suzuki-Miyaura reaction of the bis(triflate) of 3,4-dihydroxybenzophenone with two 
equivalents of boronic acids gave 3,4-diarylbenzophenones. When one equivalent of boronic acid 
was used, the reaction proceeded with site-selective attack at carbon atom C-4. 3,4-
diarylbenzophenones containing two different aryl groups were prepared by sequential addition of 
two different boronic acids. The site-selective formation of the mono-adducts can be explained by 
the fact that carbon atom C-4 (located para to the keto group) is more electron-deficient than C-3 
(located meta to the keto group). Steric parameters have no role to play, due to the similar steric 
environment of carbon atoms C-3 and C-4. The Sonogashira cross-coupling reactions of the 
bis(triflate) of 3,4-dihydroxybenzophenone with terminal alkynes display remarkable compatibility 
with regard to the formation of symmetrical and unsymmetrical alkyne-substitution and the 
reaction proceeded with the same site-selectivity as was observed in case of Suzuki-Miyaura 





































The palladium(0)-catalyzed Suzuki cross-coupling reaction of the bis(triflate) of methyl 
2,5-dihydroxybenzoate afforded p-terphenyls. The reaction takes place with very good site-
selectivity. The first attack takes place at carbon atom C-5. Carbon atom C-2 of the bis(triflate) is 
expected to be more electron deficient than C-5. On the other hand, carbon atom C-5 is less 
sterically hindered than C-2. Therefore, the site-selective formation of mono-adducts is mainly 



















Ar2 1.0 eq Ar2B(OH)2  
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The palladium(0)-catalyzed Suzuki cross-coupling reaction of the bis(triflate) of methyl 
2,4-dihydroxybenzoate resulted in the formation of m-terphenyls. The mono-adducts are formed as 
a result of site selective attack at carbon atom C-4. The steric factors have an important role to play 
in this regard. The site-selective formation of mono-adducts can be explained by the fact that 






















1.1 General Introduction: 
The development of environmentally friendly and economical reactions for the formation of 
carbon-carbon and carbon-heteratom bonds is of great interest for the chemist. This methodology 
provides a simple route for the formation of different bulky molecules from simple starting 
material. Until now, different methodologies have been used by the chemist for making carbon-
carbon bonds. Since the discovery of metal-catalyzed cross-coupling reactions, a variety of metals 
have proven to be productive in organic synthesis. For instance, different types of organometallics 
which are used by synthetic chemist are boron (Suzuki reaction), zinc (Negishi reaction), tin (Stille 
reaction) and copper (Sonogashira reaction). Recently, Perez et al, has found organoindium 
compounds as useful reagents in metal-catalyzed cross-coupling reactions.1,2 
 
1.2 Pd-catalyzed Reactions: 
Since the discovery and continuing evolution of metal-catalyzed cross coupling reactions, 
palladium(0)-catalyzed carbon-carbon bond forming reactions provide a useful methodology, 
which has not only facilitated the synthesis of complex molecules but also served as an efficient 
route for the formation of carbon-carbon bonds used by synthetic chemists.3 Palladium-catalyzed 
cross-coupling is used in research worldwide, as well as in commercial production of, for example, 
pharmaceuticals and molecules used in the electronic industry. The tool allows scientists to build 
complex chemicals such as the carbon-based ones that are the basis of life. This technique is 
applied in every field of chemistry, such as, total synthesis, nanotechnology, synthesis of advanced 
materials, medicinal and pharmacological chemistry. Various types of palladium-catalyzed cross-
coupling reactions4,5 are known in organic synthesis, such as, Heck, Stille, Suzuki, Sonogashira, 
Tsuji-Trost and Negishi reactions (Scheme 1). Since last few decades, palladium-catalyzed cross-
coupling reactions have evolved as the best tool for making carbon-carbon bonds between 
unsaturated organic moieties. The historical development and a variety of applications have put 
these reactions at the top list in synthetic organic chemistry. In short, it represents a well-












R4 = aryl, benzyl, vinyl
X = Cl, Br, I, OTf
cat. Pd
Heck Reaction




R1 =alkyl, aryl, vinyl
R2 = aryl, benzyl, vinyl
X = Br, Cl, I, OTf
Stile Reaction
R1 SnR3 + R2 X cat. Pd R1 R2
R1 = alkyl, alkynyl, aryl, vinyl
R2 = acyl, alkynyl, allyl, benzyl
X = Br, Cl, I, OTf, OAc
X + NuH Nucat. Pd
base
X = Br, Cl,OCOR,
NuH = enamines, enolates
Tsuji-Trost Reaction




R1 = alkyl, aryl, vinyl
R2 = alkyl, alkynyl, vinyl, benzyl
X = Br, Cl, I, OTf, OTs
R1 ZnR2 + R3 X R1 R3
R1 = alkyl, akynyl, aryl, vinyl
R3 = acyl, aryl, benzyl, vinyl
X = Br, I, OTf, OTs




Scheme 1: The most commonly used palladium-catalyzed cross-coupling reactions. (The picture 
was taken from Angew. Chem. Ind. Ed. 2005, 44, 4442). 
 
In the last decades, many research articles dealing with the reaction mechanism and 
synthetic applications of Pd catalysis appeared in the literature. If we closely observe the 
mechanism of a typical cross-coupling reaction, we can have an idea that the reaction proceeds to 
accomplish in three steps (Scheme 2). In the first step of the reaction, the addition of corresponding 
organic triflate or halide to the Pd(0) complex takes place. This addition results in the formation of 
organopalladium triflates or halides. The next step is the transmetallation with nucleophilic 
compounds to give a diorganopalladium complex. In the last step of the reaction, this complex 



















Scheme 2. General mechanism for palladium-catalyzed cross-coupling reaction (picture was taken 
from Tetrahedron, 2005, 61, 2245). 
 
For many years, interesting and pharmacologically active compounds have been 
synthesized by using Pd-catalyzed cross-coupling reactions.6 In particular, the ring forming 
reactions catalyzed by Pd(0) always remained a matter of interest for the synthetic organic 
chemist.7 For instance, Lautens and Mark8 have developed new Pd-catalyzed cyclization methods 
for the synthesis of highly functionalized carbocyclic, heterocyclic and arene compounds. Catellani 
and his co-workers discovered remarkable norbornene-mediated Pd-catalyzed reactions, inwhich 
three carbon-carbon bonds are formed in one pot.9 In this reaction, they used an aryl iodide to react 
with an alkyl halide and a Heck acceptor in the presence of norbornene, a Pd catalyst and a base to 
form ortho, ortho´-disubstituted vinylarenes. 
 
Pd-catalyzed Heck reactions10 and cross coupling reactions11 of aryl triflates and halides are 
powerful synthetic methodologies for new carbon-carbon bond formation in synthetic organic 
chemistry. In the last few decades, different methods have been applied by the chemist, which have 
greatly improved the synthetic utilization of these reactions, as a result of which they are now 
finding almost routine use in complex organic synthesis.12 
 
A large number of reactions involve the generation and transformation in situ of σ-vinyl 
and σ-aryl palladium complexes. These complexes provide the precursors which can be used as 
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substructures for the sythesis of many types of pharmacologically active compounds. Switching 
from vinyl and aryl mercury compounds to vinyl and aryl halides widened considerably the scope 
and utility of this methodology. More recently, the discovery of Cacchi and Sandro, that vinyl 
triflates (trifluoromethanesulfonates) can be used as precursors of σ-vinylpalladium complexes in 
the reaction with olefinic system13 and the development of a procedure by Scott and Stille to allow 
the cross-coupling of vinyl triflates with organostannanes14 marked a further significant step 
forward in homogeneous catalysis. 
 
1.3 Palladium-catalyzed Suzuki-Miyaura Reaction: 
In palladium-catalyzed catalytic tansformations, Suzuki-Miyaura cross-coupling has 
especially attracted the attention of chemists and has been used extensively in organic synthesis. 
Suzuki and Miyaura have invented this reaction in 1981. Since its inception, it has found multi-
prong use in synthetic organic chemistry. This reaction refers to the cross-coupling of organoboron 
compounds and carbon electrophiles.15 No one can deny from the importance of Suzuki-Miyaura 
cross-coupling reaction in academic and industrial chemistry as well as in production of a variety 
of fine chemicals.16 The Pd-catalyzed Suzuki-Miyaura cross-coupling reaction has attained a great 
importance for the synthetic organic chemist to prepare different types of molecules which can be 
used as a backbone for different types of substructures, used in pharmaceutical chemistry. The 
Suzuki-Miyaura cross-coupling reaction has a number of advantages over the other available 
traditional methods for the synthesis of these types of moieties. For instance, this reaction requires 
mild reaction conditions to proceed, high level of tolerance to almost all types of functional groups 
and the commercial availability and stability of the reagents (to heat, oxygen and water) used in 
such reactions. The synthetic chemist can handle and separate the byproducts produced from the 
reaction mixture in a very easy way, which further enhances the importance of this reaction. These 
interesting advantages make the Suzuki-Miyaura cross-coupling reaction an important tool in 
medicinal chemistry and also in the preparation of fine chemicals as well as in large scale 
pharmaceutical industry.17 
 
 A general mechanism for the Suzuki-Miyaura cross coupling reaction of organic halides 
and triflates with organoboron reagents is elaborated in Scheme 3. This mechanism usually 
involves three steps. In the first step of the reaction, the oxidative addition of organic halides or 
triflates to the Pd(0) complex to form a organopalladium halide (R1-Pd(II)-X) takes place. This step 
is then followed by transmetallation with a boronic acid derivative to give a diorganopalladium  
10 
 
complex (R1-Pd-R2). In the final step of the reaction, this complex undergoes a reductive 











Scheme 3. Catalytic cycle of the Suzuki reaction 
 
The rate of the Suzuki reaction is influenced by various factors, but mainly it depends upon 
the oxidative addition and transmetallation steps. In the oxidative addition step of the Suzuki 
reaction, the reactivity of the reacting substrates has a vital role to play. Generally, the reactivity of 
various substrates is observed in the following order, Ar-I > Ar-Br > Ar-OTf > Ar-Cl. The base 
supports the transmetallation step of the Suzuki reaction. The presence of a base usually enhances 
the nucleophilicity of the organoborane compound by formation of an organoborate containing a 
tetravalent boron atom. The rate of Suzuki reaction is also affected by the solvent to be used in the 
reaction. In my research work, the use of THF was most productive. 
 
The rate of success of the Suzuki-Miyaura reaction also depends upon the selection of 
catalyst to be used in the reaction. To achieve this target, a variety of catalysts are used by the 
chemist. Until 1998, triarylphosphine ligands were used for most of the catalysts which were 
applied for Suzuki-Miyaura cross-coupling reactions. New bulky and electron-rich phosphine 
ligands have been introduced and it is experimentally proved that these ligands can improve the 
efficiency and selectivity in such type of reactions. It was believed that the use of such type of 
electron-rich and bulky phosphine ligands enhances the rate of both oxidative addition and 
reductive elimination processes. A new family of ligands, dialkybiarylphosphines L1-L12, has 
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been designed by Rubert Martin and his co-workers. They applied these ligands in a wide variety 
of reactions which can be used for the synthesis of carbon-carbon, carbon-nitrogen, and carbon-
oxygen bond forming processes. With the use of these types of bulky electron-rich ligands, it 
became possible to carry out the Suzuki-Miyaura reaction with a number of unactivated substrates, 
such as, aryl chlorides, aryl tosylates, heteroaryl, and extremely hindered substrates. The most 
common catalysts, which had found their utilization in palladium-catalyzed synthetic chemistry, 
includes, Pd(OAc)2, PdCl2, Pd(PPh3)2Cl2 and Pd(PPh3)4. 
 
As these catalysts serve as a source of electron in the reaction, the electron-rich ligands are 
often the key for a successful reaction. Sterically hindered and electron-rich phosphines serve the 
purpose in a best way. The reaction with ferrocenylphosphane18, N-heterocyclic carbenes19, P(t-
Bu)320, P(Cy)3 often give good results. Jiwu Ruan and co-workers recently reported the synthesis of 
an electron-rich and bulky monophosine ligands based on [2.2] paracyclophane.21 Prof. Matthias 
Beller at Universität Rostock has worked on the invention of some innovative ligands which had 
found tremendous use in palladium-catalyzed organic synthesis. His group has developed a 
methodology for the synthesis of some very useful catalysts, which are also commercially 
available, for instance, dibutyl-1-adamatylphosphine22, and phosphino substituted N-aryl 
pyrroles.23 Many chemists all over the globe are trying to synthesize most useful ligands which can 
be employed to achieve extraordinary results in the field of palladium-catalyzed chemistry. Prof. 
Buchwald and co-workers24 have developed electron-rich, bulky biphenylphosphine ligands, such 
as S-Phos, X-Phos, Dave-Phos, and others. The organic chemists have successfully applied such 
ligands for different synthetic routes, including industrially relevant processes. I had also tried 
many types of catalyst in my projects. In my research, the best results were often achieved by using 
tetrakis(triphenylphosphine) palladium(0) for most of the Suzuki-Miyaura cross-coupling 
reactions. 
 
1.4 Pd-catalyzed Reactions of Bis(triflates): 
The palladium-catalyzed reactions had also been carried out with aryl bis(triflates). The 
palladium(0) catalyzed cross-coupling reaction of aryl triflates25 with aryl boronic acids in the 
presence of a base is a versatile method for preparing unsymmetrically substituted biaryls. The use 
of aryl triflates instead of aryl halides is particularly important in organic synthesis because it can 
provide a way of forming a carbon-carbon bond at a phenolic site, which is often useful when 
appropriate halides are unavailable.26 Since aryl triflates are easily available from the 
12 
 
corresponding hydroxy compounds, the scope and applications of these compounds in transition 
metal catalyzed reactions has therefore, attracted the interest of chemists. This coupling reaction 
offers the advantage of high yields, clean products with less side reactions, tolerance of a variety of 
functional groups on either coupling partner, and no necessity for anhydrous conditions. 
 
Recently, the group of Prof. Langer has thoroughly studied the Pd-catalyzed chemistry of 
bis(triflates). Langer et al. have reported the synthesis of bis(diaryl)sufones by site-selective Suzuki 
reactions of 2,4´-bis(trifluoromethylsulfonyloxy)diphenylsulfone A (Scheme 4).27 These 
compounds are of considerable pharmacological relevance.28 The reaction with two equivalents of 
boronic acids took place at both carbon atom of the triflate moiety, but when one equivalent of 
boronic acid was used, the site selective attack at carbon atom C-4´  takes place. This can be 


































Scheme 4. Site-selective reactions of bis(triflates) A 
 
In the last decade, a dramatic increase in the interest of organofluorine compounds has been 
observed. The carbon-fluorine bond is chemically stable; therefore, undesired metabolic 
transformations are rather rare. Schlosser et al. reported the synthesis of fluorinated arenes by 
Diels-Alder reactions of alkenes or alkynes with fluorinated 1,3-butadienes.29 Langer et al. have 
recently reported the synthesis of arenes and hetarenes based on formal [3+3] and [3+2] 
cyclizations of 1,3-bis(silyloxy)-1,3-butadienes.30-32 They also reported the synthesis of dimethyl 4-
fluoro-3,5-dihydroxyphthalate by [4+2] cycloaddition of 1-ethoxy-2-fluoro-1,3-
13 
 
bis(trimethylsilyloxy)-1,3-diene with dimethyl acetylenedicarboxylate (DMAD). Pd-catalyzed 
Suzuki reactions of the bis(triflate) B proceeded with good site selectivity and resulted in the 































Scheme 5. Site-selective reactions of bis(triflates) B 
 
Aryl chlorides possess interesting biological properties and they have also been isolated as 
natural products.34 Corral and co-workers reported the synthesis of of 4-chloro phenol by [4+2] 
cycloaddition of a chlorinated thiophene with dimethyl acetylene dicarboxylate.35 Langer and his 
co-workers has recently reported the synthesis of dimethyl 4-chloro-3,5-dihydroxyphthalate by 
[4+2] cycloaddition of 1-ethoxy-2-chloro-1,3-bis(trimethylsilyloxy)-1,3-diene with dimethyl 
acetylendicarboxylate (DMAD). Suzuki-Miyaura reactions of the bis(triflate) C afforded the 
formation of 3,5-diaryl-4-chlorophthalates (Scheme 6).36 The site-selective formation of the 


































Scheme 6. Site-selective reactions of bis(triflates) C 
 
Anthraquinones also show interesting pharmacological properties and occur in various 
natural products.37 For instance, anthracyclines are important as antitumor agents and antibiotics. In 
the group of Prof. Langer, Pd-mediated study of bis(triflates) is always a matter of interest. 
Recently, they have reported the synthesis of 1,2-diarylanthraquinones (Scheme 7) by Pd-catalyzed 
































   The group of Prof. Langer, in continuation of their studies on bis(triflate) chemistry, studied 
the synthesis of 7,8-diaryl-flavones by site-selective Suzuki-Miyaura reactions of the bis(triflate) of 
7,8-dihydroxyflavone.39 Commercially available 7,8-dihydroxyflavone was transformed to its 
bis(triflate). When the Suzuki reaction of this bis(triflate) E was carried out, it resulted in the 
formation of interesting products (Scheme 8). When two equivalent of boronic acid was used, there 
was no issue of selectivity, but when one equivalent of boronic acid was employed, it afforded site-
selective formation of products. Steric and electronic factors play a vital role in the formation of 
site-selective products. The first attack takes place at the most electron deficient and less sterially 




























Scheme 8. Site-selective reactions of bis(triflates) E 
 
Langer et al. also reported the formation of 1,4-diaryl-2-naphthoates (Scheme 9),40 starting 
from bis(triflate) F of phenyl 1,4-dihydroxynaphthoate, which is an inexpensive, commercially 
available starting material. The Suzuki reaction with two equivalents of boronic acids proceeded 
without any problem. When one equivalent of boronic acid was used, a site selective formation of 
mono-adducts took place. This site-selective formation of products is controlled by electronic 
effects. Carbon atom C-1 of the naphthoate is more electron deficient, therefore, the addition of 
electron rich palladium species first takes place at this carbon atom, resulting in the site-selective 

































2. Synthesis of Functionalized 2′,4-diarylbenzophenones, 2′,4′-
diarylbenzophenones, 3,4-diarylbenzophenones based on site-selective 
Suzuki-Miyaura cross-coupling reactions of bis(triflates) of various 
Hydroxylated Benzophenones. 
 
2.1 General Introduction to Benzophenones: 
    In this project, my target was the synthesis of functionalized benzophenones based on site-
selective Suzuki-Miyaura cross-coupling reactions. In the literature, it has been reported that these 
benzophenones show a variety of properties. For instance, 4-arylbenzophenones exhibit interesting 
pharmacological properties, such as cytotoxic and antibacterial activity,41 and the inhibition of 
various enzymes.42 In the group of Prof. Langer it has already been reported that 4-(2-
hydroxybenzoyl)salicylic acids show a good in vitro activity in a selectin bioassay.43 Similarly, 
structurally related benzoylfluorenones show interesting biological activities.44 The 4-
arylbenzophenones are are usually found in polycyclic frameworks, in anthraquinone and 
tetracycline natural products.45 2-Hydroxy- and 2-aminobenzophenones are of valuable importance 
in anticancer therapy, since they act as antitubulin agents.46 Functionalized benzophenones are also 
widely used as photosensitizers and UV-filters (suncremes).47 
 
      Selectin antagonist activity of various aryl-substituted benzophenones have also been 
reported in the literature.48  Substituted benzophenones under appropriate reaction conditions react 
to form strong fluorescent species. The 2,2´-dihydroxy-4,4´-dimethoxy-benzophenone is used as a 
new and sensitive fluorometric reagent for the determination of nitrate. The procedure to eliminate 
possible interferences from high concentrations of chloride, sulphides and humic acid substances is 
also incorporated in the automated method. This method has been applied to the analysis of a 
variety of natural waters and sediments.49 
 
      It is generally accepted that the majority of substituted benzophenones tend to produce 
phosphorescence instead of fluorescence.50-52 The main reason for this is that the majority of these 
compounds possess the lowest excited singlet state character; therefore, intersystem crossing to 
triplet manifold is usually very efficient. It is also well established that certain environmental 
factors, such as substitution, solute-solvent interaction, and nature of the catalyst, can alter these 
compounds and the nature of the transition energies and the intensity of luminescence.53 
18 
 
      Acetophenone and related compounds are known to react in concentrated sulphuric acid to 
produce polymeric species. Therefore, it is possible to alter the transition probabilities of these 
molecules by changing the reaction conditions, suitable substitution pattern, or solvent to produce 
species which may result in fluorescence instead of phosphorescence. 
 
      Some naturally available benzophenones, for instance, polyisoprenylated benzophenones, 
act as a therapeutic drug for the treatment of various diseases. Some novel therapeutic properties of 
naturally occurring benzophenones include 1) anti-microbial activity towards acne-causing 
bacteria; 2) strong anti-matrix metalloproteinase activity; and 3) anti-cyclooxygenase activity. 
Naturally occurring polyisoprenylated benzophenones have also been extensively studied as 
“cosmetics”, the definition of which, would just classify them as cleansers, beautifiers, attraction 
promoters and agents that alter physical appearance. So, there is an enormous potential in these 
natural molecules to be used as a drug. 
 
      Classic syntheses of benzophenones rely on reactions of aryllithium or magnesium reagents 
with aldehydes and subsequent oxidation and on Friedel-Crafts acylations.54,55 For the synthesis of 
functionalized benzophenones (e.g. containing a hydroxy, halide or ester group), these methods 
often give unsatisfactory results, due to competing side-reactions. Friedel-Crafts acylations of 
highly substituted derivatives not always proceed with good regioselectivity. An alternative 
strategy relies on the SmI2 mediated reaction of benzaldehydes with benzylhalides and subsequent 
oxidation.56 The group of Prof. Langer has studied domino reactions of silyl enol ethers with 
chromones. In this context, a new approach to 4-(2-hydroxybenzoyl)salicylates by cyclization of 
1,3-bis(silyloxy)-1,3-butadienes with 3-formylchromones has been developed. 
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2.2     Synthesis of Functionalized 2′,4-Diarylbenzophenones: 
    The backbone of many types of polymers, ligands, natural products and pharmaceuticals 
contain biaryls or substituted aromatic structures and it is important for synthetic organic chemists 
to study reactions which can be applied for the synthesis of these types of moieties. To serve this 
purpose, Suzuki –Miyaura cross-coupling reactions have adopted extreme importance for the 
chemist. The TMSOTf-mediated dominoaddition / retro-Michael / Mukaiyama-aldol reaction of 
3-formylchromone (2) with 1,3-bis(trimethylsilyloxy)buta-1,3-diene (1) afforded the 2′,4-
dihydroxybenzophenone57 3 which was transformed into its bis(triflate) 4 (Scheme 10). 
 
     The Suzuki reaction of 4 with boronic acids 5a-r afforded the novel 2′,4-
diarylbenzophenones 6a-r in good yields (Scheme  11, Table 1). The best yields were obtained 
when Pd(PPh3)4 (3 mol-%) was used as the catalyst, when 2.6 equiv. of the boronic acid was 
employed, and when the reaction was carried out in 1,4-dioxane (reflux, 4 h) using K3PO4 as the 
base. Benzophenones 6g and 6r were prepared from 4- and 3-bromophenylboronic acid in good 
yields, respectively. These experiments show that the bromine atom is compatible with the reaction 
conditions. The structures of all products were confirmed by spectroscopic methods. The structure 




















Scheme 10. Synthesis of 3 and 4. Reagents and conditions: i, 1) 2 (1.0 equiv), Me3SiOTf (0.3 
equiv), CH2Cl2, 0 C, 2) 1 (1.1 equiv), 0 → 20 C, 12 h, 3) HCl (10%); ii, 1) 3 (1.0 equiv), pyridine 
































Scheme 11. Synthesis of 6a-r. Reagents and conditions: (i) 1,4-Dioxane (5mL/mmol of Triflate), 4 
(1.0 equiv), 5a-r (2.6 equiv), K3PO4 (3.0 equiv), Pd(PPh3)4 (6 mol %), 110 C, 4h. 
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Table 1. Synthesis of 6a-r 
5,6 R1 R2 R3 R4 % (6a-r) a 
a H H Me H 84 
b H H H H 75 
c H H C2H5 H 62 
d H Cl H H 77 
e H H Vinyl H 72 
f H H Cl H 64 
g H H Br H 74 
h H OMe OMe H 62 























































a Yields of isolated products 
 
Figure 2. Ortep plot of 6a 
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The Suzuki reaction of 4 with one equivalent of boronic acids 5f,h-j,l,q,s,t resulted in the 
formation of the 4-arylbenzophenones 7a-h with very good site-selectivity (Scheme 12, Table 2). 
The Suzuki-Miyaura reaction of 7a,c,e-h with boronic acid 5e gave 2′,4-diarylbenzophenones 8a-f 
containing two different aryl groups (Scheme 12, Table 3). The structures of all the products were 
confirmed by spectroscopic methods. The structure of 7g was independently confirmed by X-ray 





























Scheme 12. Synthesis of 7a-h and 8a-f. Reagents and conditions: i, 4 (1.0 equiv),  5f,h-j,l,q,s,t 
(1.3 equiv), K3PO4 (3.0 equiv), Pd(PPh3)4 (3 mol %),1,4-dioxane, 110 C, 4 h; ii, 7a,c,e-h (1.0 









Table 2. Synthesis of 7a-h 
5 7 R1 R2 R3 R4 % (7a-h)a 
q a H Me H Me 78 
f b H H Cl H 45 
s c OEt H H H 89 
t d Br H H H 78 
h e H OMe OMe H 44 
i f H H OH H 63 
j g H OMe OMe OMe 43 
l h H OH H H 72 
a Yields of isolated products 
 
 










Table 3. Synthesis of 8a-f 
7 8 R1 R2 R3 R4 % (8a-f)a 
a a H Me H Me 60 
f b H H OH H 74 
e c H OMe OMe H 65 
g d H OMe OMe OMe 72 
h e H OH H H 64 
c f OEt H H H 68 
a Yields of isolated products 
 
    The site-selectivity of palladium(0)-catalyzed reactions of dihalides and bis(triflates) is 
controlled by electronic and steric parameters. The oxidative addition of palladium usually occurs 
first at the most electron deficient and sterically less hindered carbon atom. The site-selective 
formation of products 7a-h can be explained by the fact that carbon atom C-4 is more electron 
deficient and less sterically hindered than C-2′. One electron-withdrawing benzoyl group is located 
ortho to C-2′. In contrast, both an electron-withdrawing benzoyl group and an electron-













Scheme 13. Possible explanation for the site-selective formation of products 7a-h 
 
    The Suzuki-Miyaura reaction of 7d, containing a bromide and a triflate group in ortho 















Scheme 14. Synthesis of 9. Reagents and conditions: i, 7d (1.0 equiv), 5e (2.6 equiv), K3PO4 (3.0 
equiv), Pd(PPh3)4 (3 mol %), 1,4-dioxane, 110 C, 4 h 
 
    The Suzuki-Miyaura reaction of 5e (2.6 equiv.) with 6g, containing two para-bromophenyl 















Scheme 15. Synthesis of 10. Reagents and conditions: i, 6g (1.0 equiv), 5e (2.6 equiv), K3PO4 (3.0 




   The Suzuki-Miyaura reaction of 5b (2.6 equiv.) with 6r, containing two meta-bromophenyl 














Scheme 16. Synthesis of 11. Reagents and conditions: i, 6r (1.0 equiv), 5b (2.6 equiv), K3PO4 (3.0 
equiv), Pd(PPh3)4 (3 mol %), 1,4-dioxane, 110 C, 4 h. 
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2.3 Synthesis of Functionalized 2′,4′-Diarylbenzophenones: 
2,4′-dihydroxybenzophenone represents a commercially available and inexpensive 







12 13 (90%)  
Scheme 17. Synthesis of 13. Reagents and conditions: i, CH2Cl2, 12 (1.0 equiv), -78 C, pyridine 
(4.0 equiv), Tf2O (2.4 equiv), -78 → 0 C, 4 h. 
 
  The Suzuki reaction of 13 with different boronic acids (2.6 equiv.) afforded the novel 2,4´-
diarylbenzophenones 14a-d in good yields (Scheme 18, Table 4). The best yields were obtained 
when Pd(PPh3)4 (6 mol-%) was used as the catalyst, when 2.6 equiv. of the boronic acid was 
employed, and when the reaction was carried out in 1,4-dioxane (reflux, 4 h) using K3PO4 as the 
base. The structures of all products were established by spectroscopic methods. The structure of 




















Scheme 18. Synthesis of 14a-d. Reagents and conditions: (i) 1,4-Dioxane (5mL/mmol of Triflate), 




Table 4. Synthesis of 14a-d 
14 R1 R2 R3 % (14a-d)a 
a H OCH3 H 78 
b F H H 70 
c H H OCH3 68 
d H H Vinyl 66 
a Yields of isolated products. 
 
 
Figure 4. Ortep plot of 14b 
 
The Suzuki reaction of 13 with different boronic acids (1.3 equiv.), in the presence of 
Pd(PPh3)4 (3 mol-%), proceeded with very good site-selectivity (attack at carbon atom C-4´) to 
give the benzophenones 15a-h (Scheme 19, Table 5). The pure mono-coupled product was 
obtained after chromatographic purification. The reaction of 15a-h with (4-vinylphenyl) boronic 
acid (1.3 equiv.) gave 2,4-diarylbenzoates 16a-h containing two different aryl groups. The 
structures of all the products were proved by spectroscopic methods. The structure of 15f and 15h 
were independently confirmed by X-ray crystallography (Figure 5 and 6), which further give a 






























Scheme 19. Synthesis of 15a-h and 16a-h. Reagents and conditions: i, 13 (1.0 equiv), boronic 
acids (1.3 equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 mol %), 1,4-dioxane, 110 C, 4 h; ii, 15a-h (1.0 
equiv), 4-vinylphenyl boronic acid (1.3 equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 mol%), 1,4-
dioxane, 110 C, 4 h. 
 
Table 5. Synthesis of 15a-h and 16a-h 
15,16 R1 R2 R3 R4 R5 % (15a-h)a % (16a-h)a 
a H OCH3 H H H 68 70 
b OCH3 H H OCH3 H 72 72 
c OCH3 H H H OCH3 64 68 
d OEt H H H H 76 62 
e H Vinyl H H H 70 66 
f H H tBu H H 66 64 
g H CH3 H CH3 H 78 76 
h H H Et H H 74 74 




Figure 5. Ortep plot of 15f 
 
Figure 6. Ortep plot of 15h 
  The site-selective formation of 15a-h can be explained by the fact that carbon atom C-4´ 





sterically hindered Carbon C-4´ less
sterically hindered
 




2.4      Synthesis of 3,4-Diarylbenzophenones: 
   In this chapter, I report what are, to the best of my knowledge, the first site-selective 
palladium(0)-catalyzed cross-coupling reactions of the bis(triflate) of 3,4-dihydroxy benzophenone 
which represents a commercially available and inexpensive substrate. The site-selectivity can be 
explained by electronic reasons.  The products reported herein are not readily available by other 











Scheme 21. Synthesis of 18. Reagents and conditions: i, CH2Cl2, 17 (1.0 equiv), -78 C, pyridine 
(4.0 equiv), Tf2O (2.4 equiv), -78 → 0 C, 4 h. 
 
    The Suzuki reaction of 18 with different boronic acids (2.6 equiv.) afforded the novel 3,4-
diarylbenzophenones 19a-i in good yields (Scheme 22, Table 6). The best yields were obtained 
when Pd(PPh3)4 (6 mol-%) was used as the catalyst, when 2.6 equiv. of the boronic acid was 
employed, and when the reaction was carried out in 1,4-dioxane (reflux, 4 h) using K3PO4 as the 
base. The structures of all products were established by spectroscopic methods. The structure of 






















Scheme 22. Synthesis of 19a-i. Reagents and conditions: i, 18 (1.0 equiv.), boronic acids (2.6 




Table 6. Synthesis of 19a-i 
19 R1 R2 R3 R4 % (19a-i)a 
a H H H H 78 
b H H F H 69 
c H Me H Me 75 
d OMe H OMe H 74 
e OMe H H H 67 
f H H OMe H 54 
g OEt H H H 76 
h H Me Me H 58 
i H H Et H 78 
a Yields of isolated products 
 
 
Figure 7. Ortep plot of 19c 
 
    The Suzuki reaction of 18 with different boronic acids (1.3 equiv.), in the presence of 
Pd(PPh3)4 (3 mol-%), proceeded with very good site-selectivity (attack at carbon atom C-4) to give 
the benzophenones 20a-e (Scheme 23, Table 7). In some cases, a small amount of the bis-coupled 
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product could be detected in the crude product (by 1H-NMR and GC-MS). The pure mono-coupled 
product was obtained after chromatographic purification. The reaction of 20a-d with (4-
vinylphenyl) boronic acid (1.3 equiv.) gave 2,4-diarylbenzoates 21a-d containing two different aryl 



























Scheme 23. Synthesis of 20a-e and 21a-d. Reagents and conditions: i, 18 (1.0 equiv), boronic 
acids (1.3 equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 mol %), 1,4-dioxane, 110 C, 4 h; ii, 20a-e (1.0 
equiv), 4-vinylphenyl boronic acid (1.3 equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 mol%), 1,4-
dioxane, 110 C, 4 h 
Table 7. Synthesis of 20a-e and 21a-d 
20 21 R1 R2 R3 R4 % (20a-e)a % (21a-d)a 
a a H OMe H H 68 68 
b - OMe H H OMe 72 b 
c b H H Me H 64 78 
d c H OMe OMe OMe 76 64 
e d H H tBu H 70 62 


















Figure 8. Relevant NOESY-correlation for Compound 20d 
 
The structure of compound (20d) was unambiguously confirmed by 2D-NMR techniques. 
In the NOESY spectrum, an interaction was observed between the aromatic proton attached to the 
carbon atom C-5 of the ring A, to that of the aromatic protons of ring B attached to the carbons 
atoms C-2 and C-6. This confirmed that the first attack of boronic acid takes place at carbon C-
4 of the bis(triflate). These correlations are not observed, if the boronic acid is attached to the 
carbon atom C-3 of the bis(triflate). 
 
    The site-selective formation of 20a-e can be explained by the fact that carbon atom C-4 
(located para to the keto group) is more electron-deficient than C-3 (located meta to the keto 
group). Steric parameters have presumably no effect, due to the similar steric environment of 













2.5      Sonogashira reaction of the bis(triflate) of 3,4-dihydroxybenzophenone: 
   The Sonogashira reaction of 18 with different alkynes (2.6 equiv.) afforded the novel 3,4-
dialkynylbenzophenones 22a-f in good yields (Scheme 25, Table 8). The best yields were obtained 
when Pd(PPh3)2Cl2 (6 mol-%) was used as the catalyst, when 2.6 equiv. of the alkyne was 
employed, and when the reaction was carried out in DMF (reflux, 4 h) using Et3N as the base. The 
structures of all products were established by spectroscopic methods. 















Scheme 25. Synthesis of 22a-f.  Reagents and conditions: i, 18 (1.0 equiv), alkynes (2.0 equiv), 
Dry CuI (10%), Pd(PPh3)2Cl2 (5 mol %), Et3N (1.25 equiv), DMF, 110 C, 4 h. 
 
Table 8. Synthesis of 22a-f 
22 R1 R2 % (22a-f) a 
a H tBu 78 
b H H 54 
c OMe H 64 
d H Me 66 
e H F 60 
f Me H 58 
a Yields of isolated products 
 
   The Sonogashira reaction of 3,4-bis(trifluoromethylsulfonyloxy)benzophenone (18) with 
different alkynes (1.3 equiv.), in the presence of Pd(PPh3)2Cl2 (3 mol-%) as a catalyst, proceeded 




The mono-Sonogashira product 23 was treated with 4-methylphenylboronic acid (1.2 
equiv), in the presence of K3PO4 (1.5 equiv) and Pd(PPh3)4 (3 mol%) in 1,4-dioxane at 90 C, to 
give 24 in good yield (64%). The structures of all products were established by spectroscopic 
methods. The structure of 24 was independently confirmed by X-ray crystal structure analysis 
(Figure 9). The crystal structure of 24 further proves that the first regioselective attack of the 





















Scheme 26. Synthesis of 23 and 24. Reagents and conditions: i) 18 (1.0 equiv), alkynes (1.1 
equiv), dry CuI (10%), Pd(PPh3)2Cl2 (5%), Et3N (1.25 equiv), DMF, 90 C, 8 h. ii) 23 (1.0 equiv), 






Figure 9. Ortep plot of 24 
 
2.6   Conclusion: 
   In conclusion, I have reported the synthesis of 2,4′-diarylbenzophenones based on what are, 
to the best of my knowledge, the first palladium(0)-catalyzed Suzuki cross-coupling reactions of 
bis(triflates) of 2,4′-dihydroxybenzophenones. These reactions proceed with very good site-
selectivity. In addition, it has been shown that brominated 2,4′-diarylbenzophenones can be 
prepared which can be transformed into more complex bis-diphenyl-ketones and diphenyl-
triphenyl-ketones. The products reported herein were prepared by a building block strategy. I have 
also reported the synthesis of 3,4-diarylbenzophenones. The products reported herein are prepared 
by palladium(0)-catalyzed Suzuki cross-coupling reactions of the bis(triflate) of 3,4-
dihydroxybenzophenone. The Sonogashira cross-coupling reactions of the same substrate with 
terminal alkynes allow the formation of symmetrical and unsymmetrical alkynal-substituted 




3. Synthesis of Functionalized p-terphenyls and m-terphenyls based on site-
selective Suzuki cross-coupling reactions of bis(triflates) of 2,5- and 2,4-
dihydroxybenzoate 
 
3.1      Introduction: 
3.1.1 Introduction of p-terphenyls: 
Functionalized p-terphenyls occur in a great variety of pharmacologically relevant natural 
products. Examples include terphenyllin,58 terprenin,59 curtisian A,60 leucomentin-6,61 thelephorin 
A,62 ganbajunin D,63 and thelephantin A.64 Symmetrical and unsymmetrical terphenyls, 
functionalized with electron donor or acceptor groups, are the main constituents of a large number 
of mushrooms belonging to the Thelephoraceae family.65 Recently, numerous natural products 
having a terphenyl architecture, such as thelephorin,66 terphenyllin,67 terferol68 and terprenin,69 
have been reported to possess interesting biological properties. Several synthetic terphenyl 
derivatives have been designed as selective inhibitors for dihydroortate dehydrogenase70 and 
cyclooxygenase71 enzymes. 
 
Terphenyl containing acidic groups have recently been found to be potent insulin 
sensitizers.72 Recently, Yamazoe and Nozaki73 have identified a terphenyl-based novel auxin 
signaling inhibitor, terfestatin A, from Streptomyces sp. F40. Owing to their interesting optical74 
and electrical75 properties, terphenyls find several industrial applications as liquid crystals, 
conducting polymers, heat storage and heat transfer agents, as textile dye carriers and as laser dyes. 
 
Transition metal-catalyzed aryl-aryl cross coupling reactions are commonly employed for 
constructing biaryls. Palladium-catalyzed aryl-aryl cross-coupling between electrophilic aromatic 
dihalides Ar(X)2 (X being generally Br, I and OTf) and two equivalents of organometallic species 
Ar-M (M being Mg, Ni, Zn, Sn and B) constitute a versatile synthetic method for the preparation of  
symmetrical and unsymmetrical terphenyls.76 Suzuki couplings77 of a diverse array of haloarenes 
with aryl boronic acids gained wide popularity, due to the commercial availability of several aryl 
boronic acid and innocuous nature of the latter, easy work-up and tolerance of the reactions to 
aqueous media. Symmetrical terphenyls have been prepared by double coupling reactions of aryl 
boronic acids78 with aryl halides and aryl distannanes.79 The classical approach to unsymmetrical 
terphenyls requires either the reactions of biaryl boronic acids with aromatic halides80 or the 
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stepwise chemoselective cross-coupling of aryl compounds containing two dissimilar halides or 
triflates.81 
 
A recent report by Wu & Luo82 demonstrated the potential applications of para-terphenyl 
derivatives containing cyano groups in organic light emitting diode (OLED) fabrication. It has been 
well documented that the introduction of alkoxy substituents in conjugated materials enhances the 
solubility of the polymer. The presence of the cyano group influences photophysical and 
electroluminescent properties by lowering the energy of the LUMO, thus exhibiting a relatively 
low threshold voltage and high quantum efficiency in LED devices.83 
 
Polychlorinated terphenyls (PCTs) are yellow resins that have a number of qualities which 
make them useful for industrial purposes. These qualities are similar to polychlorinated biphenyls 
(PCBs), and PCTs have also been used as PCB substitutes. Technical PCT products contain small 
amounts of PCBs, generally 0.5%, sometimes up to 10%.84 Characteristics of PCTs include: very 
low electrical conductivity and extremely high resistance to thermal breakdown; insolubility in 
water, but solubility in various organic solvents and oils; resistance to attack by corrosive 
chemicals such as alkali and strong acids; heat stability and non-flammability. PCTs have been 
used in both closed systems, such as electric transformers, and open-ended applications, such as 
lubricating and cutting oils. 
 
The main uses of PCTs have been as85 plasticizers in synthetic resins, adhesives, lubricants, 
paper coatings, investment casting waxes, printing inks, carbonless copying paper, sealants (e.g., 
for concrete stave silos and caulking compounds), fire-retardants, vapour suppressants to extend 
the kill-life of insecticides, coatings to render fabric flame-proof, rot-proof and water-repellent, and 
in the manufacture of brake linings, abrasives for grinding wheels, lacquers, varnishes and paints; 
impregnants for braided cotton and asbestos insulation, in electrical wire and cable coatings, and as 
dielectric sealants, PCT-containing waxes used in making dental casts, costume jewelry and 
precision-cast aircraft parts. 
 
Natural occurrence of products with a p-terphenyl core is essentially restricted to fungi and 
lichens. In particular, p-terphenylquinones were known as fungal pigments for a long time. Indeed, 
the colouring principles in mushrooms and toadstools attracted the interest of the scientists since 
the late 19th century and the pioneering work in this field has been reviewed in the older literature. 
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Fully aromatic polyhydroxy p-terphenyls have generally been reported later than the related 
terphenylquinones. An array of biological activity has been reported for these polyhydroxy-p-
terphenyls, including cytotoxic activity against tumoral cells and other anti-proliferative properties, 
antibacterial activity, antioxidant or radical scavenging activity, anti-inflammatory activity and 
other properties of biomedical or agronomical interest. Recently, an increasing number of p-
terphenyl metabolites showing interesting biological properties and unusual structures have been 
reported.86 
 
3.1.2 Introduction of m-terphenyls: 
The chemical core structure of meta-terphenyls also occurs in a great variety of 
pharmacologically relevant natural products. Examples include various simple hydroxylated and 
alkylated meta-terphenyls, such as trifucolnonaacetate, dunnianol, or mulberrofuran R.87 Other 
derivatives, such pusilatin A, are incorporated in cyclophanes.88 The meta-terphenyl unit of various 
other natural products is incorporated in a bis(anthracene)89 or bis(carbazol)90 framework. The 
meta-terphenyl substructure is also found in complex macrocyclic natural products, such as 
acutissimins B, castalagin, or roburin A.91-93 In addition; meta-terphenyls are ideal precursors in the 
design of cyclophanes and are useful as tectones in crystal engineering.94 
 
3.2      Synthesis of Functionalized p-terphenyls: 
Tschierske and coworkers reported the synthesis of p-terphenyls by double Suzuki reactions 
of methyl 2,5-dibromobenzoate. The employment of two equivalents of the same boronic acid in 
this study gave no rise to the issue of site-selectivity. Mioskowski et al. reported site-selective 
Sonogashira reactions of 2,5-diiodobenzoic acid. The scope of this approach is limited by the fact 
that polyhalogenated benzene derivatives are often not readily available. In this chapter I have 
studied palladium-catalyzed cross-coupling reactions of the bis(triflate) of methyl 2,5-
dihydroxybenzoate, which represents a commercially available and inexpensive substrate. 
Reactions of this or related bis(triflates) have, to the best of my knowledge, not been reported to 
date. The reactions provide a facile synthesis of p-terphenyls. 
 
Methyl 2,5-dihydroxybenzoate (25) was transformed into the bis(triflate) 26 in 84% yield 
(Scheme 27). The Suzuki reaction of 26 with different boronic acids (2.6 equiv.) afforded the novel 
p-terphenyls 27a-f in good yields (Scheme 28, Table 9). The best yields were obtained when 
Pd(PPh3)4 (6 mol-%) was used as the catalyst, when 2.6 equiv. of the boronic acid was employed, 
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and when the reaction was carried out in 1,4-dioxane (reflux, 4 h) using K3PO4 as the base. The 
structures of all products were established by spectroscopic methods. The structure of 25, 26, 27b 











25 26 (84%)  
Scheme 27. Synthesis of 26. Reagents and conditions: (i) CH2Cl2, 25 (1.0 equiv), -78 C, pyridine 
(4.0 equiv), -78C, Tf2O (2.4 equiv), 4h. 
 
 



























Scheme 28. Synthesis of 27a-f. Reagents and conditions: i, 26 (1.0 equiv.), boronic acids (2.6 






Table 9. Synthesis of 27a-f 
27 R1 R2 R3 % (27a-f)a 
a OMe H H 78 
b H H tBu 75 
c H OMe OMe 56 
d H H Vinyl 77 
e H Cl H 67 
f H H H 54 
a Yields of isolated products 
 




Figure 13. Ortep plot of 27d 
 
   The Suzuki reaction of 26 with different boronic acids (1.3 equiv.), in the presence of 
Pd(PPh3)4 (3 mol-%), occurred site-selectively at carbon atom C-5, 28a-g (Scheme 29, Table 10). 
The reaction of 28a-g with 4-vinylphenyl boronic acid (1.3 equiv.) gave mixed p-terphenyls 29a-g 
containing two different boronic acids. The structures of all the products were determined by 
NMR-spectroscopic methods. The structures of the mono-products were proved by 2D-NMR 

































Scheme 29. Synthesis of 28a-g and 29a-g. Reagents and conditions: i, 26 (1.0 equiv), boronic 
acids (1.3 equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 mol-%), 1,4-dioxane (5mL per 1 mmol of 26), 
110 C, 4 h; ii, 28a-g (1.0 equiv), 4-vinylphenyl boronic acid (1.3 equiv), K3PO4 (1.5 equiv), 
Pd(PPh3)4 (3 mol-%), 1,4-dioxane (5mL per 1 mmol of 28), 110 C, 4 h. 
 
Table 10. Synthesis of 28a-g and 29a-g 
28,29 R1 R2 R3 R4 % (28a-g)a % (29a-g) a 
a H Me H Me 83 72 
b OMe H H OMe 72 78 
c H H Me H 64 68 
d H OMe OMe H 67 64 
e H H Br H 63 62 
f OMe H OMe H 73 67 
g H H Cl H 59 59 
















Figure 14. Relevant NOESY-correlation for Compound 28b 
 
The regioselectivity of compound 28b was established unambiguously by 2D NMR using 
NOESY (H-H) correlations. The phenyl proton attached with carbon C-12 showed clear correlation 
through space with the benzoate protons attached with carbons C-4 and C-6. This confirmed that 
the first attack of the boronic acid takes place at carbon C-5 of the benzoate. These careful and 
clear correlations proved unambiguously the connectivity of the aryl group to carbon C-5 of the 
benzoate. 
 
   In some cases, a small amount of the bis-coupled product and of the other regioisomer 
could be detected in the crude product (by 1H NMR and GC-MS). For example, 10% of the bis-
coupled product was detected by 1H NMR in the crude product of 28a. The pure mono-coupled 
products were obtained after chromatographic purification. The oxidative addition of palladium 
usually occurs first at the most electron deficient carbon atom. Carbon atom C-2 of bis(triflate) 26 
is expected to be more electron deficient than C-5. On the other hand, carbon C-5 is less sterically 
hindered than C-2. Therefore, the site-selective formation of 28a-g seems to be mainly influenced 
















3.3     Synthesis of Functionalized meta-terphenyls: 
  To develop a new strategy for the synthesis of meta-terphenyls, I also studied palladium-
catalyzed cross-coupling reactions of the bis(triflate) of methyl 2,4-dihydroxybenzoate which 
represents a commercially available and inexpensive substrate. Such reactions have, to the best of 
my knowledge, not been reported yet. Likewise, palladium-catalyzed cross-coupling reactions of 
2,4-dibromo- or 2,4-diiodobenzoates are unknown to date. Methyl 2,4-dihydroxybenzoate 31 was 
transformed into its bis(triflate) 32 in 88% yield (Scheme 31). The Suzuki reaction of 32 with 
different boronic acids (2.6 equiv.) afforded the novel m-terphenyls 33a-j in good yields (Scheme 
32, Table 11). The best yields were obtained when Pd(PPh3)4 (6 mol-%) was used as the catalyst, 
when 2.6 equiv. of the boronic acid was employed, and when the reaction was carried out in 1,4-











Scheme 31. Synthesis of 32. Reagents and conditions: (i) CH2Cl2, 31 (1.0 equiv), -78 C, pyridine 























Scheme 32. Synthesis of 33a-j. Reagents and conditions: i, 32 (1.0 equiv.), boronic acids (2.6 




Table 11. Synthesis of 33a-j 
33 R1 R2 R3 R4 % (33a-j)a 
a H H Cl H 72 
b OMe H H OMe 78 
c H H H H 65 
d H H tBu H 79 
e H OH H H 62 
f Br H H H 74 
g F H H H 68 
h H H F H 77 
i H CF3 H H 63 
j H H CF3 H 69 
a Yields of isolated products 
 
  The Suzuki reaction of 32 with different boronic acids (1.3 equiv.), in the presence of 
Pd(PPh3)4 (3 mol-%), proceeded with very good site-selectivity at carbon atom C-4 to yield 34a-d 
(Scheme 33, Table 12). In some cases, a small amount of the bis-coupled product could be detected 
in the crude product (by 1H NMR and GC-MS). The pure mono-coupled products were obtained 
after chromatographic purification. The reaction of 34a-d with 4-vinylphenyl boronic acid (1.3 
equiv.) gave mixed m-terphenyls 35a-d containing two different boronic acids. The structures of 
the products were proved by normal spectroscopic methods. The structure of 34c was 

































Scheme 33. Synthesis of 34a-e and 35a-g. Reagents and conditions: i, 32 (1.0 equiv), boronic 
acids (1.3 equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 mol-%), 1,4-dioxane (5mL per 1 mmol of 32), 
110 C, 4 h; ii, 34a-e (1.0 equiv), 4-vinylpheny boronic acid (1.3 equiv), K3PO4 (1.5 equiv), 
Pd(PPh3)4 (3 mol-%), 1,4-dioxane (5mL per 1 mmol of 34), 110 C, 4 h. 
 
Table 10. Synthesis of 34a-e and 35a-d 
34,35 R1 R2 R3 R4 % (34a-e)a % (35a-d) a 
a OMe H H OMe 78 76 
b H OMe OMe H 72 72 
c OMe H H H 76 64 
d OMe H OMe H 67 69 
e H Me H Me 60 b 






Figure 14. Ortep plot of 34c 
    As discussed above, the oxidative addition of palladium usually occurs first at the most 
electron deficient carbon atom. Carbon atoms C-2 and C-4 of bis(triflate) 32 are expected to be 
equally electron deficient. The site-selective formation of 34 a-e can be explained by the fact that 















In conclusion, I have reported the synthesis of p-terphenyls based on what are, to the best of 
my knowledge, the first palladium(0)-catalyzed Suzuki cross-coupling reactions of bis(triflates) of 
methyl 2,5-dihydroxybenzoate. These reactions proceed with very good site-selectivity. I have also 
reported the site-selective synthesis of m-terphenyls by Suzuki-Miyaura cross-coupling reactions of 
bis(triflates) of methyl 2,4-dihydroxybenzoate. All the products reported herein are not readily 





This PhD thesis includes palladium(0)-catalyzed Suzuki cross-coupling reactions of various 
benzophenones and benzoates. The palladium(0)-catalyzed Suzuki cross-coupling reaction of the 
bis(triflates) of 2,4′-dihydroxybenzophenones afforded 2,4′-diarylbenzophenones. The reactions 
proceeded with very good site-selectivity. The Suzuki-Miyaura reaction of the bis(triflate) of 3,4-
dihydroxybenzophenone with two equivalents of boronic acids gave 3,4-diarylbenzophenones. The 
reaction with one equivalent of arylboronic acids resulted in a site-selective attack. The 
Sonogashira cross-coupling reactions of the same substrate with terminal alkynes display 
remarkable compatibility with regard to the formation of symmetrical and unsymmetrical 
alkynylated products.The palladium(0)-catalyzed Suzuki cross-coupling reaction of the 
bis(triflates) of methyl 2,5-dihydroxybenzoate and methyl 2,4-dihydroxybenzoate afforded p-
terphenyls and m-terphenyls respectively. 
 
Diese Doktorarbeit umfasst neue Palladium(0)-katalysierte Suzuki-
Kreuzkupplungsreaktionen von verschiedenen Benzophenonen und Benzoaten. Die Palladium(0)-
katalysierten Suzuki-Kreuzkupplungsreaktionen der Bis(triflate) von 2,4′-
Dihydroxybenzophenonen führten zur Bildung von 2,4′-Diarylbenzophenonen. Diese Reaktionen 
verliefen mit sehr guter Regioselektivität. Die Suzuki-Miyaura-Reaktion der Bis(triflate) von 3,4-
Dihydroxybenzophenonen mit jeweils zwei Äquivalenten verschiedener Boronsäuren lieferte 3,4-
Diarylbenzophenone. Die analoge Reaktion mit einem Äquivalent der Arylboronsäure ergab einen 
regioselektiven Angriff in 4-Position. Die Sonogashira-Kreuzkupplungsreaktion mit terminalen 
Alkinen, ausgehend vom gleichen Substrat, führte zur Bildung von symmetrischen und 
unsymmetrischen Alkinylderivaten. Die Palladium(0)-katalysierten Suzuki-
Kreuzkupplungsreaktionen der Bis(triflate) von Methyl-2,5-dihydroxybenzoaten und Methyl-2,4-








































































2.0 eq ArB(OH)2OTf Ar
1.0 eq Ar1B(OH)21.0 eq Ar1B(OH)2


























Scheme 35: Content of the present thesis 
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5. Experimental Section: 
5.1    General: Equipment, Chemicals and Work Technique: 
 
1H NMR Spectroscopy: 
Bruker: AM 250, Bruker ARX 300, Bruker ARX 500; δ = 0.00 ppm for Tetramethylsilane; δ = 
2.04 ppm for Acetone-d6; δ = 7.26 ppm for (CDCl3); 2.50 ppm for DMSO-d6; Characterization of 
the signal fragmentations: s = singlet, d = doublet, dd = double of doublet, ddd = doublet of a 
double doublet, t = triplet, q = quartet, quint = quintet; sext = Sextet, sept = Septet, m = multiplet, 
br = broadly. Spectra were evaluated according to first order rule. All coupling constants are 
indicated as (J). 
 
13C NMR Spectroscopy: 
 Bruker: AM 250, (62.9 MHz); Bruker: ARX 300, (75 MHz), Bruker: ARX 500, (125 MHz)  Ref: 
29.84 ± 0.01 ppm and 206.26 ± 0.13 ppm for (CD3)2CO. δ = 128.00 ppm for benzene-d6; δ = 77.00 
ppm for CDCl3. The multiplicity of the carbon atoms was determined by the DEPT 135 and APT 
technique (APT = Attached Proton Test) and quoted as CH3, CH2, CH and C for primary, 
secondary, tertiary and quaternary carbon atoms. Characterization of the signal fragmentations: 
quart = quartet the multiplicity of the signals was determined by the DEPT recording technology 
and/or the APT recording technology. 
 
Mass Spectroscopy: 
AMD MS40, AMD 402 (AMD Intectra),  Varian MAT CH 7, MAT 731 
 
High Resolution mass spectroscopy: 
Finnigan MAT 95 or Varian MAT 311; Bruker FT 
CIR, AMD 402 (AMD Intectra). 
 
Infrared Spectroscopy (IR): 
Bruker IFS 66 (FT IR), Nicolet 205 FT IR; Nicolet Protege 460, Nicolet 360 Smart Orbit 
(ATR); KBr ,KAP, Nujol, and ATR; Abbreviations for signal allocations: w = weak, m = 






LECO CHNS-932, Thermoquest Flash EA 1112 
 
X-ray crystal structure analysis: 
Bruker X8Apex Diffractometer with CCD-Kamera (Mo-Ka und Graphit Monochromator, 
λ = 0.71073 Å). 
 
Melting points: 
Micro heating table HMK 67/1825 Kuestner (Büchi apparatus); Melting 
points are uncorrected. 
 
Column Chromatography: 
Chromatography was performed over Merck silica gel 60 (0,063 -0,200 mm, 70 - 230 mesh) as 
normal and/or over mesh silica gel 60 (0,040 - 0,063 mm, 200 -400 mesh) as Flash 
Chromatography. All solvent were distilled before use. 
 
TLC: 
Merck DC finished foils silica gel 60 F254 on aluminum foil and Macherey finished 
foils Alugram® Sil G/UV254. Detection under UV light with 254 nm and/or 366 nm without 
dipping reagent, as well as with anisaldehyde sulfuric acid reagent (1 mL anisaldehyde consisting 
in 100 mL stock solution of 85% methanol, 14% acetic acid and 1% sulfuric acid). 
Chemicals and work technique: 
     All solvents for using were distilled by standard methods. All reactions were carried out 
under an inert atmosphere, oxygen and humidity exclusion. All of the chemicals are standard, 
commercially available from Merck®, Aldrich®, Arcos® and others. The order of the characterized 










5.2       Procedures and Spectroscopic Data: 
 
General Procedure for the Synthesis of Triflates: 
To a soln of hydroxylated benzophenone or benzoate (1.0 equiv) in CH2Cl2 (10 mL/mmol), 
was added pyridine (4.0 equiv) at – 78 C under an argon atmosphere. After 10 min, Tf2O (2.4 
equiv) was added at -78C. The mixture was allowed to warm up to 0 C and stirred for 4h. The 
reaction mixture was filtered and the filtrate was concentrated in vacuo. The products of the 
reaction mixture were isolated by rapid column chromatography (flash silica gel, heptanes/EtOAc). 
 
General Procedure for the Synthesis of Biarayls: 
1,4-dioxane soln of the arylboronic acid, K3PO4, Pd (PPh3)4 and triflate of benzophenones 
was stirred at 110 C for 4 h. After cooling to r.t., sat. aq NH4Cl soln was added, the organic and 
aqueous layer were separated and the later was extracted with CH2Cl2. The combined organic 
layers were dried (Na2SO4), filtered and filtrate was concentrated in vacuo. The residue was 
purified by column chromatography. 
 
Methyl 2-hydroxy-5-(2-hydroxybenzoyl)benzoate (3): Starting with 2 (1740 mg, 10 mmol), 1,3-
bis(silyloxy)-1,3-butadiene (1) (2860 mg, 11 mmol) and  TMSOTf 
(0.54 ml, 3 mmol), 3 was isolated as yellowish oil (1650 mg, 60 
%); 1H NMR (300 MHz, CDCl3):  = 3.89 (s, 3H, OCH3), 6.79-
6.85 (m, 1H, ArH), 6.94-6.98 (m, 1H, ArH),  7.02 (s, 1H, ArH), 
7.39-7.43 (m, 1H, ArH), 7.49 (dd, 1H, J = 1.6, 7.9 Hz, ArH), 7.77 (dd, 1H, J = 2.2, 8.7 Hz, ArH), 
8.18 (d, 1H, J = 2.2 Hz, ArH), 11.1 (s, 1H, OH), 11.7 (s, 1H, OH). 13C NMR (62.90 MHz, CDCl3): 
 = 52.7 (OCH3), 117.8, 118.5, 118.7 (CHAr), 131.8 (CAr), 132.4, 132.9 (CHAr), 135.1, 135.6 (CAr), 
136.1, 136.6 (CHAr), 161.9, 163.6 (CAr), 168.9 (COO), 197.9 (C=O). IR (KBr): ~ = 3117, 3076, 
3040 (w), 1671, 1624 (m), 1582 (s), 1438, 1341, 1291 (m), 1237, 1202 (s), 1164, 1087, 988, 933, 
819, 779 (m), 725, 678 (s), 537 (m) cm-1. GC-MS (EI, 70 eV): m/z (%): 272 (M+, 92), 239 (25), 
212 (06), 196 (02), 184 (11), 147 (38), 128 (04), 121 (96), 120 (100), 92 (20), 79 (07), 65 (13), 53 
(05), 39 (06). HRMS (EI) calcd for C15H12O5 [M+H]: 272.07575, found 273.07625. 
 
Methyl 2,5-(bis(trifluoromethylsulfonyloxy)benzoyl)-benzoate (4): Starting with 3 (120 mg, 
0.44 mmol), pyridine (0.14 ml, 1.76 mmol) and  Tf2O (0.17 ml, 













84 %), mp. = 124-126°C; 1H NMR (300 MHz, CDCl3):  = 3.90 (s, 3H, OCH3), 7.37 (dd, 2H, J = 
2.2, 8.6 Hz, ArH), 7.48 (dd, 1H, J = 0.5, 7.1 Hz, ArH), 7.53 (dd, 1H, J = 2.1, 7.6 Hz, ArH), 7.60-
7.66 (m, 1H, ArH), 8.00 (dd, 1H, J = 2.3, 8.5 Hz, ArH), 8.38 (d, 1H, J = 2.3 Hz, ArH); 13C NMR 
(75.46 MHz, CDCl3):  = 53.0 (OCH3), 120.5 (q, JF,C= 320.0 Hz, CF3), 120.7 (q, JF,C= 320.2, CF3), 
122.8, 123.4 (CHAr), 124.9 (CAr), 128.5, 131.2, 133.7, 134.4, 135.3 (CHAr), 136.4, 146.7, 151.1 
(CAr), 163.2 (COO), 190.1 (C=O); 19F NMR (282 MHz, CDCl3):  = -73.28 (CF); IR (KBr): ~ = 
3117, 3076, 3040 (w), 1671, 1624 (s), 1582 (m), 1479, 1341, 1237 (m), 1202 (s), 1164, 1087, 988 
(m), 866, 793, 703 (s), 589, 537 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 536 (M+, 89), 505 (40), 
467 (06), 403 (09), 375 (23), 311 (100), 247 (61), 211 (20), 183 (30), 155 (34), 120 (29), 92 (16), 
69 (50); HRMS (EI) calcd for C17H10F6O9S2 [M+]: 535.96649, found 535.966638. 
 
Methyl 4'-methyl-4-(4'-methylbiphenylcarbonyl)biphenyl-2-carboxylate (6a): Starting with 4 
(220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd (PPh3)4 
(6 mol%), p-tolylboronic acid (144 mg, 1.06 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 6a was isolated as a colorless 
crystalline solid, yield 145 mg, (84 %) mp. = 114-116°C; 1H 
NMR (300 MHz, CDCl3):  = 2.17 (s, 3H, CH3), 2.30 (s, 3H, 
CH3), 3.56 (s, 3H, OCH3), 6.95 (d, 2H, J = 8.0 Hz, ArH), 7.04-
7.21 (m, 6H, ArH), 7.35-7.53 (m, 5H, ArH), 7.70 (dd, 1H, J = 
2.9, 8.1 Hz, ArH), 7.98 (d, 1H, J = 1.9 Hz, ArH); 13C NMR (62.89 MHz, CDCl3):  = 21.0 (CH3), 
21.2 (CH3), 52.1 (OCH3), 126.9, 127.9, 128.8, 128.9, 129.0 (CHAr), 129.9 (CAr), 130.2, 130.6, 
131.4, 132.1 (CHAr), 135.8, 137.1, 137.2, 137.7, 138.3, 141.3, 146.3 (CAr), 168.4 (COO), 197.4 
(C=O); IR (KBr): ~ = 3080, 3057, 3025 (w), 1724, 1659 (s), 1613 (w), 1595 (m), 1574, 1518 (w), 
1438, 1310, 1277 (m), 1231 (s), 1152, 1082, 972 (m), 819, 704 (s), 536 (m) cm-1; MS (EI, 70 eV): 
m/z (%): 420 (M+, 100), 405 (21), 373 (09), 359 (23), 332 (07), 253 (26), 210 (07), 195 (40), 165 
(39) 152 (25); HRMS (EI) calcd for C29H24O3 [M+]: 420.17200, found 420.171525. 
 
Methyl 4-(biphenylcarbonyl) biphenyl-2-carboxylate (6b): Starting with 4 (220 mg, 0.41 
mmol), K3PO4 (261 mg, 1.23 mmol), Pd (PPh3)4 (6 mol%), 
phenylboronic acid (144 mg, 1.06 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 6b was isolated as a colorless solid, yield 











= 3.51 (s, 3H, OCH3),  7.06-7.19 (m, 8H, ArH), 7.23(s, 1H, ArH), 7.37-7.54 (m, 6H, ArH), 7.69 
(dd, 1H, J = 2.2, 8.4 Hz, ArH), 7.97 (d, 1H, J = 1.9 Hz, ArH); 13C NMR (62.89 MHz, CDCl3):  = 
52.0 (OCH3), 115.3 (CAr), 127.3, 127.4, 127.8, 128.0, 128.1, 128.3, 128.9, 129.0, 130.2, 130.6, 
130.8, 131.5, 132.1 (CHAr), 136.1, 138.3, 140.1, 140.2, 141.3, 146.3 (CAr), 168.2 (COO), 197.3 
(C=O); IR (KBr): ~ = 3056, 3024, 2849 (w), 1721, 1663 (s), 1596 (m), 1556 (w), 1433 (m), 1398 
(w), 1303 (m), 1230 (s), 1151, 1086, 939, 967 (m), 742 (s), 539 (m) cm-1; MS (EI, 70 eV): m/z (%): 
392 (M+, 100), 359 (11), 331 (41), 305 (11), 239 (39), 181 (54), 165 (06), 152 (51) 139 (04); 
HRMS (EI) calcd for C27H20O3 [M+]: 392.14070, found 392.140174. 
 
Methyl 4'-ethyl-4-(4'-ethyl biphenyl carbonyl) biphenyl-2-carboxylate (6c): Starting with 4 
(220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd 
(PPh3)4  (6 mol%), 4-ethylphenyboronic acid (144 mg, 
1.06 mmol) and 1,4-dioxane (5ml/mmol of triflate), 6c was 
isolated as a yellow solid; yield 115 mg, (62 %) mp. = 93-
94°C; 1H NMR (300 MHz, CDCl3):  = 1.06 (t, 3H, J = 7.6 
Hz, CH3ethyl), 1.18 (t, 3H, J = 7.6 Hz, CH3ethyl), 2.47 (q, 2H, 
J = 7.6 Hz, CH2ethyl), 2.62 (q, 2H, J = 7.5 Hz, CH2ethyl), 
3.56 (s, 3H, OCH3),  6.96 (d, 2H, J = 8.1 Hz, ArH), 7.02-712 (m, 4H, ArH), 7.14-7.18 (m, 2H, 
ArH), 7.21 (s, 1H, ArH), 7.37-7.44 (m, 2H, ArH), 7.48-7.54 (m, 2H, ArH), 7.68 (dd, 1H, J = 1.8, 
7.7 Hz, ArH), 7.95 (d, 1H, J = 2.1 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 15.3 (CH3), 15.4 
(CH3), 28.4, 28.5 (2CH2ethyl), 52.0 (OCH3), 127.0, 127.6, 127.8, 128.0, 128.9, 129.0, 130.1, 130.5, 
130.6  (CHAr), 130.7 (CAr), 131.4, 132.0 (CHAr), 135.9, 137.4, 138.3, 141.4, 143.5, 143.9, 146.2, 
147.2 (CAr), 168.4 (COO), 197.5 (C=O); IR (KBr): ~ = 3055, 3021, 2962 (w), 1721, 1663 (s), 1597 
(m), 1552, 1515 (w), 1434, 1303 (m), 1229 (s), 1150, 1085, 939 (m), 829, 760 (s), 584 (m) cm-1; 
GC-MS (EI, 70 eV): m/z (%): 448 (M+, 100), 419 (41), 387 (31), 359 (07), 267 (21), 209 (25), 165 
(29), 152 (16); HRMS (EI) calcd for C31H28O3 [M+]: 448.20330, found 448.202658. 
 
Methyl 3'-chloro-4-(3'-chlorobiphenylcarbonyl)biphenyl-2-carboxylate (6d): Starting with 4 
(220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd (PPh3)4  
(6 mol%), 3-chlorophenylboronic acid (144 mg, 1.06 mmol) 
and 1,4-dioxane (5ml/mmol of triflate), 6d was isolated as 
colorless oil; yield 146 mg, (77 %); 1H NMR (300 MHz, 













7.15-7.20 (m, 4H, ArH), 7.26 (s, 1H, ArH), 7.39-7.45 (m, 2H, ArH), 7.52-7.58 (m, 2H, ArH), 7.73 
(dd, 1H, J = 1.9, 8.1 Hz, ArH), 7.94 (d, 1H, J = 1.9 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 
52.2 (OCH3), 126.3, 127.4, 127.5, 127.9, 128.1, 129.1, 129.2, 129.3, 129.5, 130.1 (CHAr), 130.5 
(CAr), 130.7, 131.1, 131.7, 132.0 (CHAr), 134.0, 134.2, 136.5, 138.1, 140.0, 141.8, 141.9, 145.0 
(CAr), 167.5 (COO), 196.8 (C=O); IR (KBr): ~ = 3059, 3024 (w), 1725, 1663, 1593 (s), 1557 (w), 
1435 (m), 1303, 1231 (s), 1152, 1087 (m), 987 (w), 851 (m), 786 (s), 538 (m) cm-1; GC-MS (EI, 70 
eV): m/z (%): 461 (M-, 47), 460 (97), 429 (18), 399 (70), 365 (12), 338 (10), 302 (09), 273 (74), 
215 (88) 197 (36), 165 (28), 152 (100); HRMS (EI) calcd for C27H18O3Cl2 [M+]: 460.06275, found 
460.062304. 
 
Methyl 4'-vinyl-4-(4'-vinylbiphenylcarbonyl)biphenyl-2-carboxylate (6e): Starting with 4 (220 
mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd (PPh3)4 (6 
mol%), 4-vinylphenylboronic acid (144 mg, 1.06 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 6e was isolated as a yellow 
solid; yield 132 mg, (72 %) mp. = 89-90°C; 1H NMR (300 
MHz, CDCl3):  = 3.55 (s, 3H, OCH3), 5.16 (ddd, 2H, J = 0.8, 
10.8, 24.2 Hz, CH2vinyl), 5.65 (ddd, 2H, J = 0.8, 17.5, 33.0 Hz, 
CH2vinyl), 6.59 (ddd, 2H, J = 10.9, 17.6, 28.5 Hz, 2CHvinyl), 
7.00-7.12 (m, 4H, ArH), 7.14-7.18 (m, 2H, ArH), 7.21 (s, 1H, ArH), 7.34 (d, 2H, J = 8.1 Hz, ArH), 
7.40-7.50 (m, 4H, ArH), 7.71 (dd, 1H, J = 1.8, 8.0 Hz, ArH), 7.99 (d, 1H, J = 1.6 Hz, ArH); 13C 
NMR (75.46 MHz, CDCl3):  = 52.1 (OCH3), 114.2, 114.4, (2CH2vinyl), 126.0, 126.2, 127.3, 128.3, 
128.9, 129.2, 130.1, 130.6, 130.8, 131.6, 132.2, 136.2, 136.3 (CHAr), 136.7, 137.1, 138.2, 139.5, 
139.6, 141.0, 146.1 (CAr), 168.2 (COO), 197.3 (C=O); IR (KBr): ~ = 3435, 3057, 3021, 2948 (w), 
1721, 1663 (s), 1597 (m), 1548, 1514 (w), 1435, 1305 (m), 1230 (s), 1151, 1085, 939 (m), 838, 768 
(s), 539 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 444 (M+, 100), 417 (05), 383 (08), 356 (04), 265 








Methyl 4'-chloro-4-(4'-chlorobiphenylcarbonyl)biphenyl-2-carboxylate (6f): Starting with 4 
(220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd (PPh3)4  
(6 mol%), 4-chlorophenylboronic acid (144 mg, 1.06 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 6f was isolated as a colorless 
solid; yield 122 mg, (64 %) mp. = 49-50°C; 1H NMR (300 MHz, 
CDCl3):  = 3.56 (s, 3H, OCH3), 7.11 (s, 5H, ArH), 7.20 (d, 1H, 
J = 8.4 Hz, ArH), 7.30 (d, 2H, J = 8.6 Hz, ArH), 7.38-7.50 (m, 
5H, ArH), 7.72 (dd, 1H, J = 1.8, 8.0 Hz, ArH), 7.98 (d, 1H, J = 
1.8 Hz, ArH); 13C NMR (62.89 MHz, CDCl3):  = 52.2 (OCH3), 127.6, 128.3, 128.5, 129.0, 129.4, 
130.1, 130.3 (CHAr), 130.5 (CAr), 130.8, 130.9, 131.7, 132.2 (CHAr), 133.7, 134.1, 136.2, 138.1, 
138.6, 140.1, 145.5 (CAr), 167.7 (COO), 196.9 (C=O); IR (KBr): ~ = 3058, 3027, 2949 (w), 1724, 
1663 (s), 1599 (m), 1573, 1554 (w), 1472 (m), 1394 (w), 1230 (s), 1190 (w), 1152 (m), 1087 (s), 
939 (m), 826 (s), 778, 535 (m) cm-1; GC-MS (70 eV): m/z (%): 460 (M+), 461 (46), 460 (100), 429 
(15), 401 (30), 372 (07), 273 (67), 215 (69), 197 (31), 180 (10) 165 (21), 152 (82); HRMS (EI) 
calcd for C27H18O3Cl2 [M+]: 460.06275, found 460.062308. 
 
Methyl 4'-bromo-4-(4'-bromobiphenylcarbonyl)biphenyl-2-carboxylate (6g): Starting with 4 
(220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd (PPh3)4  
(6 mol%), 4.bromophenylboronic acid (144 mg, 1.06 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 6g was isolated as a yellow 
solid; yield 168 mg, (74 %) mp. = 49-51°C; 1H NMR (300 MHz, 
CDCl3):  = 3.6 (s, 3H, OCH3),  7.12 (d, 4H, J = 5.9 Hz, ArH), 
7.43 (d, 4H, J = 6.1 Hz, ArH), 7.40 (s, 1H, ArH), 7.50-7.80 (m, 
4H, ArH), 7.91 (dd, 1H, J = 2.0, 5.9 Hz, ArH), 8.19 (d, 1H, J = 
1.7 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 52.3 (OCH3), 122.7, 123.2, 126.7, 127.3, 128.2, 
129.8, 130.2, 131.9, 132.5, 133.0, 133.7 (CHAr), 139.0, 139.3, 139.6, 146.3, 146.8, 147.0, 167.6 
(CAr), 167.9, (COO), 191.3 (C=O); IR (KBr): ~ = 3063, 3031, 2951 (w), 1727, 1669 (s), 1477 (m), 
1422 (s), 1307 (m), 1205 (s), 1167 (w), 1134 (m), 1086 (s), 944 (m), 884 (s), 781, 569 (m) cm-1; 
MS (70 eV): m/z (%): 550 (M+, 100), 513 (16), 410 (07), 379 (16), 319 (37), 298 (25), 215 (13), 















Methyl 4-(3',4'-dimethoxybiphenylcarbonyl)-3',4'-dimethoxybiphenyl-2-carboxylate (6h): 
Starting with 4 (220 mg, 0.41 mmol), K3PO4 (261 
mg, 1.23 mmol), Pd (PPh3)4 (6 mol%), 3,4-
dimethoxyphenylboronic acid (144 mg, 1.06 mmol) 
and 1,4-dioxane (5ml/mmol of triflate), 6h was 
isolated as a yellow solid; yield 132 mg, (62 %) mp. 
= 65-67°C; 1H NMR (300 MHz, CDCl3):  = 3.54 (s, 
3H, OCH3), 3.70 (s, 6H, 2OCH3), 3.80 (s, 3H, 
OCH3), 3.83 (s, 3H, OCH3), 6.63 (d, 1H, J = 9.0 Hz, 
ArH), 6.69-6.72 (m, 2H, ArH), 6.73 (d, 2H, J = 2.7 Hz, ArH), 6.80 (d, 1H, J = 7.7 Hz, ArH), 7.19 
(d, 2H, J = 2.2 Hz, ArH), 7.22 (s, 1H, ArH), 7.36-7.46 (m, 3H, ArH), 7.69 (dd, 1H, J = 2.2, 8.2 Hz, 
ArH), 7.86 (d, 1H, J = 1.8 Hz, ArH); 13C NMR (62.89 MHz, CDCl3):  = 52.1, 55.7, 55.8, 55.8, 
55.9 (5OCH3), 110.8, 111.0, 111.4, 112.3, 120.6, 121.6, 127.1, 128.6, 129.8, 130.4, 130.6 (CHAr), 
130.8 (CAr), 131.2, 131.6, (CHAr), 132.6, 132.8, 135.6, 138.4, 140.7, 145.7, 148.4, 148.6, 148.7, 
148.9 (CAr), 168.7 (COO), 197.7 (C=O); IR (KBr): ~ = 3057, 2998, 2950 (w), 1720 (m), 1662 (s), 
1569 (w), 1518 (s), 1480 (m), 1437 (s), 1325 (m), 1243, 1214, 1171 (s), 1086, 941 (m), 881, 850, 
756, 699 (s), 597 (m) cm-1; MS (EI, 70 eV): m/z (%): 512 (M+, 100), 496 (04), 465 (02), 299 (03), 
241 (09), 210 (04), 167 (01), 126 (02) 91 (01), 43 (05); HRMS (EI) calcd for C31H28O7 [M+]: 
512.18295, found 512.183285. 
 
Methyl 4'-hydroxy-4-(4'-hydroxybiphenylcarbonyl)biphenyl-2-carboxylate (6i): Starting with 
4 (220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd 
(PPh3)4  (6 mol%), 4-hydroxyphenylboronic acid (144 mg, 1.06 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 6i was isolated 
as a yellow solid; yield 114 mg, (65 %) mp. = 77-79°C; 1H 
NMR (300 MHz, CDCl3):  = 3.64 (s, 3H, OCH3),  6.52 (s, 1H, 
OH), 6.55 (s, 1H, OH), 6.66 (d, 2H, J = 7.9 Hz, ArH), 6.97-
7.02 (m, 4H, ArH), 7.15 (s, 1H, ArH), 7.19 (d, 1H, J = 2.2 Hz, 
ArH), 7.39-7.41 (m, 3H, ArH), 7.48-7.51 (m, 2H, ArH), 7.66 (dd, 1H, J = 1.8, 8.0 Hz, ArH), 7.90 
(d, 1H, J = 1.7 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 52.5 (OCH3), 115.4, 115.5, 126.8, 
129.1, 129.5, 130.1, 130.4, 130.7, 131.0, 131.4 (CHAr), 131.7, 132.2 (CAr), 132.3 (CHAr), 135.5, 
137.9, 141.3, 146.2, 155.6, 156.1 (CAr), 169.5 (COO), 198.4 (C=O); IR (KBr): ~ = 3352, 3060, 















(m), 1087 (s), 941 (m), 832 (s), 761, 660, 539 (m) cm-1; GC-MS (70 eV): m/z (%): 424 (M+, 96), 
392 (100), 372 (24), 255 (18), 223 (35), 212 (16), 197 (58), 168 (14), 139 (23) 115 (13), 89 (02); 
HRMS (EI) calcd for C27H20O5 [M+]: 424.13053, found 424.130645. 
 
Methyl 3',4',5'-trimethoxy-4-(3',4',5'-trimethoxy biphenyl carbonyl) biphenyl-2-carboxylate 
(6j): Starting with 4 (220 mg, 0.41 mmol), K3PO4 
(261 mg, 1.23 mmol), Pd (PPh3)4 (6 mol%), 4-
hydroxyphenylboronic acid (144 mg, 1.06 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 6i was isolated as 
a yellow solid; yield 136 mg, (58 %) mp. = 58-60°C; 
1H NMR (300 MHz, CDCl3):  = 3.52 (s, 3H, OCH3), 
3.62 (s, 3H, OCH3), 3.69 (s, 6H, 2OCH3), 3.78 (s, 6H, 
2OCH3), 3.81 (s, 3H, OCH3), 6.35 (s, 2H, ArH), 6.39 
(s, 2H, ArH), 7.21 (dd, 1H, J = 1.1, 7.4 Hz, ArH), 7.42-7.47 (m, 2H, ArH), 7.52-7.56 (m, 2H, 
ArH), 7.71 (d, 2H, J = 1.0 Hz, ArH); 13C NMR (62.89 MHz, CDCl3):  = 52.1 (OCH3), 55.9 
(2OCH3), 56.1 (2OCH3), 60.6 (OCH3), 60.9 (OCH3), 105.2, 106.7, 127.6, 128.8, 129.4, 130.1, 
130.8 (CHAr), 130.9 (CAr), 131.0, 131.1 (CHAr), 135.6, 135.8, 136.0, 137.3, 137.8, 138.4, 141.1, 
145.6, 152.9, 153.0 (CAr), 168.7, (COO), 197.8 (C=O); IR (KBr): ~ = 3057, 2921, 2851 (w), 1722 
(m), 1661 (s), 1583 (w), 1563 (s), 1461 (m), 1432 (s), 1377 (m), 1343, 1292, 1236, 1171 (s), 1067, 
942 (m), 884, 875, 765 , 679 (s), 532 (m) cm-1; MS (EI, 70 eV): m/z (%): 572 (M+, 100), 556 (08), 
525 (03), 286 (07), 240 (02), 197 (01), 127 (01), 69 (03); HRMS (EI) calcd for C33H32O9 [M+]: 
572.20408, found 572.204330. 
 
Methyl 4'-fluoro-4-(4'-fluorobiphenyl carbonyl)biphenyl-2-carboxylate (6k): Starting with 4 
(220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd (PPh3)4  
(3 mol%), 4-flourophenylboronic acid (144 mg, 1.06 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 6k was isolated as a yellow 
oil; yield 110 mg, (62 %); 1H NMR (300 MHz, CDCl3):  = 3.55 
(s, 3H, OCH3),  6.82 (t, 2H, J = 8.7 Hz, ArH), 6.9 (t, 2H, J = 8.6 
Hz, ArH), 7.10-7.17 (m, 4H, ArH), 7.20 (s, 1H, ArH), 7.38-7.50 
(m, 4H, ArH), 7.70 (dd, 1H, J = 2.2, 8.3 Hz, ArH), 7.96 (d, 1H, J 
= 1.9 Hz, ArH); 13C NMR (62.89 MHz, CDCl3):  = 52.1 (OCH3), 115.0 (d, 3JC,F = 7.5 Hz, CHAr), 

















4.4 Hz, CHAr), 131.6, 132.0 (CHAr), 136.1 (d, 4JC,F = 3.7 Hz, CF), 136.2, 138.2, 140.1, 145.5, 160.4 
(d, JC,F = 20.1 Hz, CF), 164.3 (d, JC,F = 21.1 Hz, CF), 167.9 (COO), 197.1 (C=O); 19F NMR (282 
MHz, CDCl3):  = -73.34 (CF); IR (KBr): ~ = 3062, 2950 (w), 1722, 1664 (s), 1557 (w), 1476, 
1394, 1305, 1220 (m), 1154, 1085, 987 (m), 833, 760 (s), 657, 547 (m) cm-1; GC-MS (EI, 70 eV): 
m/z (%): 428 (M+, 100), 395 (09), 367 (30), 340 (10), 257 (51), 214 (10), 199 (59), 170 (47), 120 
(02) 59 (02); HRMS (EI) calcd for C27H18O3F2 [M+]: 428.12185, found 428.121344. 
 
Methyl 3'-hydroxy-4-(3'-hydroxybiphenylcarbonyl)biphenyl-2-carboxylate (6l): Starting with 
4 (220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd 
(PPh3)4  (6 mol%), 3-hydroxyphenylboronic acid (144 mg, 
1.06 mmol) and 1,4-dioxane (5ml/mmol of triflate), 6l was 
isolated as a colorless solid; yield 114 mg, (65 %) mp. = 48-
49°C; 1H NMR (300 MHz, CDCl3):  = 3.63 (s, 3H, OCH3), 
6.75-6.88 (m, 5H, ArH), 7.02 (dd, 1H, J = 1.1, 8.5 Hz, ArH), 
7.22 (d, 2H, J = 7.6 Hz, ArH), 7.42-7.48 (m, 3H, ArH), 7.54 
(dd, 2H, J = 1.5, 8.0 Hz, ArH), 7.75 (dd, 1H, J = 2.1, 7.7 Hz, ArH), 8.02 (d, 1H, J = 1.8 Hz, ArH), 
11.84 (s, 2H, OH); 13C NMR (62.89 MHz, CDCl3):  = 52.4, (OCH3), 115.0, 115.2, 116.2, 117.1, 
118.5, 118.9, 119.2, 120.6, 129.5, 130.7, 131.1, 131.6, 132.2, 133.3, 136.7, (CHAr), 141.5, 142.2, 
143.4, 144.2, 145.3, 147.2, 149.1, 155.6, 163.2 (CAr), 168.3 (COO), 197.5 (C=O). IR (KBr): ~ = 
3071, 3048, 2962, 2839, 2831 (w), 1721, 1662 (s), 1593, 1582 (m), 1478, 1452 (m), 1391, 1343, 
1301 (m), 1281, 1235, 1168 (s), 1092, 941 (s), 892, 863, 774 , 694 (s), 591, 572, 530 (m) cm-1; MS 
(EI, 70 eV): m/z (%): 424 (M+, 50), 410 (20), 390 (36), 380 (45), 341 (17), 312 (38), 285 (23), 249 
(80), 221 (11), 134 (13), 110 (100), 91 (13), 64 (19); HRMS (EI) calcd for C27H20O5 [M+]: 
424.03841, found 424.045844. 
 
Methyl 4'-(trifluoromethyl)-4-(4'-(trifluoromethyl) biphenylcarbonyl) biphenyl-2-carboxylate 
(6m): Starting with 4 (220 mg, 0.41 mmol), K3PO4 (261 mg, 
1.23 mmol), Pd (PPh3)4 (6 mol%), 4-
(trifluoromethyl)phenylboronic acid (144 mg, 1.06 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 6m was isolated as 
colorless oil; yield 165 mg, (76 %); 1H NMR (300 MHz, 
CDCl3):  = 3.55 (s, 3H, OCH3),  7.18-7-28 (m, 4H, ArH), 













ArH), 7.54-7.58 (m, 3H, ArH), 7.74 (dd, 1H, J = 1.8, 8.0 Hz, ArH), 8.02 (d, 1H, J = 1.8 Hz, ArH); 
13C NMR (75.46 MHz, CDCl3):  = 52.2 (OCH3), 125.0 (q, 4JF,C=  3.6 Hz, CHAr), 125.2 (q, 4JF,C=  
3.9 Hz, CHAr), 128.1, 128.4, 129.3, 129.4 (CHAr), 129.8 (CAr), 130.2 (CHAr), 130.4 (CAr), 130.8, 
131.2, 131.8, 132.2 (CHAr), 136.7, 138.1, 140.1, 143.7, 143.9, 145.4, 146.2 (CAr), 167.7 (COO), 
196.6 (C=O); 19F NMR (282 MHz, CDCl3):  = -73.30 (CF); IR (KBr): ~ = 3063, 2953, 2855 (w), 
1727, 1666 (s), 1600 (w), 1437, 1321, 1233 (m), 1161, 1066, 940 (m), 838, 785, 705, (s), 671, 607, 
539 (m) cm-1; MS (EI, 70 eV): m/z (%): 528 (M+, 10), 291 (17), 290 (100), 271 (23), 240 (12), 201 
(16), 162 (14), 97 (12), 84 (73) 71 (16), 57 (29); HRMS (EI) calcd for C29H18O3F6 [M+]: 
528.11547, found 528.114737. 
 
Methyl 4-(2',5'-dimethoxy biphenylcarbonyl)-2',5'-dimethoxy biphenyl-2-carboxylate (6n): 
Starting with 4 (220 mg, 0.41 mmol), K3PO4 (261 
mg, 1.23 mmol), Pd(PPh3)4 (6 mol%), 2,5-
dimethoxyphenylboronic acid (144 mg, 1.06 mmol) 
and 1,4-dioxane (5ml/mmol of triflate), 6n was 
isolated as a colorless solid; yield 140 mg, (67 %) 
mp. = 50-52°C; 1H NMR (300 MHz, CDCl3):  = 
3.27 (s, 3H, OCH3), 3.55 (s, 3H, OCH3), 3.57 (s, 3H, OCH3), 3.67 (s, 3H, OCH3), 3.72 (s, 3H, 
OCH3), 6.50 (d, 1H, J = 8.9 Hz, ArH), 6.63 (dd, 1H, J = 3.6, 8.8 Hz, ArH), 6.71-6.74 (m, 2H, 
ArH), 6.78 (dd, 2H, J = 2.6, 7.7 Hz, ArH), 7.23 (d, 1H, J = 7.9 Hz, ArH), 7.37 (dd, 2H, J = 3.1, 7.3 
Hz, ArH), 7.46-7.52 (m, 2H, ArH), 7.83 (dd, 1H, J = 1.8, 7.9 Hz, ArH), 8.08 (d, 1H, J = 1.7 Hz, 
ArH); 13C NMR (75.47 MHz, CDCl3):  = 51.8 (OCH3), 54.8 (OCH3), 55.7 (2OCH3), 55.8 
(OCH3), 111.1, 111.5, 113.5, 113.8, 116.0, 116.8, 127.0, 128.7, 130.9, 131.0, 131.1, 131.2, 132.5, 
(CHAr), 136.1, 137.8, 138.5, 142.3, 149.5, 150.2, 153.6, 153.7, 153.8, 156.0, 158.8 (CAr), 167.8 
(COO), 195.7 (C=O). IR (KBr): ~ = 3070, 3050, 2970, 2842, 2832 (w), 1721, 1662 (s), 1594, 1582 
(m), 1475, 1452 (m), 1391, 1341, 1301 (m), 1281, 1233, 1164 (s), 1091, 940 (s), 891, 862, 773 , 
691 (s), 592, 574, 530 (m) cm-1; MS (EI, 70 eV): m/z (%): 512 (M+, 40), 448 (19), 409 (31), 385 
(04), 340 (15), 323 (33), 288 (20), 250 (81), 195 (01), 182 (38), 167 (40), 151 (10), 138 (25), 123 
(36), 94 (68), 84 (100), 65 (10), 47 (21), 43 (44); HRMS (EI) calcd for C31H29O7 [M+H] +: 










Methyl 2'-methoxy-4-(2'-methoxybiphenylcarbonyl)biphenyl-2-carboxylate (6o): Starting with 
4 (220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd 
(PPh3)4  (6 mol%), 2-methoxyphenylboronic acid (144 mg, 
1.06 mmol) and 1,4-dioxane (5ml/mmol of triflate), 6o was 
isolated as a colorless solid; yield 128 mg, (69 %) mp. = 
139-140°C; 1H NMR (300 MHz, CDCl3):  = 3.32 (s, 3H, 
OCH3), 3.56 (s, 3H, OCH3), 3.61 (s, 3H, OCH3), 6.58 (d, 
1H, J = 7.2 Hz, ArH), 6.80-6.89 (m, 3H, ArH), 6.92-6.98 (m, 2H, ArH), 7.08-7.14 (m, 2H, ArH), 
7.16 (s, 1H, ArH), 7.20-7.30 (m, 2H, ArH), 7.37 (dd, 1H, J = 3.0, 7.7 Hz, ArH), 7.46-7.52 (m, 1H, 
ArH), 7.82 (dd, 1H, J = 2.0, 8.4 Hz, ArH), 8.10 (d, 1H, J = 1.86 Hz, ArH); 13C NMR (62.90 MHz, 
CDCl3):  = 51.8 (OCH3), 54.4 (OCH3), 55.2, (OCH3), 109.9, 110.1, 110.3, 126.8, 128.6, 129.1, 
129.4, 129.7, 130.8, 131.0, 131.1, 131.2, 132.5, 132.8 (CHAr), 135.1 (CAr), 136.8 (CHAr), 138.0, 
138.5, 142.6, 144.2, 146.8, 155.2, 155.9, 164.5 (CAr), 167.9 (COO), 195.8 (C=O). IR (KBr): ~ = 
3072, 3049, 2968, 2842, 2832 (w), 1719, 1664 (s), 1593, 1581 (m), 1475, 1452 (m), 1389, 1341, 
1301 (m), 1281, 1231, 1164 (s), 1092, 941 (s), 891, 864, 779 , 693 (s), 591, 573, 538 (m) cm-1; MS 
(EI, 70 eV): m/z (%): 452 (M+, 12), 421 (100), 405 (01), 375 (01), 347 (08), 269 (03), 195 (09), 168 
(05), 139 (05); HRMS (EI) calcd for C29H24O5 [M+]: 452.16183, found 452.161882. 
 
Methyl 2'-methoxy-4-(2'-methoxybiphenylcarbonyl)biphenyl-2-carboxylate (6p): Starting with 
4 (220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd 
(PPh3)4 (6 mol%), 4-tert-butylphenylboronic acid (144 mg, 
1.06 mmol) and 1,4-dioxane (5ml/mmol of triflate), 6p was 
isolated as a colorless solid; yield 150 mg, (72 %) mp. = 131-
133°C; 1H NMR (300 MHz, CDCl3):  = 1.13 (s, 9H, 3CH3), 
1.26 (s, 9H, 3CH3), 3.53 (s, 3H, OCH3), 7.06 (d, 2H, J = 8.6 
Hz, ArH), 7.10 (d, 2H, J = 4.2 Hz, ArH), 7.14 (s, 1H, ArH), 
7.16 (d, 1H, J = 2.0 Hz, ArH), 7.30 (d, 2H, J = 8.8 Hz, ArH), 
7.38-7.44 (m, 3H, ArH), 7.48-7.53 (m, 2H, ArH), 7.63 (dd, 1H, J = 1.9, 8.1 Hz, ArH), 7.89 (d, 1H, 
J = 1.8 Hz, ArH); 13C NMR (75.47 MHz, CDCl3):  = 31.3 (6CH3), 34.6 (2CtBu), 52.0 (OCH3), 
125.1, 125.2 (CHAr), 126.3 (CAr), 127.0, 127.8, 128.9, 129.0, 130.0, 130.4 (CHAr), 130.6 (CAr), 
130.8, 131.3, 131.9 (CHAr), 136.1, 137.2, 138.4, 141.4, 145.9, 150.4, 150.8 (CAr), 168.5 (COO), 
197.7 (C=O). IR (KBr): ~ = 3068, 3049, 2969, 2842, 2829 (w), 1721, 1663 (s), 1592, 1581 (m), 










590, 572, 533 (m) cm-1; MS (EI, 70 eV): m/z (%): 504 (M+, 100), 490 (32), 489 (89), 457 (42), 447 
(14), 401 (12), 359 (01), 295 (03), 252 (02), 237 (39), 181 (24), 152 (09), 126 (03), 57 (24), 41 
(10); HRMS (EI) calcd for C35H36O3 [M+]: 504.26590, found 504.265979. 
 
Methyl 4-(3',5'-dimethylbiphenylcarbonyl)-3',5'-dimethylbiphenyl-2-carboxylate (6q): 
Starting with 4 (220 mg, 0.41 mmol), K3PO4 (261 mg, 
1.23 mmol), Pd(PPh3)4 (6 mol%), 3,5-
dimethylphenylboronic acid (144 mg, 1.06 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 6q was isolated as a 
colorless solid; yield 144 mg, (78 %) mp. = 109-111°C; 
1H NMR (300 MHz, CDCl3):  = 2.11 (s, 6H, 2CH3), 
2.26 (s, 6H, 2CH3), 3.55 (s, 3H, OCH3), 6.69 (s, 1H, 
ArH), 6.77 (d, 2H, J = 3.0 Hz, ArH), 6.92 (s, 1H, ArH), 7.16 (s, 1H, ArH), 7.19 (d, 1H, J = 2.8 Hz, 
ArH), 7.40 (d, 1H, J = 1.9 Hz, ArH), 7.42 (s, 2H, ArH), 7.49-7.54 (m, 2H, ArH), 7.66 (dd, 1H, J = 
1.9, 7.8 Hz, ArH), 7.84 (d, 1H, J = 2.7 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 21.0 (2CH3), 
21.2 (2CH3), 52.0 (OCH3), 125.8, 127.1, 128.9, 129.0, 129.5, 129.9, 130.3, 130.7, 131.1, 131.5 
(CHAr), 136.1, 137.6, 137.7, 138.3, 139.9, 140.1, 141.7, 146.1 (CAr), 168.5 (COO), 197.6 (C=O). 
IR (KBr): ~ = 3068, 3048, 2969, 2837, 2821 (w), 1721, 1659 (s), 1593, 1579 (m), 1481, 1461 (m), 
1389, 1331, 1301 (m), 1282, 1239, 1164 (s), 1090, 941 (s), 893, 863, 776 , 691 (s), 593, 575, 530 
(m) cm-1; MS (EI, 70 eV): m/z (%): 448 (M+, 87), 433 (100), 401 (32), 387 (17), 267 (12), 209 
(37), 179 (19), 165 (36), 115 (01), 77 (01); HRMS (EI) calcd for C31H28O3 [M+]: 448.20330, found 
448.202841. 
 
Methyl 3'-bromo-4-(3'-bromobiphenylcarbonyl)biphenyl-2-carboxylate (6r): Starting with 4 
(220 mg, 0.41 mmol), K3PO4 (261 mg, 1.23 mmol), Pd (PPh3)4  
(6 mol%), 3-bromophenylboronic acid (144 mg, 1.06 mmol) 
and 1,4-dioxane (5ml/mmol of triflate), 6r was isolated as 
colorless oil; yield 144 mg, (64 %); 1H NMR (300 MHz, 
CDCl3):  = 3.57 (s, 3H, OCH3),  6.80 (d, 2H, J = 7.1 Hz, 
ArH), 6.90 (t, 2H, J = 6.2 Hz, ArH), 7.06 (d, 2H, J = 5.1 Hz, 
ArH), 7.26 (s, 1H, ArH), 7.39-7.58 (m, 6H, ArH), 7.73 (dd, 
1H, J = 2.5, 8.3 Hz, ArH), 7.94 (d, 1H, J = 1.9 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 52.2 














(CHAr), 134.0, 135.2, 136.5, 137.1, 138.1, 139.9, 141.8, 141.9, 145.0 (CAr), 167.5 (COO), 196.8 
(C=O); IR (KBr): ~ = 3059, 3024 (w), 1725, 1663, 1593 (s), 1557 (w), 1435 (m), 1303, 1231 (s), 
1152, 1087 (m), 987 (w), 851 (m), 786 (s), 538 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 550 (M+, 
47), 510 (46), 489 (48), 456 (21), 461 (92), 427 (16), 398 (72), 362 (10), 336 (12), 302 (09), 271 
(72), 212 (86) 195 (32), 162 (26), 150 (100), 120 (45), 102 (36), 89 (42), 62 (46), 48 (28); HRMS 
(EI) calcd for C27H18O3Br2 [M+]: 550.24062, found 550.230120. 
 
Methyl 3',5'-dimethyl-4-(2-(trifluoromethyl sulfonyloxy) benzoyl) biphenyl-2-carboxylate 
(7a): Starting with 4 (150 mg, 0.27 mmol), K3PO4 (171 mg, 
0.81 mmol), Pd (PPh3)4  (3 mol%), 3,5-dimethylphenylboronic 
acid (140 mg, 0.70 mmol) and  1,4-dioxane (5ml/mmol of 
triflate), 7ª was isolated as colorless oil; yield 120 mg, (78 %); 
1H NMR (300 MHz, CDCl3):  = 2.28 (s, 6H, 2CH3), 3.58 (s, 
3H, OCH3),  6.88 (s, 2H, ArH), 6.96 (s, 1H, ArH), 7.36 (s, 1H, 
ArH), 7.47-7.61 (m, 4H, ArH), 7.89 (dd, 1H, J = 2.1, 8.3 Hz, ArH), 8.11 (d, 1H, J = 2.4 Hz, ArH); 
13C NMR (62.90 MHz, CDCl3):  = 21.2 (2CH3), 52.2 (OCH3), 110.8 (C), 121.0 (q, JF,C= 320.7 
Hz, CF3), 122.6, 125.9, 128.1, 129.8, 131.0, 131.1, 131.3 (CHAr), 131.5, 132.0 (CAr), 132.2, 132.9 
(CHAr), 135.0, 137.1, 139.8, 146.8, 147.6 (CAr), 168.4 (COO), 191.4 (C=O) 19F NMR (282 MHz, 
CDCl3):  = -73.34 (CF); IR (KBr): ~ = 3065, 3004, 2950 (w), 1724 (m), 1669 (s), 1560 (w), 1422 
(s), 1308 (m), 1245, 1205, 1135 (s), 1092, 944 (m), 886, 855, 593 (s) cm-1; MS (EI, 70 eV): m/z 
(%): 492 (M+, 100), 461 (19), 359 (03), 327 (31), 300 (14), 267 (19), 255 (07), 209 (03) 165 (09); 
HRMS (EI) calcd for C24H19O6F3S [M+]: 492.08490, found 492.084987. 
 
Methyl 4'-chloro-4-(2-(trifluoromethylsulfonyloxy)benzoyl)biphenyl-2-carboxylate (7b): 
Starting with 4 (150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 
mmol), Pd(PPh3)4 (3 mol%), 4-chlorophenylboronic acid (140 
mg, 0.70 mmol) and 1,4-dioxane (5ml/mmol of triflate), 7b was 
isolated as a yellow solid; yield 90 mg, (64 %) mp. = 99-100°C; 
1H NMR (300 MHz, CDCl3):  = 3.61 (s, 3H, OCH3), 7.21 (d, 
2H, J = 8.5 Hz, ArH), 7.32 (s, 1H, ArH), 7.35-7.42 (m, 3H, ArH), 7.48 (dd, 1H, J = 1.0, 7.3 Hz, 
ArH), 7.53-7.63 (m, 2H, ArH), 7.90 (dd, 1H, J = 1.9, 8.0 Hz, ArH), 8.20 (d, 1H, J = 1.8 Hz, ArH); 
13C NMR (75.46 MHz, CDCl3):  = 52.3 (OCH3), 116.3 (CAr), 120.5 (q, JF,C= 321.1, CF3), 122.7, 












138.5, 146.3, 146.8 (CAr), 167.6 (COO), 191.3 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.29 
(CF); IR (KBr): ~ = 3066, 3033, 2952 (w), 1727, 1670 (s), 1603 (m), 1573, 1554 (w), 1475, 1308 
(m), 1245, 1134, 1084 (s), 1040 (w), 944 (m), 827, 767, 592 (s) cm-1; GC-MS (70 eV): m/z (%): 
498 (M+, 100), 467 (30), 333 (26), 306 (14), 273 (32), 253 (07), 215 (06), 151 (07), 69 (06); HRMS 
(EI) calcd for C22H14O6ClF3S [M+]: 498.01462, found 498.014917. 
 
Methyl 2'-ethoxy-4-(2-(trifluoromethylsulfonyloxy)benzoyl)biphenyl-2-carboxylate (7c): 
Starting with 4 (150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 mmol), 
Pd(PPh3)4 (3 mol%), 2-methoxyphenylboronic acid (140 mg, 0.70 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 7c was isolated as 
yellow oil; yield 117 mg (82 %); 1H NMR (300 MHz, CDCl3):  = 
1.32 (t, 3H, J = 3.1 Hz, CH3), 3.89 (s, 1H,  OCH3), 4.05 (q, 2H, J = 
4.1 Hz, OCH2), 6.82 (s, 1H, ArH), 6.90-7.76 (m, 8H, ArH), 7.91 (dd, 1H, J = 1.8, 8.1 Hz, ArH), 
8.21 (d, 1H, J = 1.8 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 14.8 (CH3), 51.8 (OCH3), 63.9 
(OCH2), 111.2 (CH), 120.8 (q, JF,C= 320.1, CF3), 122.6, 128.2, 129.6, 129.7, 131.1, 131.3, 131.8, 
132.6, 132.9, 133.0 (CHAr), 135.0, 136.8, 137.5, 144.5, 146.8, 155.3, 163.9 (CAr), 167.6 (COO), 
191.6 (C=O); 19F NMR (282 MHz, CDCl3):  = -73.34 (CF); IR (KBr): ~ = 3497, 3067, 3032 (w), 
1725, 1669 (s), 1599 (m), 1575, 1500 (w), 1445, 1309, 1282 (m), 1245, 1206 (s), 1083, 945 (m), 
884, 751 (s), 569 (m) cm-1; MS (EI, 70 eV): m/z (%): 508 (M+ 100), 477 (04), 463 (38), 448 (64), 
415 (38), 315 (78), 287 (18), 271 (42), 253 (18) 223 (46), 139 (28), 121 (14), 69 (10); HRMS (EI) 
calcd for C24H19F3O7S [M+]: 508.07981, found 508.079693. 
 
Methyl 2'-bromo-4-(2-(trifluoromethylsulfonyloxy)benzoyl)biphenyl-2-carboxylate (7d): 
Starting with 4 (150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 mmol), 
Pd (PPh3)4 (3 mol%), 2-bromophenylboronic acid (140 mg, 0.70 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 7d was isolated as a 
colorless solid; yield 118 mg, (78 %) mp. = 124-126°C; 1H NMR 
(300 MHz, CDCl3):  = 3.58 (s, 3H, OCH3), 7.13 (s, 1H, ArH), 
7.28-7.40 (m, 4H, ArH), 7.48-7.62 (m, 4H, ArH), 7.94 (dd, 1H, J = 2.1, 8.1 Hz, ArH), 8.36 (d, 1H, 
J = 2.1 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 52.3 (OCH3), 122.7 (q, JF,C= 321.4, CF3), 
127.1, 128.3, 129.2, 129.7, 129.8, 130.2, 131.3, 131.8, 132.3, 132.9, 133.2, (CHAr), 134.9, 135.0, 
136.0, 141.5, 146.7, 146.8, 147.2 (CAr), 166.2 (COO), 191.4 (C=O). 19F NMR (282 MHz, CDCl3): 











1294 (m), 1241, 1203 (s), 1168 (m), 1087 (s), 948 (m), 887, 769, 592 (s) cm-1; MS (EI, 70 eV): m/z 
(%): 543 (M+, 100), 489 (19), 462 (21), 402 (13), 389 (29), 347 (31), 331 (12), 301 (48), 271 (24), 
242 (75), 215 (7), 183 (5), 151 (11), 69 (15); HRMS (EI) calcd for C22H14BrF3O6S [M+]: 543.9647, 
found 543.171525. 
 
Methyl 3',4'-dimethoxy-4-(2-(trifluoromethyl sulfonyloxy) benzoyl) biphenyl-2-carboxylate 
(7e): Starting with 4 (150 mg, 0.27 mmol), K3PO4 (171 mg, 
0.81 mmol), Pd(PPh3)4  (3 mol%), 3,4-
dimethoxyphenylboronic acid (140 mg, 0.70 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 7e was isolated as a yellow 
solid; yield 97 mg, (68 %) mp. = 48-49°C; 1H NMR (300 
MHz, CDCl3):  = 3.61 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 
3.86 (s, 3H, OCH3), 6.81 (s, 1H, ArH), 6.86 (d, 1H, J = 6.2 Hz, ArH), 7.19 (s, 1H, ArH), 7.37 (d, 
1H, J = 6.9 Hz, ArH), 7.45-7.85 (m, 4H, ArH), 7.91 (dd, 1H, J = 3.9, 7.2 Hz, ArH), 8.1 (d, 1H, J = 
1.9 Hz, ArH); 13C NMR (62.89 MHz, CDCl3):  = 52.3, 55.8, 55.9, (3OCH3), 110.9, 111.4 (CHAr), 
120.7 (q, JF,C= 320.1, CF3), 122.6, 123.0, 128.1, 130.9, 131.1, 131.4, 132.2, 132.9, (CHAr), 133.9, 
134.3, 134.8, 144.8, 146.8, 146.9, 148.7, 149.1 (CAr), 168.6 (COO), 191.3 (C=O). 19F NMR (282 
MHz, CDCl3):  = -73.30 (CF); IR (KBr): ~ = 3064, 2994, 2924 (w), 1726 (s), 1668, 1520, 1482 
(m), 1421 (s), 1308 (m), 1243, 1206, 1170, 1086 (s), 944 (m), 891 (s), 830 (m), 763 (s), 732, 
655(m), 602 (s), 592 (m) cm-1; MS (EI, 70 eV): m/z (%): 524 (M+, 100), 493 (03), 392 (11), 359 
(29), 332 (07), 289 (04), 218 (02), 189 (02) 121 (04), 69 (05); HRMS (EI) calcd for C24H19O8F3S 
[M+]: 524.07472, found 524.075184. 
 
Methyl 4'-hydroxy-4-(2-(trifluoromethylsulfonyloxy)benzoyl)biphenyl-2-carboxylate (7f): 
Starting with 4 (150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 
mmol), Pd(PPh3)4 (3 mol%), 4-hydroxyphenylboronic acid (140 
mg, 0.70 mmol) and 1,4-dioxane (5ml/mmol of triflate), 7f was 
isolated as a colorless solid; yield 89 mg, (66 %) mp. = 47-
48°C; 1H NMR (300 MHz, CDCl3):  = 3.60 (s, 3H, OCH3),  
6.78 (d, 2H, J = 6.9 Hz, ArH), 7.13 (d, 2H, J = 6.2 Hz, ArH), 7.18 (s, 1H, OH), 7.37 (s, 1H, ArH), 
7.40-7.62 (m, 4H, ArH), 7.89 (dd, 1H, J = 4.6, 6.9 Hz, ArH), 8.13 (d, 1H, J = 5.8 Hz, ArH); 13C 
NMR (62.89 MHz, CDCl3):  = 52.3 (OCH3), 115.3 (CHAr), 122.7 (q, JF,C= 321.2, CF3), 128.1, 












155.9 (CAr), 168.5 (COO), 191.4 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.71 (CF); IR (KBr): 
~ = 3377, 3060, 2952 (w), 1715, 1667 (s), 1599 (m), 1555, 1520 (w), 1480, 1310 (m), 1245, 1134, 
1086 (s), 1040 (w), 944 (m), 884, 767, 656, 592 (s) cm-1; GC-MS (70 eV): m/z (%): 480 (M+, 22), 
449 (05), 348 (100), 315 (45), 289 (87), 272 (22), 255 (57), 228 (24), 197 (16), 139 (22), 121 (88), 
93 (18), 65 (13); HRMS (EI) calcd for C22H15O7F3S [M+]: 480.04851, found 480.048783. 
 
Methyl 3',4',5'-trimethoxy-4-(2-(trifluoromethyl sulfonyloxy) benzoyl) biphenyl-2-
carboxylate (7g): Starting with 4 (150 mg, 0.27 mmol), 
K3PO4 (171 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 3,4,5-
trimethoxyphenylboronic acid (140 mg, 0.70 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 7g was isolated as crystalline 
yellow solid; yield 116 mg, (74 %) mp. = 103-104°C; 1H 
NMR (300 MHz, CDCl3):  = 3.61 (s, 9H, 3OCH3), 3.83 (s, 
3H, OCH3), 6.49 (s, 2H, ArH), 7.40 (s, 1H, ArH), 7.45-7.63 (m, 4H, ArH), 7.91 (dd, 1H, J = 4.2, 
6.4 Hz, ArH), 8.08 (d, 1H, J = 6.2 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 52.4 (OCH3), 
56.2 (2OCH3), 60.9 (OCH3), 105.5 (CHAr), 122.7 (q, JF,C= 320.1, CF3), 128.2, 129.0, 130.8, 131.1, 
131.2, 132.2, 133.0 (CHAr), 134.1, 135.1, 135.9, 136.8, 137.6, 138.0, 146.8, 153.1 (CAr), 168.5 
(COO), 191.3 (C=O). 19F NMR (282.40 MHz, CDCl3):  = -73.27 (CF); IR (KBr): ~ = 3074, 
3052, 2972, 2846, 2835 (w), 1723, 1667 (s), 1597, 1586 (m), 1479, 1454 (m), 1394, 1344, 1300 
(m), 1287, 1237, 1169 (s), 1093, 942 (s), 890, 865, 776 , 696 (s), 593, 579, 532 (m) cm-1; MS (EI, 
70 eV): m/z (%): 554 (M+, 100), 539 (08), 422 (04), 389 (17), 347 (09), 319 (04), 203 (03), 69 (07); 
HRMS (EI) calcd for C25H21O9F3S [M+]: 554.08529, found 554.085710. 
 
Methyl 3'-hydroxy-4-(2-(trifluoromethylsulfonyloxy)benzoyl)biphenyl-2-carboxylate (7h): 
Starting with 4 (150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 mmol), 
Pd(PPh3)4 (3 mol%), 3-hydroxyphenylboronic acid (140 mg, 0.70 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 7h was isolated as 
yellow oil; yield 100 mg, (74 %); 1H NMR (300 MHz, CDCl3):  = 
3.62 (s, 3H, OCH3), 6.91 (s, 1H, ArH), 7.11 (s, 1H, ArH), 7.32 (d, 
1H, J = 6.2 Hz, ArH), 7.34 (t, 1H, J = 2.2 Hz, ArH), 7.53 (d, 1H, J = 7.0 Hz, ArH), 7.54 (m, 4H, 
ArH), 7.81 (dd, 1H, J = 6.4, 2.1 Hz, ArH), 8.15 (d, 1H, J = 6.2 Hz, ArH), 11.80 (s, 1H, OH); 13C 
NMR (62.90 MHz, CDCl3):  = 52.4, (OCH3), 118.8, (CAr), 118.6, 119.0 (CHAr), 120.6 (q, JF,C= 













142.9, 143.6, 144.2, 149.2 (CAr), 168.5 (COO), 199.8 (C=O). 19F NMR (282.40 MHz, CDCl3):  = 
-73.27 (CF); IR (KBr): ~ = 3071, 3049, 2965, 2832, 2826 (w), 1716, 1654 (s), 1582, 1578 (m), 
1462, 1448 (m), 1389, 1339, 1301 (m), 1282, 1234, 1164 (s), 1091, 940 (s), 897, 862, 771 , 692 (s), 
591, 575, 531 (m) cm-1; MS (EI, 70 eV): m/z (%): 480 (M+, 40), 448 (19), 421 (31), 387 (04), 347 
(15), 315 (33), 287 (20), 255 (81), 226 (15), 139 (14), 121 (100), 93 (18), 69 (19), 44 (04); HRMS 
(EI) calcd for C22H15O7F3S [M+]: 480.04851, found 480.048846. 
 
Methyl 3',5'-dimethyl-4-(2-(trifluoromethyl sulfonyloxy)benzoyl)biphenyl-2-carboxylate (8a): 
Starting with 4 (150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 
mmol), Pd(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (140 
mg, 0.70 mmol) and 1,4-dioxane (5ml/mmol of triflate), 10a 
was isolated as colorless crystalline solid; yield 82 mg, (60 %), 
mp. = 49-50°C; 1H NMR (300 MHz, CDCl3):  = 2.24 (s, 6H, 
2CH3), 3.54 (s, 3H, OCH3), 5.14 (dd, 1H, J = 2.3, 6.8 Hz, 
CH2vinyl), 5.63 (dd, 1H, J = 1.5, 8.1 Hz, CHvinyl), 6.59 (dd, 1H, 
J = 1.2, 6.8 Hz, CH2vinyl), 6.76 (s, 2H, ArH), 6.91 (s, 1H, ArH), 
7.13 (s, 1H, ArH), 7.21 (d, 2H, J = 7.2 Hz, ArH), 7.37 (d, 2H, J = 6.2 Hz, ArH), 7.54-7.65 (m, 4H, 
ArH), 7.71 (dd, 1H, J = 1.9, 8.0 Hz, ArH), 7.95 (d, 1H, J = 1.8 Hz, ArH); 13C NMR (75.47 MHz, 
CDCl3):  = 21.3 (2CH3), 52.0 (OCH3), 113.1, 124.8, 125.0, (CAr), 125.9, 126.2, 127.2, 128.9, 
129.6, 130.6, 131.3, 132.2, 133.4, 134.3, 136.3, (CHAr), 137.1, 137.3, 138.5, 139.0, 139.9, 145.6 
(CAr), 167.4 (COO), 196.3 (C=O); IR (KBr): ~ = 3057, 3019, 2948 (w), 1720, 1663 (s), 1596 (m), 
1556, 1513 (w), 1435, 1306 (m), 1231 (s), 1151, 1099, 940 (m), 864, 786 (s), 694, 647, 575, 540 
(m) cm-1; GC-MS (EI, 70 eV): m/z (%): 446 (M+, 100), 414 (16), 385 (16), 358 (08), 267 (29), 207 
(20), 194 (08), 178 (49), 152 (14), 77 (01); HRMS (EI) calcd for C31H26O3 [M+]: 446.18765, found 
446.187064. 
 
Methyl 4'-hydroxy-4-(4'-vinylbiphenylcarbonyl)biphenyl-2 carboxylate (8b): Starting with 7f 
(150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 mmol), Pd(PPh3)4  
(3 mol%), 4-vinylphenylboronic acid (140 mg, 0.70 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 8b was isolated as a 
colorless oil; yield 100 mg, (74 %); 1H NMR (300 MHz, 
CDCl3):  = 3.59 (s, 3H, OCH3), 5.15 (dd, 1H, J = 3.9, 7.2 Hz, 












J = 1.6, 6.8 Hz, CHvinyl), 6.72 (d, 2H, J = 6.2 Hz, ArH), 6.90 (d, 2H, J = 6.8 Hz, ArH), 7.01 (d, 2H, 
J = 6.4 Hz, ArH), 7.14 (d, 2H, J = 6.7 Hz, ArH), 7.31-7.56 (m, 4H, ArH). 6.73 (dd, 2H, J = 1.4, 8.2 
Hz, ArH), 7.97 (d, 1H, J = 1.9 Hz, ArH), 9.43 (s, 1H, OH); 13C NMR (62.89 MHz, CDCl3):  = 
52.1 (OCH3), 114.1 (CH2vinyl), 115.2, 126.2, 127.2 (CHAr), 127.9, 128.0, 128.1 (CAr), 128.8, 129.2, 
130.1, 130.6, 130.7, 131.5, 132.1, 135.2, 136.2 (CHAr), 136.7, 138.2, 139.5, 140.9, 146.1, 155.7 
(CAr), 168.6 (COO), 197.4 (C=O); IR (KBr): ~ = 3417, 3060, 3022, 2946 (w), 1715, 1692 (s), 1597 
(m), 1555, 1519 (w), 1434, 1306 (m), 1233 (s), 1153, 1087, 987, 939 (m), 831, 769 (s), 699, 607, 
571, 539 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 434 (M+, 100), 401 (07), 373 (09), 347 (04), 255 
(20), 212 (09), 178 (30), 152 (07), 91 (03); HRMS (EI) calcd for C29H22O4 [M+]: 434.15126, found 
434.150613. 
 
Methyl 3',4'-dimethoxy-4-(4'-vinylbiphenylcarbonyl)biphenyl-2-carboxylate (8c): Starting 
with 7e (150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 mmol), 
Pd(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (140 mg, 
0.70 mmol) and 1,4-dioxane (5ml/mmol of triflate), 8c was 
isolated as a colorless crystalline solid; yield 89 mg, (65 %), 
mp. = 75-76°C; 1H NMR (300 MHz, CDCl3):  = 3.57 (s, 
3H, OCH3), 3.79 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 5.15 
(dd, 1H, J = 1.6, 7.2 Hz, CH2vinyl), 5.64 (dd, 1H, J = 3.2, 6.2 
Hz, CHvinyl), 6.60 (dd, 1H, J = 7.2, 6.4 Hz, CH2vinyl), 6.69 (d, 
1H, J = 6.4 Hz, ArH), 6.83 (d, 1H, J = 7.2 Hz, ArH), 6.90 (d, 
2H, J = 6.4 Hz, ArH), 7.00 (s, 1H, ArH), 7.12, (d, 2H, J = 6.1 Hz, ArH), 7.21 (s, 1H, ArH), 7.38-
7.56 (m, 4H, ArH), 7.73 (dd, 1H, J = 1.8, 8.0 Hz, ArH), 7.94 (d, 1H, J = 1.6 Hz, ArH); 13C NMR 
(75.47 MHz, CDCl3):  = 52.2, 55.9, 55.9 (3OCH3), 111.4 (CHvinyl), 114.1 (CH2vinyl), 120.7, 126.2, 
127.2, 128.8, 129.2, 130.1, 130.5, 130.7, 131.3, 132.0, 135.2, 136.2 (CHAr), 136.7, 138.3, 139.5, 
140.9, 141.1, 142.3, 143.6, 145.9, 148.6, 149.0 (CAr), 168.7 (COO), 197.2 (C=O); IR (KBr): ~ = 
3056, 2999 (w), 1720, 1663 (s), 1596 (m), 1554, 1519 (w), 1436, 1306 (m), 1232 (s), 1140, 1086, 
940 (m), 843, 765 (s), 699, 606, 539 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 478 (M+, 100), 418 
(02), 387 (03), 300 (05), 225 (12), 178 (20), 145 (06), 96 (03), 74 (02); HRMS (ESI+) calcd for 











Methyl 3',4',5'-trimethoxy-4-(4'-vinylbiphenylcarbonyl) biphenyl-2-carboxylate (8d): Starting 
with 7g (150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 mmol), 
Pd(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (140 mg, 
0.70 mmol) and 1,4-dioxane (5ml/mmol of triflate), 8d was 
isolated as a colorless oil; yield 100 mg, (72 %); 1H NMR 
(300 MHz, CDCl3):  = 3.57 (s, 3H, OCH3), 3.77 (s, 6H, 
2OCH3), 3.81 (s, 3H, OCH3), 5.15 (dd, 1H, J = 5.9, 6.2 Hz, 
CH2vinyl), 5.64 (dd, 1H, J = 4.6, 7.5 Hz, CH2vinyl), 6.37 (s, 2H, 
ArH), 6.60 (dd, 1H, J = 7.1, 6.7 Hz, CHvinyl), 7.14 (d, 2H, J = 
7.5 Hz, ArH), 7.30 (d, 2H, J = 6.2 Hz, ArH), 7.41-7.61 (m, 4H, ArH), 7.73 (dd, 2H, J = 4.2, 7.2 Hz, 
ArH), 7.93 (d, 1H, J = 6.2 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 52.2, 56.1, 60.9 
(3OCH3), 114.1 (CH2vinyl), 127.2 (CH), 127.9, 128.5 (CAr), 128.9, 129.2, 130.1, 130.4, 130.8, 131.2, 
131.9, 134.9, 135.0, 136.2 (CHAr), 136.1, 136.7, 138.2, 139.5, 140.9, 141.7, 145.9, 153.0 (CAr), 
168.6 (COO), 197.2 (C=O); IR (KBr): ~ = 3055, 2925, 2850 (w), 1722, 1663 (s), 1583 (m), 1556, 
1512 (w), 1433, 1397, 1342 (m), 1296, 1233 (s), 1151, 1122, 1094, 1028, 940 (m), 880, 831, 769 
721, (s), 693, 644,  539 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 508 (M+, 100), 493 (35), 277 (09), 
262 (21), 219 (35), 201 (11), 183 (31), 152 (13), 108 (19), 57 (18), 44 (29); HRMS (EI) calcd for 
C32H28O6 [M+]: 508.18804, found 508.187819. 
 
Methyl 3'-hydroxy-4-(4'-vinylbiphenylcarbonyl)biphenyl-2-carboxylate (8e): Starting with 7h 
(150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 mmol), Pd(PPh3)4  (3 
mol%), 4-vinylphenylboronic acid (140 mg, 0.70 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 8e was isolated as yellow oil; yield 
87 mg, (64 %); 1H NMR (300 MHz, CDCl3):  = 3.61 (s, 3H, 
OCH3), 4.12 (dd, 1H, J = 2.6, 8.1 Hz, CH2vinyl), 5.19 (dd, 1H, J = 
2.8, 8.6 Hz, CH2vinyl), 5.77 (dd, 1H, J = 2.4, 8.2 Hz, CHvinyl), 6.72 
(d, 1H, J = 6.2 Hz, ArH), 6.90 (d, 1H, J = 6.8 Hz, ArH), 7.11 (s, 
1H, ArH), 7.20 (t, 1H, J = 6.7 Hz, ArH), 7.30 (s, 1H, ArH). 7.35-
7.45 (m, 4H, ArH), 7.54-7.65 (m, 4H, ArH), 7.73 (dd, 1H, J = 5.4, 
6.2 Hz, ArH), 7.97 (d, 1H, J = 2.9 Hz, ArH); 13C NMR (62.89 MHz, CDCl3):  = 51.5 (OCH3), 
114.3 (CH2vinyl), 115.2, 117.2, 118.3, 126.2, 127.2 (CHAr), 127.9, 128.0, 128.1 (CAr), 128.8, 129.2, 
130.1, 130.6, 130.7, 131.5, 132.1, 136.2 (CHAr), 136.5, 138.1, 139.2, 140.4, 146.0, 155.2 (CAr), 













1553, 1517 (w), 1431, 1303 (m), 1231 (s), 1159, 1083, 981, 938 (m), 833, 767 (s), 691, 605, 573, 
534 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 434 (M+, 100), 401 (16), 375 (40), 341 (07), 314 (09), 
281 (33), 255 (33), 207 (87), 191 (09), 133 (06), 121 (46), 93 (10), 65 (09), 44 (15); HRMS (EI) 
calcd for C29H22O4 [M+]: 434.15180, found 434.48260. 
 
Methyl 2'-ethoxy-4-(4'-vinylbiphenylcarbonyl)biphenyl-2-carboxylate (8f): Starting with 7c 
(150 mg, 0.27 mmol), K3PO4 (171 mg, 0.81 mmol), Pd(PPh3)4 (3 
mol%), 4-vinylphenlboronic acid (140 mg, 0.70 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 8f was isolated as a colorless 
crystalline solid; yield 93 mg (68 %), mp. = 53-55°C; 1H NMR 
(300 MHz, CDCl3):  = 1.32 (t, 3H, J = 3.1 Hz, CH3), 3.54 (s, 1H,  
OCH3), 3.82 (q, 2H, J = 4.1 Hz, OCH2), 6.82 (s, 1H, ArH), 
6.907.12 (m, 4H, ArH), 7.20-7.30 (m, 4H, ArH), 7.42 (d, 2H, J = 
2.4, 8.2 Hz, ArH), 7.52-7.62 (m, 2H, ArH), 7.91 (dd, 1H, J = 2.8, 
7.2 Hz, ArH), 8.21 (d, 1H, J = 6.8 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 14.4 (CH3), 51.7 
(OCH3), 63.8 (OCH2), 111.3 (CHvinyl), 114.0 (CH2vinyl), 120.7, 126.2, 127.2 (CHAr), 128.0 (CAr), 
128.9, 129.2, 129.7, 130.1, 131.0, 131.4, 132.3, 133.2, 134.6, 136.2 (CHAr), 136.6, 137.2, 138.4, 
139.5, 140.9, 141.1, 143.4, 144.2, 155.2 (CAr), 167.7 (COO), 197.5 (C=O); 19F NMR (282 MHz, 
CDCl3):  = -73.34 (CF); IR (KBr): ~ = 3491, 3062, 3029 (w), 1723, 1661 (s), 1592 (m), 1571, 
1504 (w), 1442, 1307, 1281 (m), 1241, 1202 (s), 1081, 942 (m), 883, 750 (s), 567 (m) cm-1; MS 
(EI, 70 eV): m/z (%): 462 (M+ 100), 430 (07), 417 (21), 401 (46), 373 (30), 357 (04), 313 (04), 283 
(06), 223 (21) 201 (27), 178 (67), 139 (19); HRMS (EI) calcd for C31H26O4 [M+]: 462.18256, found 
462.183193. 
 
4''-Vinyl-4-(4'-vinyl-biphenyl-2-carbonyl)-[1,1';2',1'']terphenyl-2-carboxylic acid methyl 
ester (9). Starting with 7d (150 mg, 0.27 mmol), K3PO4 (171 mg, 
0.81 mmol), Pd(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (140 
mg, 0.70 mmol) and 1,4-dioxane (5ml/mmol of triflate), 9 was 
isolated as yellow oil; yield 90 mg, (62 %);  1H NMR (300 MHz, 
CDCl3):  = 3.45 (s, 3H, OCH3), 5.15 (ddd, 2H, J = 0.8, 5.7, 10.9 
Hz, CH2vinyl), 5.62 (ddd, 2H, J = 0.8, 5.0, 17.6 Hz, CH2vinyl), 6.57 
(ddd, 2H, J = 1.9, 10.9, 17.6 Hz, 2CHvinyl), 6.86 (d, 4H, J = 6.4 Hz, 










7.20 (t, 2H, J = 4.9 Hz, ArH), 7.31 (s, 1H, ArH). 7.40 (dd, 1H, J = 4.5, 6.7 Hz, ArH), 7.43-7.52 (m, 
4H, ArH), 7.94 (d, 1H, J = 6.8 Hz, ArH); 13C NMR (62.89 MHz, CDCl3):  = 52.0 (OCH3), 113.8, 
114.3 (2CH2vinyl), 115.4 (CAr), 125.7, 126.1, 127.3, 128.9, 129.2, 129.8, 130.0, 130.7, 131.3, 131.9, 
132.0, 133.2, 134.6, 136.2, 136.4 (CHAr), 136.6, 138.2, 138.9, 139.5, 139.8, 140.0, 140.7, 141.2, 
143.4, 146.9 (CAr), 167.2 (COO), 197.4 (C=O); IR (KBr): ~ = 3056, 3019, 2948 (w), 1724, 1662 
(s), 1596 (m), 1555, 1514 (w), 1435, 1399, 1305 (m), 1258, 1230 (s), 1152, 1085, 988, 941 (m), 
843, 765 (s), 694, 633, 596, 540 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 520 (M+, 16), 488 (100), 
417 (14), 386 (32), 357 (07), 309 (20), 262 (48), 207 (50), 179 (77), 152 (20), 108 (13); HRMS 
(EI) calcd for C37H28O3 [M+]: 520.20330, found 520.202889. 
 
4''-Vinyl-4-(4''-vinyl-[1,1';4',1'']terphenyl-2-carbonyl)-[1,1';4',1'']terphenyl-2-carboxylic acid 
methyl ester (10). Starting with 6g (150 mg, 0.27 
mmol), K3PO4 (171 mg, 0.81 mmol), Pd(PPh3)4 (3 
mol%), 4-vinylphenylboronic acid (140 mg, 0.70 mmol) 
and 1,4-dioxane (5ml/mmol of triflate), 10 was isolated 
as a colorless crystalline solid; yield 100 mg, (72 %), 
mp. = 169-171°C; 1H NMR (300 MHz, CDCl3):  = 3.58 
(s, 3H, OCH3), 5.05 (dd, 2H, J = 6.2, 5.4 Hz, CH2vinyl), 
5.16 (dd, 2H, J = 5.2, 6.4 Hz, CH2vinyl), 5.23 (d, 2H, J = 
6.4, 5.8 Hz, CHvinyl), 5.48 (d, 8H, J = 6.4 Hz, ArH), 7.44 
(d, 4H, J =  6.4 Hz, ArH), 7.59 (d, 4H, J = 6.2 Hz, ArH), 
7.65-8.00 (m, 7H, ArH); 13C NMR (62.89 MHz, CDCl3): 
 = 52.1 (OCH3), 114.1 (CH2vinyl), 126.2, 127.0, 127.9, 
128.0, 128.9, 129.2, 130.1, 130.7, 131.1, 131.8, 132.2, 133.0 (CHAr), 134.9, 135.0, 136.1, 136.8, 
138.2, 139.7, 140.1, 141.0, 146.0 (CAr), 168.2 (COO), 197.3 (C=O); IR (KBr): ~ = 3427, 2948 (w), 
1722, 1666 (s), 1596 (m), 1556, 1514 (w), 1434, 1305 (m), 1231 (s), 1152, 1093, 999, 939 (m), 
843, 818, 768 (s), 726, 691, 649, 540 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 596 (M+, 10), 540 
(30), 502 (12), 480 (21), 439 (15), 414 (16), 385 (16), 358 (08), 267 (29), 207 (20), 194 (08), 178 







4-([1,1';3',1'']Terphenyl-2-carbonyl)-[1,3';1',1'']terphenyl-2-carboxylic acid methyl ester  
(11). Starting with 6r (150 mg, 0.27 mmol), K3PO4 (171 mg, 
0.81 mmol), Pd(PPh3)4 (3 mol%), phenylboronic acid (140 mg, 
0.70 mmol) and 1,4-dioxane (5ml/mmol of triflate), 11 was 
isolated as yellow oil; yield 90 mg, (60 %); 1H NMR (300 
MHz, CDCl3):  = 3.46 (s, 3H, OCH3), 7.10 (s, 1H, ArH), 7.23 
(s, 2H, ArH), 7.25-7.50 (m, 17H, ArH), 7.57 (t, 1H, J = 5.9 Hz, 
ArH), 7.65 (d, 2H, J = 6.2 Hz, ArH), 7.73 (dd, 1H, J = 6.2, 4.6 
Hz, ArH), 7.94 (d, 1H, J = 6.8 Hz, ArH); 13C NMR (62.89 
MHz, CDCl3):  = 52.0 (OCH3), 126.2, 127.0, 127.5, 127.9, 128.1, 128.7, 129.0, 130.9, 131.5, 
131.8, 134.9, 135.0, 135.8 (CHAr), 136.3, 138.5, 140.6, 141.1, 142.0, 143.0, 146.2, 166.3 (CAr), 
168.1 (COO), 197.5 (C=O); IR (KBr): ~ = 3055, 3028, 2947 (w), 1720, 1662 (s), 1595 (m), 1572, 
1487,  (w), 1434, 1303 (m), 1210 (s), 1151, 1086, 1031, 940 (m), 896, 783 (s), 696, 628, 539 (m) 
cm-1; GC-MS (EI, 70 eV): m/z (%): 544 (M+, 20), 520 (20), 490 (10), 465 (12), 430 (19), 414 (16), 
385 (16), 358 (08), 267 (29), 207 (20), 194 (08), 178 (49), 152 (14), 77 (01); HRMS (EI) calcd for 
C39H28O3 [M+]: 544.20380, found 544.63780. 
 
2-(4-(Trifluoromethylsulfonyloxy)benzoyl)phenyl trifluoromethanesulfonate (13): Starting 
with 12 (168 mg, 1.0 mmol), pyridine (0.32 ml, 4.0 mmol) and  Tf2O (0.39 
ml, 2.4 mmol), 13 was isolated as a yellow oil, yield, (330 mg, 88 %); 1H 
NMR (300 MHz, CDCl3):  = 7.31-7.38 (m, 3H, ArH), 7.43-7.53 (m, 2H, 
ArH), 7.58-7.64 (m, 1H, ArH), 7.83 (d, 2H, J = 8.91 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 
115.8 (q, JF,C = 320.0 Hz, CF3), 120.9 (q, JF,C = 321.3 Hz, CF3), 121.6, 122.7, 128.3, 131.1, 132.2, 
133.3 (CHAr), 133.3, 136.3, 146.6, 152.7 (CAr), 190.8 (C=O). 19F NMR (282 MHz, CDCl3):  = -
73.3, 72.6 (2CF). IR (KBr): ~= 1598, 1589, 1580,  (m), 1496, 1431, 1414, 1319, 1291 (m), 1265 
(s), 1165, 1077, 1028, 989, 976, 932 (m), 887, 787, 757 (s), 680, 595, 572 (m) cm-1; GC-MS (EI, 
70 eV): m/z (%): 478 (M+, 58), 345 (06), 317 (13), 281 (09), 253 (100), 212 (12), 184 (28), 155 











(3'-Methoxybiphenyl-2-yl)(3'-methoxybiphenyl-4-yl)methanone (14a): Starting with 13 (200 
mg, 0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 3-methoxyphenylboronic acid (162 mg, 1.06 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 14a was isolated as a 
colorless solid, yield 128 mg, (78 %) mp. = 152-154°C; 1H 
NMR (300 MHz, CDCl3):  = 3.61, 3.78 (s, 6H, 2OCH3), 6.61-
6.64 (m, 2H, ArH), 6.75-6.86 (m, 3H, ArH), 6.99-7.07 (m, 2H, 
ArH), 7.26 (t, 1H, J = 7.95 Hz, ArH), 7.39-7.51 (m, 6H, ArH), 7.63-7.66 (m, 2H, ArH). 13C NMR 
(75.47 MHz, CDCl3):  = 55.1, 55.3 (2OCH3), 113.0, 113.2, 113.4, 114.4, 119.7, 121.5, 126.8, 
127.1, 128.5, 129.3, 129.9, 130.2, 130.4, 131.0 (CHAr), 136.2, 139.0, 140.8, 141.3, 141.5, 145.2, 
159.3, 160.0 (CAr), 198.2 (C=O). IR (KBr): ~= 3058, 2998, 2834 (w), 1725 (w), 1661, 1581, 1477, 
1435, 1398, 1307 (m), 1278, 1210 (s), 1170, 1150, 1049, 1027, 1019 (m), 929 (s), 844, 775 (m), 
757, 689 (s), 672, 617, 565, 531 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 394 (M+, 100), 363 (15), 
281 (04), 211 (47), 168 (23), 139 (19), 44 (05); HRMS (EI) calcd for C27H22O3 [M+]: 394.15689, 
found 394.46178. 
 
(2'-Fluorobiphenyl-2-yl)(2'-fluorobiphenyl-4-yl)methanone (14b): Starting with 13 (200 mg, 
0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 mol%), 2-
fluorophenylboronic acid (149 mg, 1.06 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 14b was isolated as colorless crystalline solid, 
yield 108 mg, (70 %) mp. = 146-148°C; 1H NMR (300 MHz, CDCl3): 
 = 6.80 (t, 1H, J = 8.67 Hz, ArH), 6.93-7.00 (m, 2H, ArH), 7.04-7.12 
(m, 3H, ArH), 7.17-7.23 (m, 3H, ArH), 7.34-7.42 (m, 3H, ArH), 7.46-
7.50 (m, 2H, ArH), 7.67 (d, 2H, J = 8.25 Hz, ArH). 13C NMR (75.47 MHz, CDCl3):  = 115.5 (d, 
2JC,F = 22.3 Hz, CHAr), 116.3 (d, 2JC,F = 22.6 Hz, CHAr), 124.2 (d, 4JC,F = 3.6 Hz, CHAr), 124.5 (d, 
4JC,F = 3.6 Hz, CHAr), 127.5 (CHAr), 128.7 (d, 4JC,F = 3.1 Hz, CHAr), 129.2 (CHAr), 129.5 (d, 3JC,F = 
8.1 Hz, CHAr), 129.7 (d, 3JC,F = 8.3 Hz, CHAr), 130.1, 130.6, 131.2 (CHAr), 131.4 (d, 4JC,F = 3.2 Hz, 
CHAr), 135.3, 136.3, 139.1, 140.1, 157.4, 158.1, 160.7, 161.4 (CAr), 197.0 (C=O). 19F NMR (282 
MHz, CDCl3):  = -117.3, -115.6 (2CF). IR (KBr): ~= 3310, 3039, 2954, 2852, 1728 (w), 1665 
(s), 1606, 1593, 1567, 1447, 1404, 1313, 1280, 1260, 1201, 1187, 1156, 1103, 1079, 1036, 975, 
963, 945, 883, 844, 790 (m), 728, 719 (s), 694, 638, 614, 559 (w) cm-1; GC-MS (EI, 70 eV): m/z 
(%): 370 (M+, 100), 351 (26), 199 (72), 170 (48), 151 (10); HRMS (EI) calcd for C25H16OF2 [M+]: 









(4'-Methoxybiphenyl-2-yl)(3'-methoxybiphenyl-4-yl)methanone (14c): Starting with 13 (200 
mg, 0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 4-methoxyphenylboronic acid (162 mg, 1.06 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 14c was isolated as a yellow 
solid, yield 112 mg, (68 %) mp. = 138-140°C; 1H NMR (300 
MHz, CDCl3):  = 3.61, 3.78 (s, 6H, 2OCH3), 6.61-6.64 (m, 2H, 
ArH), 6.75-6.86 (m, 3H, ArH), 6.99-7.07 (m, 2H, ArH), 7.26 (t, 
1H, J = 7.95 Hz, ArH), 7.39-7.51 (m, 6H, ArH), 7.63-7.66 (m, 
2H, ArH). 13C NMR (75.47 MHz, CDCl3):  = 55.1, 55.3 (2OCH3), 113.0, 113.4, 114.4, 119.7, 
121.5, 126.8, 127.1, 128.5, 129.9, 130.4 (CHAr), 136.1, 139.2, 140.6, 141.4, 141.8, 145.6, 159.8, 
160.3 (CAr), 198.3 (C=O). IR (KBr): ~= 3033, 2965, 2839 (w), 1671, 1594, 1526, 1480, 1442, 
1399, 1297, 1267 (m), 1248, 1226, 1189, 1133, 1090, 1030 (m), 1010, 936, 876, 824, 768 (s), 743, 
717, 690, 627, 616, 542 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 394 (M+, 100), 363 (15), 281 (04), 
211 (47), 168 (23), 139 (19), 44 (05); HRMS (EI) calcd for C27H22O3 [M+]: 394.15689, found 
394.46178. 
 
(4'-Vinylbiphenyl-2-yl)(4'-vinylbiphenyl-4-yl)methanone (14d): Starting with 13 (200 mg, 0.41 
mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 mol%), 4-
vinylphenylboronic acid (157 mg, 1.06 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 14d was isolated as a colorless oil, yield 107 
mg, (66 %); 1H NMR (300 MHz, CDCl3):  = 5.01-5.11 (dd, 1H, J 
= 1.7, 10.8 Hz, CH2vinyl), 5.19-5.24 (dd, 1H, J = 1.7, 11.2 Hz, 
CH2vinyl), 5.54-5.61 (dd, 1H, J = 1.7, 17.5 Hz, CH2vinyl), 5.68-5.74 
(dd, 1H, J = 1.6, 17.5 Hz, CH2vinyl), 6.47-6.57 (dd, 1H, J = 10.8, 17.5 Hz, CHvinyl), 6.62-6.72 (dd, 
1H, J = 10.8, 17.5 Hz, CHvinyl), 7.18 (m, 4H, ArH), 7.31-7.38 (m, 4H, ArH), 7.40-7.48 (m, 4H, 
ArH), 7.54 (s, 1H, ArH), 7.66 (d, 2H, J = 8.5 Hz, ArH); 13C NMR (75.47 MHz, CDCl3):  = 114.2, 
114.8 (2CH2vinyl), 125.3, 125.7, 126.3, 126.6, 126.9, 127.2, 128.6, 129.2, 129.7, 130.0, 130.3, 130.7 
(CHAr), 136.1 (CAr), 136.3, 136.5 (CHAr), 136.8, 138.3, 138.9, 139.7, 140.2, 140.7, 146.4 (CAr), 
198.2 (C=O). IR (KBr): ~= 3043, 3029, 2952, 2847, 1721 (w), 1657, 1597 (s), 1579, 1513, 1475, 
1447, 1403, 1317 (m), 1266, 1253, 1235 (s), 1187, 1153, 1041, 987 (m), 925 (s), 861, 803, 783, 
708, 665, 627, 543 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 386 (M+, 100), 369 (8), 281 (07), 253 








2-(3'-Methoxybiphenylcarbonyl)phenyl trifluoromethanesulfonate (15a): Starting with 13 (200 
mg, 0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 mol%), 3-
methoxyphenylboronic acid (80 mg, 0.53 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 15a was isolated as a colorless oil, yield 124 
mg, (68 %); 1H NMR (300 MHz, CDCl3):  = 3.77 (s, 3H, OCH3), 6.86 
(dd, 1H, J = 1.8, 8.10 Hz, ArH), 7.07-7.14 (m, 2H, ArH), 7.27-7.38 (m, 
2H, ArH), 7.43 (d, 1H, J = 7.11 Hz, ArH), 7.50-7.54 (m, 3H, ArH), 7.61 (d, 1H, J = 8.31 Hz, ArH), 
7.80 (d, 2H, J = 8.28 Hz, ArH). 13C NMR (62.90 MHz, CDCl3):  = 55.3 (OCH3), 113.1, 113.7, 
119.8 (CHAr), 121.0 (q, JF,C = 320 Hz, CF3), 122.5, 127.2, 128.0, 130.0, 130.7, 131.1, 132.6 (CHAr), 
135.2, 141.1, 146.3, 146.7, 147.2, 160.0 (CAr), 198.2 (C=O). 19F NMR (282 MHz, CDCl3):  = -
73.3 (CF3). IR (KBr): ~= 3066, 2921, 1727 (w), 1665 (m), 1599 (s), 1479 (m), 1421 (s), 1400, 
1309, 1293, 1274, 1247 (m), 1205, 1135 (s), 1086, 1051, 1028, 1013 (m), 936, 879, 845, 765 (s), 
748, 691, 618, 568 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 436 (M+, 100), 303 (40), 287 (08), 260 
(18), 231 (07), 211 (22), 168 (06), 139 (13), 69 (04); HRMS (EI) calcd for C21H15O5F3S [M+]: 
436.05868 found 436.058091. 
 
2-(2',5'-Dimethoxybiphenylcarbonyl)phenyl trifluoromethanesulfonate (15b): Starting with 13 
(200 mg, 0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 
mol%), 2,5-dimethoxyphenylboronic acid (96 mg, 0.53 mmol) 
and 1,4-dioxane (5ml/mmol of triflate), 15b was isolated as a 
reddish solid, yield 140 mg, (72 %) mp. = 138-140°C; 1H NMR 
(300 MHz, CDCl3):  = 3.66 (s, 6H, 2OCH3), 6.60 (d, 2H, J = 8.4 Hz, ArH), 7.17-7.26 (m, 2H, 
ArH), 7.35-7.43 (m, 3H, ArH), 7.52-7.58 (m, 2H, ArH), 7.77 (d, 2H, J = 8.37 Hz, ArH). 13C NMR 
(75.47 MHz, CDCl3):  = 55.9 (2OCH3), 104.2 (CHAr), 118.2 (CAr), 120.6 (q, JF,C = 320 Hz, CF3), 
122.4, 127.8, 129.5, 129.6, 130.0, 131.3, 131.4, 132.3 (CHAr), 132.7, 133.0, 134.5, 140.6, 146.9, 
157.5 (CAr), 192.3 (C=O). 19F NMR (282 MHz, CDCl3):  = -74.6 (CF3). IR (KBr): ~= 3068, 
3002, 2839, 1726 (w), 1665, 1603, 1588 (m), 1471 (s), 1402, 1294, 1272 (m), 1204, 1135, 1103, 
1087 (s), 1036, 935 (m), 878, 782, 725 (s), 693, 620, 569 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 
466 (M+, 100), 317 (25), 287 (15), 241 (12), 198 (05), 155 (04), 69 (04); HRMS (EI) calcd for 











2-(2',6'-Dimethoxybiphenylcarbonyl)phenyl trifluoromethanesulfonate (15c): Starting with 13 
(200 mg, 0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 
mol%), 2,6-dimethoxyphenylboronic acid (96 mg, 0.53 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 15c was isolated as a clolorless solid, 
yield 124 mg, (64 %) mp. = 162-164°C; 1H NMR (300 MHz, CDCl3): 
 = 3.65 (s, 6H, 2OCH3), 6.57 (d, 2H, J = 8.4 Hz, ArH), 7.21 (t, 1H, J = 8.37 Hz, ArH), 7.33-7.41 
(m, 4H, ArH), 7.50-7.56 (m, 2H, ArH), 7.75 (d, 2H, J = 8.37 Hz, ArH). 13C NMR (62.90 MHz, 
CDCl3):  = 55.8 (2OCH3), 104.2 (CHAr), 118.2 (CAr), 120.6 (q, JF,C = 320 Hz, CF3), 122.4, 127.8, 
129.5, 129.6, 131.3, 131.4, 132.3 (CHAr), 132.6, 134.5, 140.6, 146.9, 157.4 (CAr), 192.2 (C=O). 19F 
NMR (282 MHz, CDCl3):  = -73.5 (CF3). IR (KBr): ~= 3065, 3004, 2841, 1721 (w), 1667, 1605, 
1587 (m), 1473 (s), 1403, 1295, 1273 (m), 1205, 1137, 1105, 1081 (s), 1033, 931 (m), 877, 781, 
722 (s), 693, 620, 569 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 466 (M+, 100), 317 (23), 287 (14), 
241 (11), 198 (05), 155 (04), 69 (04); HRMS (EI) calcd for C22H17O6F3S [M+]: 466.06925 found 
466.069423. 
 
2-(2'-Ethoxybiphenylcarbonyl)phenyl trifluoromethanesulfonate (15d): Starting with 13 (200 
mg, 0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 
mol%), 2-ethoxyphenylboronic acid (88 mg, 0.53 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 15d was isolated as a colorless 
solid, yield 144 mg, (76 %) mp. = 150-152°C; 1H NMR (300 MHz, 
CDCl3):  = 1.25 (t, 3H, J = 6.99 Hz, CH3), 3.97 (q, 2H, J = 6.9 Hz, OCH2), 6.89-6.98 (m, 2H, 
ArH), 7.23-7.28 (m, 2H, ArH), 7.34-7.44 (m, 2H, ArH), 7.51-7.61 (m, 4H, ArH), 7.76 (d, 2H, J = 
8.52 Hz, ArH). 13C NMR (75.47 MHz, CDCl3):  = 14.7 (CH3), 64.1 (OCH2), 112.6 (CHAr), 120.6 
(q, JF,C = 321.0 Hz, CF3), 120.9, 122.4, 128.0 (CHAr), 129.3 (CAr), 129.6, 129.7, 129.8, 130.7, 
131.2, 132.4 (CHAr), 132.7, 134.6, 144.5, 146.8, 155.9 (CAr), 192.3 (C=O). 19F NMR (282 MHz, 
CDCl3):  = -73.4 (CF3). IR (KBr): ~= 3068, 3034, 2925, 1722 (w), 1665, 1602 (m), 1581, 1511, 
1446 (w), 1422 (s), 1312, 1264 (m), 1204, 1135 (s), 1086, 1039, 935 (m), 879, 750 (s), 693, 668, 
646, 590 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 450 (M+, 100), 422 (28), 289 (30), 215 (08), 197 










2-(3'-Vinylbiphenylcarbonyl)phenyl trifluoromethanesulfonate (15e): Starting with 13 (200 
mg, 0.41 mmol), K3PO4 (114 mg, 0.54 mmol), Pd (PPh3)4 (3 mol%), 
3-vinylphenylboronic acid (78 mg, 0.53 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 15e was isolated as yellow oil, yield 127 mg, 
(70 %); 1H NMR (300 MHz, CDCl3):  = 5.23 (d, 1H, J = 10.95 Hz, 
CH2vinyl), 5.74 (d, 1H, J = 17.55 Hz, CH2vinyl), 6.65-6.74 (dd, 1H, J = 10.8, 17.5 Hz, CHvinyl), 7.33-
7.38 (m, 3H, ArH), 7.40-7.43 (m, 2H, ArH), 7.50-7.55 (m, 3H, ArH), 7.61 (d, 2H, J = 8.43 Hz, 
ArH), 7.80 (d, 2H, J = 8.40 Hz, ArH); 13C NMR (75.47 MHz, CDCl3):  = 114.7 (CH2vinyl), 120.6 
(q, JC,F = 322.20 Hz, CF3), 122.5, 125.3, 126.1, 126.8, 127.2, 128.1, 129.2, 130.8, 131.2, 132.6 
(CHAr), 135.2 (CAr), 136.5 (CHAr), 138.3, 139.4, 140.0, 146.4, 146.8 (CAr), 192.1 (C=O). 19F NMR 
(282 MHz, CDCl3):  = -73.3 (CF3). IR (KBr): ~= 3085, 3060, 2957, 2854 (w), 1665, 1601 (m), 
1579, 1559, 1480 (w), 1421 (s), 1294, 1274, 1246 (w), 1204, 1134 (s), 1087 (m), 1039, 1014, 955 
(w), 878, 866, 778, 766 (s), 747, 710, 670, 617, 568, 545 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 
432 (M+, 100), 299 (35), 284 (14), 255 (09), 207 (42), 178 (23), 152 (09), 69 (05); HRMS (EI) 
calcd for C22H15O4F3S [M+]: 432.06377, found 432.062617. 
 
2-(4'-Tert-butylbiphenylcarbonyl)phenyl trifluoromethanesulfonate (15f): Starting with 13 
(200 mg, 0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 
mol%), 4-tert-butylphenylboronic acid (94 mg, 0.53 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 15f was isolated as a colorless 
crystalline solid, yield 128 mg, (66 %), mp = 140-142°C; 1H NMR 
(300 MHz, CDCl3):  = 1.27 (s, 9H, 3CH3), 7.32-7.42 (m, 4H, 
ArH), 7.48-7.52 (m, 4H, ArH), 7.60 (d, 2H, J = 8.28 Hz, ArH), 7.78 (d, 2H, J = 8.25 Hz, ArH). 13C 
NMR (75.47 MHz, CDCl3):  = 31.3 (3CH3), 34.6 (CtBu), 120.0 (q, JF,C = 320 Hz, CF3), 122.5, 
126.0, 127.0, 127.1, 128.0, 130.8, 131.2, 132.5 (CHAr), 132.6, 134.9, 136.7, 146.4, 146.8, 151.7 
(CAr), 192.1 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.4 (CF3). IR (KBr): ~= 3070, 3030, 
2929 (w), 1660, 1600 (m), 1550, 1521, 1495, 1443 (w), 1425 (s), 1393, 1366, 1300 (w), 1278,1269 
(m), 1197, 1142 (s), 1112, 1040, 1003, 937, 882, 864 (m), 831, 767, 735 (s), 700, 645, 596, 567 (w) 
cm-1; GC-MS (EI, 70 eV): m/z (%): 462 (M+, 43), 447 (100), 313 (43), 299 (09), 273 (04), 178 






2-(3',5'-Dimethylbiphenylcarbonyl)phenyl trifluoromethanesulfonate (15g): Starting with 13 
(200 mg, 0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 
mol%), 3,5-dimethylphenylboronic acid (79 mg, 0.53 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 15g was isolated as a colorless 
oil, yield 142 mg, (78 %); 1H NMR (300 MHz, CDCl3):  = 2.28 (s, 
6H, 2CH3), 6.94 (s, 1H, ArH), 7.14 (s, 2H, ArH), 7.35 (dd, 2H, J = 
8.25, 19.6 Hz, ArH), 7.47-7.51 (m, 2H, ArH), 7.56 (d, 2H, J = 8.3 Hz, ArH), 7.75 (d, 2H, J = 8.3 
Hz, ArH). 13C NMR (75.47 MHz, CDCl3):  = 21.3 (2CH3), 120.6 (q, JF,C = 321.0 Hz, CF3), 122.5, 
125.2, 127.2, 128.0, 130.1, 130.7, 131.2, 132.6 (CHAr), 133.0, 135.0, 138.5, 139.6, 146.8, 146.9, 
(CAr), 192.2 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.4 (CF3). IR (KBr): ~= 3032, 2850, 
2850, 1725 (w), 1665, 1600 (m), 1560, 1480 (w), 1422 (s), 1294, 1246 (m), 1203, 1135 (s), 1084, 
1038, 1016 (m), 936 (m), 879, 850, 779 (s), 742, 639, 618, 568 (w) cm-1; GC-MS (EI, 70 eV): m/z 
(%): 434 (M+, 100), 301 (57), 285 (06), 258 (07), 209 (30), 165 (19), 69 (05); HRMS (EI) calcd for 
C22H17O4F3S [M+]: 434.07942 found 434.079488. 
 
2-(4'-Ethylbiphenylcarbonyl)phenyl trifluoromethanesulfonate (15h): Starting with 13 (200 
mg, 0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 
mol%), 4-ethylphenylboronic acid (79 mg, 0.53 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 15h was isolated as a colorless 
crystalline solid, yield 134 mg, (74 %) mp. = 170-172°C; 1H 
NMR (300 MHz, CDCl3):  = 1.17 (t, 3H, J = 7.5 Hz, CH3ethyl), 2.59 (q, 2H, J = 7.5 Hz, CH2ethyl), 
7.19 (d, 2H, J = 8.1 Hz, ArH), 7.35 (dd, 2H, J = 8.2, 18.5 Hz, ArH), 7.44-7.51 (m, 4H, ArH), 7.57 
(d, 2H, J = 8.4 Hz, ArH), 7.77 (d, 2H, J = 8.4 Hz, ArH). 13C NMR (75.47 MHz, CDCl3):  = 14.4 
(CH3), 28.6 (CH2), 120.6 (q, JF,C = 321.0 Hz, CF3), 122.5, 127.0, 127.2, 128.0, 128.5, 130.8, 131.2, 
132.6 (CHAr), 133.0, 134.8, 137.0, 144.8, 146.5, 146.8 (CAr), 192.1 (C=O). 19F NMR (282 MHz, 
CDCl3):  = -73.4 (CF3). IR (KBr): ~= 3065, 3031, 2923, 1721 (w), 1663, 1605 (m), 1583, 1511, 
1443 (w), 1421 (s), 1312, 1264 (m), 1203, 1137 (s), 1083, 1037, 931 (m), 877, 751 (s), 691, 667, 
645, 591 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 434 (M+, 100), 419 (08), 301 (41), 273 (17), 209 










(3'-Methoxybiphenyl-4-yl)(4'-vinylbiphenyl-2-yl)methanone (16a): Starting with 15a (100 mg, 
0.23 mmol), K3PO4 (63 mg, 0.30 mmol), Pd (PPh3)4 (3 mol%), 4-
vinylphenylboronic acid (44 mg, 0.30 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 16a was isolated as yellow oil; yield 63 mg, (70 
%); 1H NMR (300 MHz, CDCl3):  = 3.76 (s, 3H, OCH3), 5.08-5.12 
(dd, 1H, J = 1.7, 10.8 Hz, CH2), 5.55-5.61 (dd, 1H, J = 1.2, 17.6 Hz, 
CH2), 6.48-6.57 (dd, 1H, J = 10.8, 17.6 Hz, CH), 6.81-6.85 (m, 1H, 
ArH), 6.99 (t, 1H, J = 1.7 Hz, ArH), 7.03-7.07 (m, 1H, ArH), 7.18 (s, 
4H, ArH), 7.24 (t, 1H, J = 7.9 Hz, ArH), 7.40-7.47 (m, 6H, ArH), 7.66 (d, 2H, J = 8.4 Hz, ArH); 
13C NMR (75.47 MHz, CDCl3):  = 55.3 (OCH3), 113.0, 113.5 (CHAr), 114.0 (CH2), 119.7, 126.2, 
126.9, 127.0, 128.7, 129.1, 129.9, 130.0, 130.3, 130.5 (CHAr), 136.2 (CAr), 136.3 (CHAr), 136.6, 
138.9, 139.6, 140.7, 141.3, 145.4, 160.0 (CAr), 198.1 (C=O). IR (KBr): ~= 3054, 3001, 2953, 
2851, 1725 (w), 1660, 1582, 1512, 1477, 1464, 1398, 1308 (m), 1212, 1170, 1116, 1050, 1012, 
1003, 992 (m), 927, 842, 767, 743, 690 (s), 667, 641, 568 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 
390 (M+, 100), 373 (09), 283 (04), 211 (42), 178 (24), 152 (13), 101 (05); HRMS (EI) calcd for 
C28H22O2 [M+]: 390.16143, found 390.161279. 
 
(2',5'-Dimethoxybiphenyl-4-yl)(4'-vinylbiphenyl-2-yl)methanone (16b): Starting with 15b (100 
mg, 0.21 mmol), K3PO4 (57 mg, 0.27 mmol), Pd (PPh3)4 (3 
mol%), 4-vinylphenylboronic acid (40 mg, 0.27 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 16b was isolated as colorless oil; 
yield 65 mg, (72 %); 1H NMR (300 MHz, CDCl3):  = 3.61 (s, 
6H, 2OCH3), 5.12 (d, 1H, J = 11.3 Hz, CH2), 5.58-5.64 (dd, 1H, J 
= 1.4, 17.6 Hz, CH2), 6.56 (d, 1H, J = 8.4 Hz, CH), 7.17 (s, 1H, 
ArH), 7.22 (s, 4H, ArH), 7.24-7.27 (m, 3H, ArH), 7.34-7.48 (m, 
5H, ArH), 7.68 (d, 2H, J = 8.3 Hz, ArH); 13C NMR (75.47 MHz, CDCl3):  = 55.9 (2OCH3), 104.2, 
104.4 (CHAr), 113.8 (CH2), 118.5 (CAr), 126.1, 126.8, 128.8, 128.9, 129.2, 129.3, 129.4, 130.1, 
130.6, 130.9 (CHAr), 135.5 (CAr), 136.4 (CHAr), 136.6, 139.0, 139.5, 139.8, 141.0, 157.5 (CAr), 
198.1 (C=O). IR (KBr): ~= 3056, 3002, 2954, 2851, 1724 (w), 1661, 1601, 1587, 1514, 1441, 
1432, 1401, 1330, 1277 (m), 1244 (s), 1183, 1171, 1033, 1001, 953, 879, 798, 768, 755, 693, 638, 
611, 572 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 420 (M+, 100), 403 (07), 241 (40), 198 (10), 178 









(2',6'-Dimethoxybiphenyl-4-yl)(4'-vinylbiphenyl-2-yl)methanone (16c): Starting with 15c (100 
mg, 0.21 mmol), K3PO4 (57 mg, 0.27 mmol), Pd (PPh3)4 (3 mol%), 4-
vinylphenylboronic acid (40 mg, 0.27 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 16c was isolated as yellow oil; yield 62 mg, (68 
%); 1H NMR (300 MHz, CDCl3):  = 3.59 (s, 6H, 2OCH3), 5.08-5.12 
(dd, 1H, J = 1.7, 10.8 Hz, CH2), 5.57-5.63 (dd, 1H, J = 1.8, 17.6 Hz, 
CH2), 6.54 (d, 1H, J = 8.4 Hz, CH), 7.14-7.21 (m, 6H, ArH), 7.24 (d, 
2H, J = 8.4 Hz, ArH), 7.33-7.36 (m, 1H, ArH), 7.41-7.46 (m, 4H, ArH), 7.66 (d, 2H, J = 8.4 Hz, 
ArH); 13C NMR (62.90 MHz, CDCl3):  = 55.9 (2OCH3), 104.4 (CHAr), 113.8 (CH2), 118.5 (CAr), 
126.1, 126.7, 128.9, 129.2, 129.3, 129.4, 130.1, 130.6, 130.9 (CHAr), 135.5 (CAr), 136.4 (CHAr), 
136.5, 139.0, 139.5, 139.8, 141.0, 157.5 (CAr), 198.1 (C=O). IR (KBr): ~= 3054, 3029, 2951, 
2857, 1726 (w), 1667, 1623, 1593, 1517, 1443, 1435, 1403, 1332, 1279 (m), 1245 (s), 1187, 1173, 
1035, 1003, 957, 881, 783, 761, 757, 689, 632, 609, 571 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 
420 (M+, 100), 403 (08), 241 (35), 198 (09), 178 (23), 152 (07), 127 (05); HRMS (EI) calcd for 
C29H24O3 [M+]: 420.17200, found 420.171372. 
 
(2'-Ethoxybiphenyl-4-yl)(4'-vinylbiphenyl-2-yl)methanone (16d): Starting with 15d (100 mg, 
0.22 mmol), K3PO4 (61 mg, 0.29 mmol), Pd (PPh3)4 (3 mol%), 4-
vinylphenylboronic acid (42 mg, 0.29 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 16d was isolated as pink oil; yield 56 mg, 
(62 %); 1H NMR (300 MHz, CDCl3):  = 1.21 (t, 3H, J = 6.9 Hz, 
CH3), 3.92 (q, 2H, J = 6.9 Hz, OCH2), 5.09-5.13 (dd, 1H, J = 1.7, 
10.8 Hz, CH2), 5.56-5.62 (dd, 1H, J = 1.8, 17.6 Hz, CH2), 6.49-
6.59 (dd, 1H, J = 10.8, 17.6 Hz, CH), 6.86-6.59 (m, 2H, ArH), 7.15-7.21 (m, 6H, ArH), 7.40-7.46 
(m, 6H, ArH), 7.65 (d, 2H, J = 8.5 Hz, ArH); 13C NMR (75.47 MHz, CDCl3):  = 14.7 (CH3), 64.1 
(OCH2), 112.8 (CHAr), 113.9 (CH2), 118.5 (CAr), 120.9, 126.1, 126.9, 128.8, 129.1, 129.3, 129.4, 
129.7, 130.0, 130.2, 130.7 (CHAr), 135.5 (CAr), 136.3 (CHAr), 136.5, 139.1, 139.7, 140.8, 143.5, 
155.8 (CAr), 198.3 (C=O). IR (KBr): ~= 3056, 3031, 2954, 2850, 1724 (w), 1661, 1599 (s), 1580, 
1511, 1473, 1446, 1401, 1311 (m), 1277, 1260, 1237 (s), 1185, 1150, 1039, 988 (m), 927 (s), 860, 
803, 785, 708, 666, 628, 541 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 404 (M+, 100), 375 (18), 357 
(10), 225 (23), 197 (14), 178 (44), 168 (13), 139 (12), 115 (06); HRMS (EI) calcd for C29H24O2 









(4'-Vinylbiphenyl-2-yl)(3'-vinylbiphenyl-4-yl)methanone (16e): Starting with 15e (100 mg, 0.23 
mmol), K3PO4 (61 mg, 0.30 mmol), Pd (PPh3)4 (3 mol%), 4-
vinylphenylboronic acid (44 mg, 0.30 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 16e was isolated as colorless oil; yield 59 
mg, (66 %); 1H NMR (300 MHz, CDCl3):  = 5.01-5.11 (dd, 1H, J 
= 1.7, 10.8 Hz, CH2vinyl), 5.19-5.24 (dd, 1H, J = 1.7, 11.2 Hz, 
CH2vinyl), 5.54-5.61 (dd, 1H, J = 1.7, 17.5 Hz, CH2vinyl), 5.68-5.74 
(dd, 1H, J = 1.6, 17.5 Hz, CH2vinyl), 6.47-6.57 (dd, 1H, J = 10.8, 17.5 Hz, CHvinyl), 6.62-6.72 (dd, 
1H, J = 10.8, 17.5 Hz, CHvinyl), 7.18 (s, 4H, ArH), 7.31-7.38 (m, 4H, ArH), 7.40-7.48 (m, 5H, 
ArH), 7.66 (d, 2H, J = 8.5 Hz, ArH); 13C NMR (75.47 MHz, CDCl3):  = 114.0, 114.6 (2CH2vinyl), 
125.2, 125.9, 126.2, 126.7, 126.9, 127.0, 128.7, 129.0, 129.1, 130.0, 130.3, 130.5 (CHAr), 136.1 
(CAr), 136.3, 136.5 (CHAr), 136.6, 138.2, 138.9, 139.6, 140.2, 140.7, 145.4 (CAr), 198.2 (C=O). IR 
(KBr): ~= 3043, 3029, 2952, 2847, 1721 (w), 1657, 1597 (s), 1579, 1513, 1475, 1447, 1403, 1317 
(m), 1266, 1253, 1235 (s), 1187, 1153, 1041, 987 (m), 925 (s), 861, 803, 783, 708, 665, 627, 543 
(m) cm-1; GC-MS (EI, 70 eV): m/z (%): 386 (M+, 100), 359 (10), 281 (04), 207 (50), 193 (07), 178 
(53), 152 (16); HRMS (EI) calcd for C29H22O [M+]: 386.16652, found 386.165803. 
 
(4'-Tert-butylbiphenyl-4-yl)(4'-vinylbiphenyl-2-yl)methanone (16f): Starting with 15f (100 mg, 
0.21 mmol), K3PO4 (59 mg, 0.28 mmol), Pd (PPh3)4 (3 mol%), 4-
vinylphenylboronic acid (41 mg, 0.28 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 16f was isolated as yellow oil; yield 58 mg, 
(64 %); 1H NMR (300 MHz, CDCl3):  = 1.26 (s, 9H, 3CH3), 5.07-
5.11 (dd, 1H, J = 1.8, 10.8 Hz, CH2), 5.54-5.60 (dd, 1H, J = 1.8, 
17.5 Hz, CH2), 6.47-6.57 (dd, 1H, J = 10.8, 17.6 Hz, CH), 7.17 (s, 
4H, ArH), 7.35-7.39 (m, 4H, ArH), 7.42-7.49 (m, 6H, ArH), 7.66 
(d, 2H, J = 10.2 Hz, ArH). 13C NMR (62.90 MHz, CDCl3):  = 31.2 (3CH3), 34.6 (C), 125.8, 126.2, 
126.6, 126.9, 127.0, 128.6, 129.1, 130.0, 130.2, 130.5 (CHAr), 135.8 (CAr), 136.3 (CHAr), 136.5, 
136.9, 139.0, 139.6, 140.7, 145.3, 151.4 (CAr), 198.2 (C=O). IR (KBr): ~= 3055, 3030, 2956 (w), 
1724, 1661, 1600 (m), 1573, 1514, 1476, 1440, 1392, 1311 (w), 1276 (s), 1242, 1183, 1150, 1112, 
1070, 1018, 987, 951 (w), 927 (s), 907, 861, 842, 781 (m), 756, 722 (s), 696, 649, 570 (w) cm-1; 
GC-MS (EI, 70 eV): m/z (%): 416 (M+, 100), 401 (92), 383 (05), 281 (05), 237 (10), 207 (20), 178 






(3',5'-Dimethylbiphenyl-4-yl)(4'-vinylbiphenyl-2-yl)methanone (16g): Starting with 15g (100 
mg, 0.23 mmol), K3PO4 (63 mg, 0.30 mmol), Pd (PPh3)4 (3 mol%), 
4-vinylphenylboronic acid (44 mg, 0.30 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 16g was isolated as colorless viscous oil; 
yield 68 mg, (76 %); 1H NMR (250 MHz, CDCl3):  = 2.28 (s, 6H, 
2CH3), 5.10 (d, 1H, J = 11.5 Hz, CH2), 5.54-5.62 (dd, 1H, J = 1.6, 
17.6 Hz, CH2), 6.47-6.58 (dd, 1H, J = 10.8, 17.6 Hz, CH), 6.93 (s, 
1H, ArH), 7.08 (s, 2H, ArH), 7.18 (s, 4H, ArH), 7.36-7.48 (m, 6H, 
ArH), 7.64 (d, 2H, J = 8.4 Hz, ArH). 13C NMR (62.90 MHz, CDCl3):  = 21.3 (2CH3), 113.9 
(CH2vinyl), 125.1, 126.2, 126.8, 127.0, 128.6, 129.1, 129.8, 130.0, 130.2, 130.4 (CHAr), 135.8 (CAr), 
136.3 (CHAr), 136.5, 138.4, 139.0, 139.6, 139.8, 140.7, 145.8 (CAr), 198.2 (C=O). IR (KBr): ~= 
3019, 2916, 1724 (w), 1661 (m), 1598 (s), 1556, 1475, 1440, 1397, 1313 (m), 1277 (s), 1209, 1184, 
1150, 1117, 1071, 1033, 1002, 987 (m), 928 (s), 907, 781, 768, 695, 646, 581 (m) cm-1; GC-MS 
(EI, 70 eV): m/z (%): 388 (M+, 100), 371 (10), 209 (28), 194 (05), 178 (21), 165 (22), 152 (06); 
HRMS (EI) calcd for C29H24O [M+]: 388.18217, found 388.182014. 
 
(4'-Ethylbiphenyl-4-yl)(4'-vinylbiphenyl-2-yl)methanone (16h): Starting with 15h (100 mg, 
0.23 mmol), K3PO4 (63 mg, 0.30 mmol), Pd (PPh3)4 (3 mol%), 
4-vinylphenylboronic acid (44 mg, 0.30 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 16h was isolated as colorless oil; yield 
66 mg, (74 %); 1H NMR (250 MHz, CDCl3):  = 1.16 (t, 3H, J 
= 7.6 Hz, CH3), 2.58 (q, 2H, J = 7.6 Hz, CH2CH3), 5.06 (d, 1H, 
J = 11.5 Hz, CH2), 5.52-5.60 (dd, 1H, J = 1.7, 17.6 Hz, CH2), 
6.45-6.56 (dd, 1H, J = 10.8, 17.5 Hz, CH), 7.17 (s, 4H, ArH), 7.32 (d, 2H, J = 6.2 Hz, ArH), 7.37 
(d, 2H, J = 6.8 Hz, ArH), 7.39-7.49 (m, 6H, ArH), 7.64 (d, 2H, J = 8.4 Hz, ArH). 13C NMR (62.90 
MHz, CDCl3):  = 15.5 (CH3), 28.5 (CH2Ethyl), 114.0 (CH2vinyl), 126.2, 126.6, 127.0, 127.1, 128.4, 
128.6, 129.1, 130.0, 130.2, 130.5 (CHAr), 135.8 (CAr), 136.3 (CHAr), 136.5, 137.1, 139.0, 139.6, 
140.7, 144.5, 145.5 (CAr), 198.1 (C=O). IR (KBr): ~= 3053, 2926, 1725 (w), 1660, 1598 (s), 1574, 
1523, 1514, 1476, 1440, 1399, 1310 (m), 1277 (s), 1189, 1118, 1060, 1032, 1003, 987 (m), 928 (s), 
908, 842, 780 (m), 735 (s), 700, 654, 539 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 388 (M+, 100), 










4-Benzoyl-1,2-phenylene bis(trifluoromethanesulfonate) (18): Starting with 17 (168 mg, 1.0 
mmol), pyridine (0.32 ml, 4.0 mmol) and  Tf2O (0.39 ml, 2.4 mmol), 18 
was isolated as a colorless oil, yield, (318 mg, 84 %); 1H NMR (300 MHz, 
CDCl3):  = 7.44-7.60 (m, 5H, ArH), 7.68-7.72 (m, 2H, ArH), 7.86 (s, 1H, 
ArH); 13C NMR (62.89 MHz, CDCl3):  = 115.9 (q, JF,C = 320.0 Hz, CF3), 121.1 (q, JF,C = 321.3 
Hz, CF3), 123.6, 125.2, 128.7, 129.9, 130.9, 133.6 (CHAr), 135.7, 138.7, 140.2, 142.9 (CAr), 192.6 
(C=O). 19F NMR (282 MHz, CDCl3):  = -73.3, 72.0 (2CF). IR (KBr): ~ = 3061, (w), 1598, 1589, 
1580,  (m), 1496, 1431, 1414, 1319, 1291 (m), 1265 (s), 1165, 1077, 1028, 989, 976, 932 (m), 887, 
787, 757 (s), 680, 595, 572 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 478 (M+, 74), 401 (05), 345 
(08), 253 (26), 225 (32), 204 (04), 167 (22), 156 (06), 128 (27), 105 (100), 77 (43), 69 (30), 51 
(14); HRMS (EI) calcd for C15H8F6O7S2 [M+]: 477.96101 found 477.960958. 
 
Phenyl-([1,1';2',1'']terphenyl-4'-yl)-methanone (19a): Starting with 18 (200 mg, 0.46 mmol), 
K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 mol%), phenylboronic acid 
(64 mg, 0.53 mmol) and 1,4-dioxane (5ml/mmol of triflate), 19a was 
isolated as a colorless solid, yield 108 mg, (78 %) mp. = 138-140°C; 1H 
NMR (300 MHz, CDCl3):  = 7.00-7.12 (m, 10H, ArH), 7.38-7.47 (m, 
4H, ArH), 7.72 (d, 1H, J = 6.5 Hz, ArH), 7.74-7.80 (m, 3H, ArH). 13C NMR (75.47 MHz, CDCl3): 
 = 126.9, 127.2, 128.0, 128.1, 128.4, 129.1, 129.7, 129.8, 130.0, 130.6, 132.2, 132.5 (CHAr), 
136.5, 137.7, 138.3, 140.6, 140.7, 144.7 (CAr), 196.3 (C=O). IR (KBr): ~ = 3286, 3010, 2912, 
2854, 2728 (w), 1728, (s), 1574, 1502 (m), 1492, 1452, 1436, 1386, 1328, 1294 (m), 1250 (s), 
1198, 1116, 1064, 1036, 959, 902 (m), 882, 840, 793, 738 (s), 695, 648, 594, 563 (m) cm-1; GC-
MS (EI, 70 eV): m/z (%): 334 (M+, 100), 257 (52), 228 (31), 202 (07), 128 (06), 105 (24), 77 (20); 
HRMS (EI) calcd for C25H18O [M+]: 334.13522, found 334.134837. 
 
Phenyl-(4,4''-Difluoro-[1,1';2',1'']terphenyl-4'-yl)-methanone (19b): Starting with 18 (200 mg, 
0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 mol%), 4-
fluorophenylboronic acid (74 mg, 0.53 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 19b was isolated as a yellow oil, yield 107 mg, 
(69 %); 1H NMR (300 MHz, CDCl3):  = 6.82-6.90 (m, 3H, ArH), 
6.99-7.10 (m, 4H, ArH), 7.40-7.55 (m, 5H, ArH), 7.73-7.80 (m, 4H, ArH). 13C NMR (75.47 MHz, 
CDCl3):  = 115.0, 115.3, 128.4, 129.3, 130.0, 130.5, 131.1, 131.4, 132.1, 132.5 (CHAr), 136.3, 










2996, 2830, (w), 1716, (s), 1656, 1596 (m), 1490, 1456, 1432, 1398, 1317, 1273 (m), 1178, 1118, 
1072, 1054, 945, 936 (m), 843, 827, 796, 746 (s), 695, 642, 581, 532 (m) cm-1; GC-MS (EI, 70 
eV): m/z (%): 370 (M+, 100), 293 (58), 264 (17), 244 (19), 105 (22), 77 (16); HRMS (EI) calcd for 
C25H16OF2 [M+]: 370.11637, found 370.116373. 
 
Phenyl-(3,5,3'',5''-tetramethyl-[1,1';2',1'']terphenyl-4'-yl)-methanone (19c): Starting with 18 
(200 mg, 0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 3,5-dimethylphenylboronic acid (79 mg, 0.53 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 19c was isolated as a colorless 
crystalline solid, yield 123 mg, (75 %) mp. = 140-142°C; 1H NMR 
(250 MHz, CDCl3):  = 2.09 (s, 6H, 2CH3), 2.11 (s, 6H, 2CH3), 
6.68 (d, 3H, J = 4.45 Hz, ArH), 6.75 (d, 2H, J = 6.55 Hz, ArH), 
7.38-7.48 (m, 5H, ArH), 7.68, 7.72 (dd, 1H, J = 1.85, 9.8 Hz, ArH), 7.75 (m, 3H, ArH). 13C NMR 
(75.46 MHz, CDCl3):  = 21.2 (2CH3), 21.3 (2CH3), 125.1, 127.5, 127.7, 128.3, 128.6, 128.8, 
130.0, 130.4, 132.1, 132.3 (CHAr), 136.3, 137.1, 137.8, 138.1, 140.4, 140.9, 144.9 (CAr), 196.4 
(C=O). IR (KBr): ~ = 3289, 3013, 2916, 2857, 2732 (w), 1732, (s), 1574 1505 (m), 1495, 1455, 
1436, 1386, 1328, 1296 (m), 1250 (s), 1199, 1118, 1067, 1036, 959, 902 (m), 882, 842, 793, 738 
(s), 695, 648, 596, 567 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 390 (M+, 100), 313 (29), 270 (13), 
239 (07), 148 (04), 105 (22), 77 (11); HRMS (EI) calcd for C29H26O [M+]: 390.19782, found 
390.197629. 
 
Phenyl-(2,4,2'',4''-tetramethoxy-[1,1';2',1'']terphenyl-4'-yl)-methanone (19d): Starting with 18 
(200 mg, 0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 2,4-dimethoxyphenylboronic acid (96 mg, 0.53 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 19d was isolated as a colorless 
oil, yield 140 mg, (74 %) mp. = 136-138°C; 1H NMR (250 MHz, 
CDCl3):  = 3.53, 3.55, 3.77, 3.78 (s, 12H, 4OCH3), 6.35-6.41 (m, 3H, ArH), 6.93 (t, 1H, J = 8.9 
Hz, ArH), 7.48-7.57 (m, 5H, ArH), 7.81-7.92 (m, 5H, ArH). 13C NMR (75.46 MHz, CDCl3):  = 
55.1, 55.3 (4OCH3), 98.2, 103.9 (CHArH), 123.0 (CArH), 128.1, 128.4, 130.0, 131.0, 131.5, 132.0, 
133.1 (CHAr), 135.6, 138.0, 142.9, 157.1, 160.0 (CAr), 196.3 (C=O). IR (KBr): ~ = 3288, 3012, 
2914, 2856, 2730 (w), 1731, (s), 1572, 1505 (m), 1495, 1455, 1436, 1386, 1328, 1296 (m), 1250 











GC-MS (EI, 70 eV): m/z (%): 454 (M+, 100), 377 (03), 227 (05), 105 (37); HRMS (EI) calcd for 
C29H26O5 [M+]: 45417748, found 454.177776. 
 
Phenyl-(2,2''-Dimethoxy-[1,1';2',1'']terphenyl-4'-yl)-methanone (19e): Starting with 18 (200 
mg, 0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 mol%), 2-
methoxyphenylboronic acid (80 mg, 0.53 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 19e was isolated as a colorless solid, yield 110 
mg, (67 %) mp. = 152-154°C; 1H NMR (250 MHz, CDCl3):  = 3.39, 
3.41 (s, 6H, 2OCH3), 6.61-6.77 (m, 2H, ArH), 6.94-7.09 (m, 5H, ArH), 7.35-7.46 (m, 4H, ArH), 
7.75-7.82 (m, 5H, ArH). 13C NMR (62.90 MHz, CDCl3):  = 54.9 (2OCH3), 110.4, 120.0, 128.2, 
128.5, 128.7, 130.0, 130.7, 131.2, 132.1, 132.7 (CHAr), 135.9, 137.9, 138.4, 143.0, 156.0, 156.8 
(CAr), 196.3 (C=O). IR (KBr): ~ = 3055, 3024, 2998, 2832, (w), 1712, (s), 1654, 1597 (m), 1493, 
1459, 1434, 1396, 1317, 1273 (m), 1178, 1118, 1074, 1051, 946, 932 (m), 843, 827, 796, 748 (s), 
695, 642, 581, 531 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 394 (M+, 100), 363 (21), 317 (80), 289 
(20), 274 (46), 259 (11), 202 (18), 158 (15), 105 (83), 77 (68); HRMS (EI) calcd for C27H22O3 
[M+]: 394.15689, found 394.46178. 
 
Phenyl-(4,4'-Dimethoxy-[1,1';2',1'']terphenyl-4'-yl)-methanone (19f): Starting with 18 (200 
mg, 0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 4-methoxyphenylboronic acid (80 mg, 0.53 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 19f  was isolated as a yellow 
oil, yield 90 mg, (54 %); 1H NMR (300 MHz, CDCl3):  = 3.68, 
3.69 (s, 6H, 2OCH3), 6.66-6.71 (m, 4H, ArH), 6.96-7.04 (m, 4H, ArH), 7.37-7.46 (m, 3H, ArH), 
7.68, 7.71 (d, 1H, J = 1.80, 9.75 Hz, ArH), 7.74-7.79 (m, 4H, ArH). 13C NMR (62.90 MHz, 
CDCl3):  = 55.1 (2OCH3), 113.5, 128.3, 128.8, 130.0, 130.5, 130.8, 131.0, 132.3, 132.4, 132.9 
(CHAr), 133.0, 136.2, 137.8, 140.1, 144.2, 158.8 (CAr), 196.3 (C=O). IR (KBr): ~ = 3052, 3022, 
2996, 2830, (w), 1716, (s), 1652, 1596 (m), 1492, 1456, 1432, 1394, 1316, 1272 (m), 1176, 1116, 
1072, 1050, 945, 932 (m), 843, 827, 796, 748 (s), 692, 642, 579, 529 (m) cm-1; GC-MS (EI, 70 
eV): m/z (%): 394 (M+, 100), 317 (11), 289 (04), 258 (03), 202 (07), 105 (24); HRMS (EI) calcd 










Phenyl-(2,2'-diethoxy-[1,1';2',1'']terphenyl-4'-yl)-methanone (19g): Starting with 18 (200 mg, 
0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 mol%), 2-
ethoxyphenylboronic acid (88 mg, 0.53 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 19g was isolated as a colorless solid, yield 135 
mg, (76 %) mp. = 168-170°C; 1H NMR (300 MHz, CDCl3):  = 1.09-
1.15 (m, 6H, 2CH3), 3.64 (q, 4H, J = 6.8 Hz, 2CH2), 6.59-6.70 (m, 4H, ArH), 6.90-6.96 (m, 2H, 
ArH), 7.00-7.10 (m, 2H, ArH), 7.32-7.44 (m, 4H, ArH), 7.72, 7.75 (dd, 1H, J = 1.86, 7.89 Hz, 
ArH), 7.77-7.81 (m, 3H, ArH). 13C NMR (62.90 MHz, CDCl3):  = 14.5, 14.7 (2CH3), 63.1, 63.3 
(2CH2), 111.3, 119.6, 128.2, 128.6, 130.0, 131.0, 131.5, 131.7, 132.1, 132.9 (CHAr), 135.6, 138.0, 
138.5, 143.1, 155.5, 155.6 (CAr), 196.5 (C=O). IR (KBr): ~ = 3048, 3024, 2994, 2832, (w), 1718, 
(s), 1654, 1598 (m), 1494, 1452, 1430, 1396, 1318, 1274 (m), 1178, 1116, 1074, 1052, 947, 932 
(m), 843, 823, 798, 748 (s), 690, 644, 577, 527 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 422 (M+, 
100), 407 (07), 365 (06), 347 (04), 289 (08), 261 (11), 202 (08), 144 (05), 105 (89), 77 (33); 
HRMS (EI) calcd for C29H26O3 [M+]: 422.18765, found 422.187400. 
 
Phenyl-(3,4,3'',4''-tetramethyl-[1,1';2',1'']terphenyl-4'-yl)-methanone (19h): Starting with 18 
(200 mg, 0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 3,4-dimethylphenylboronic acid (79 mg, 0.53 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 19h was isolated as a colorless 
oil, yield 96 mg, (58 %); 1H NMR (300 MHz, CDCl3):  = 2.03, 
2.05, 2.06, 2.08 (s, 12H, 4CH3), 6.71-6.83 (m, 4H, ArH), 6.90 (d, 
2H, J = 6.8 Hz, ArH), 7.30-7.41 (m, 5H, ArH), 7.64, 7.66 (dd, 1H, 
J = 1.8, 7.9 Hz, ArH), 7.72, 7.74 (dd, 2H, J = 1.9, 4.5 Hz, ArH). 13C NMR (62.90 MHz, CDCl3):  
= 19.4, 19.5, 19.7, 19.8 (4CH3), 126.7, 127.3, 128.3, 128.8, 129.2, 130.0, 130.6, 130.8, 130.9, 
132.3 (CHAr), 135.0, 135.4, 136.1, 137.8, 138.2, 140.7, 144.7 (CAr), 196.4 (C=O). IR (KBr): ~ = 
3044, 3020, 2990, 2838, (w), 1716, (s), 1656, 1594 (m), 1492, 1450, 1432, 1396, 1318, 1270 (m), 
1172, 1118, 1072, 1050, 945, 930 (m), 841, 821, 796, 746 (s), 692, 644, 575, 525 (m) cm-1; GC-
MS (EI, 70 eV): m/z (%): 390 (M+, 100), 375 (04), 313 (15), 285 (04), 270 (18), 239 (08), 148 (05), 












Phenyl-(4,4'-diethyl-[1,1';2',1'']terphenyl-4'-yl)-methanone (19i): Starting with 18 (200 mg, 
0.41 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 mol%), 
4-ethylphenylboronic acid (79 mg, 0.53 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 19i was isolated as a colorless solid, yield 
128 mg, (78 %) mp. = 138-140°C; 1H NMR (300 MHz, CDCl3): 
 = 1.06-1.13 (m, 6H, 2CH3), 2.45-2.54 (m, 4H, 2CH2), 6.95-7.02 (m, 8H, ArH), 7.32-7.45 (m, 4H, 
ArH), 7.69, 7.71 (dd, 1H, J = 1.8, 7.9 Hz, ArH), 7.72-7.77 (m, 3H, ArH). 13C NMR (62.90 MHz, 
CDCl3):  = 15.3 (2CH3), 28.4, 28.5 (2CH2), 127.5, 127.6, 128.3, 128.9, 129.6, 129.7, 130.0, 130.7, 
132.3, 132.4 (CHAr), 133.0, 136.6, 137.4, 138.6, 138.7, 142.7 (CAr), 196.3 (C=O). IR (KBr): ~ = 
3046, 3026, 2992, 2834, (w), 1716, (s), 1652, 1596 (m), 1492, 1454, 1432, 1394, 1316, 1276 (m), 
1176, 1114, 1072, 1054, 945, 934 (m), 841, 825, 796, 746 (s), 692, 642, 574, 524 (m) cm-1; GC-
MS (EI, 70 eV): m/z (%): 390 (M+, 100), 375 (06), 313 (16), 241 (12), 105 (58), 77 (17); HRMS 
(EI) calcd for C29H26O [M+]: 390.19782, found 390.197822. 
 
Phenyl-(2,2'-dichloro-[1,1';2',1'']terphenyl-4'-yl)-methanone (19j): Starting with 18 (200 mg, 
0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 mol%), 2-
chlorophenylboronic acid (82 mg, 0.53 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 19j was isolated as a colorless oil, yield 144 mg, 
(68 %); 1H NMR (300 MHz, CDCl3):  = 6.96-7.06 (m, 5H, ArH), 7.20-
7.26 (m, 2H, ArH), 7.39-7.50 (m, 5H, ArH), 7.80-7.86 (m, 4H, ArH). 13C 
NMR (62.90 MHz, CDCl3):  = 126.2, 127.2, 128.3, 128.9, 129.1, 129.7, 130.0, 130.1, 130.9, 
131.2, 132.5, 132.8 (CHAr), 133.0, 136.6, 137.4, 138.6, 138.7, 142.7 (CAr), 196.0 (C=O). 19F NMR 
(282 MHz, CDCl3):  = -73.4 (CF3). IR (KBr): ~ = 3054, 2958, 2842 (w), 1662, 1594 (s), 1558, 
1486 (m), 1442, 1428, 1396, 1312, 1276, 1242 (m), 1211 (s), 1160, 1132, 1096, 1024, 983 (m), 
873, 816, 792, 761 (s), 692, 672, 571 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 402 (M+, 100), 367 
(09), 325 (81), 291 (07), 262 (61), 226 (80), 200 (07), 150 (05), 113 (06), 105 (64), 77 (36), 51 
(06); HRMS (EI) calcd for C25H16Cl2O [M+]: 402.05782 found 402.29994. 
 
4-Benzoyl-3'-methoxybiphenyl-2-yl trifluoromethanesulfonate (20a): Starting with 18 (200 mg, 
0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 mol%), 3-
methoxyphenyl boronic acid (80 mg, 0.53 mmol) and 1,4-dioxane 











124 mg, (68 %); 1H NMR (250 MHz, CDCl3):  = 3.76 (s, 3H, OCH3), 6.89-7.01 (m, 3H, ArH), 
7.28 (d, 1H, J = 7.8 Hz, ArH), 7.40-7.54 (m, 3H, ArH), 7.73-7.81 (m, 2H, ArH). 13C NMR (75.47 
MHz, CDCl3):  = 55.3 (OCH3), 114.7, 114.8, 11.7 (q, JF,C = 320 Hz, CF3), 123.8, 128.6, 129.8, 
129.9, 130.0, 131.9, 133.1 (CHAr), 135.9, 136.5, 138.2, 139.2, 146.4, 159.7 (CAr), 194.0 (C=O). 19F 
NMR (282 MHz, CDCl3):  = -73.8 (CF3). IR (KBr): ~ = 3063, 3003, 2940 (w), 1660, 1598 (s), 
1580, 1552, 1479 (m), 1447, 1421, 1396, 1317, 1278, 1244 (m), 1204 (s), 1179, 1167, 1047, 1020, 
990 (m), 883, 841, 788, 762 (s), 695, 629, 597, 568 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 436 
(M+, 80), 303 (07), 225 (03), 202 (05), 183 (04), 155 (06), 127 (05), 105 (100), 77 (32); HRMS 
(EI) calcd for C21H15O5F3S [M+]: 436.05868 found 436.058307. 
 
4-Benzoyl-2',5'-dimethoxybiphenyl-2-yl trifluoromethanesulfonate (20b): Starting with 18 
(200 mg, 0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 
mol%), 2,5-dimethoxyphenylboronic acid (96 mg, 0.53 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 20b was isolated as a colorless 
solid, yield 140 mg, (72 %) mp. = 138-140°C; 1H NMR (250 MHz, 
CDCl3):  = 3.69 (s, 6H, 2OCH3), 6.61 (d, 1H, J = 8.4 Hz, ArH), 7.18 (s, 1H, ArH), 7.28-7.38 (m, 
2H, ArH), 7.42-7.56 (m, 3H, ArH), 7.70-7.84 (m, 4H, ArH). 13C NMR (75.47 MHz, CDCl3):  = 
55.8 (2OCH3), 103.8, 104.0, 121.1 (q, JF,C = 320 Hz, CF3), 122.7, 128.3, 128.4, 129.0, 130.0, 
130.1, 131.0, 132.8, 133.8 (CHAr), 136.1, 136.8, 137.1, 137.9, 148.0, 157.7 (CAr), 194.3 (C=O). 19F 
NMR (282 MHz, CDCl3):  = -74.6 (CF3). IR (KBr): ~ = 3061, 3005, 2929 (w), 1661, 1590 (s), 
1554, 1472 (m), 1446, 1418, 1399, 1317, 1280, 1244 (m), 1204 (s), 1169, 1137, 1087, 1033, 985 
(m), 880, 844, 794, 766 (s), 699, 671, 587 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 466 (M+, 100), 
333 (28), 302 (24), 225 (32), 197 (04), 105 (84), 77 (28); HRMS (EI) calcd for C22H17O6F3S [M+]: 
466.06925 found 466.068859. 
 
4-Benzoyl-4'-methylbiphenyl-2-yl trifluoromethanesulfonate (20c): Starting with 18 (200 mg, 
0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 mol%), 4-
methoxyphenylboronic acid (72 mg, 0.53 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 20c was isolated as a colorless viscous oil, 
yield 112 mg, (64 %); 1H NMR (250 MHz, CDCl3):  = 2.33 (s, 
3H, OCH3), 7.19 (d, 3H, J = 7.8 Hz, ArH), 7.34 (d, 1H, J = 8.2 Hz, ArH), 7.40-7.55 (m, 5H, ArH), 
7.72-7.77 (m, 3H, ArH). 13C NMR (75.47 MHz, CDCl3):  = 21.3 (CH3), 121.1 (q, JF,C = 321 Hz, 










146.5, 149.2 (CAr), 194.1 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.8 (CF3). IR (KBr): ~ = 
3060, 3027, 2922 (w), 1660, 1597 (s), 1549, 1484 (m), 1446, 1421, 1317, 1277, 1244 (m), 1204 (s), 
1167, 1135, 1098, 1037, 985 (m), 876, 814, 788, 762 (s), 697, 669, 573 (m) cm-1; GC-MS (EI, 70 
eV): m/z (%): 420 (M+, 59), 209 (04), 181 (04), 139 (06), 105 (100), 77 (29); HRMS (EI) calcd for 
C21H15O4F3S [M+]: 420.06377 found 420.063160. 
 
4-Benzoyl-3',4',5'-trimethoxybiphenyl-2-yl trifluoromethanesulfonate (20d): Starting with 18 
(200 mg, 0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 
mol%), 3,4,5-trimethoxyphenylboronic acid (112 mg, 0.53 mmol) 
and 1,4-dioxane (5ml/mmol of triflate), 20d was isolated as a 
yellow solid, yield 159 mg, (76 %) mp. = 139-140°C; 1H NMR 
(300 MHz, CDCl3):  = 3.82 (s, 6H, 2OCH3), 3.83 (s, 3H, OCH3), 
6.62 (s, 2H, ArH), 7.39-7.47 (m, 3H, ArH), 7.56 (s, 1H, ArH), 7.68-7.78 (m, 3H, ArH), 7.88 (d, 
1H, J = 6.4 Hz, ArH). 13C NMR (75.47 MHz, CDCl3):  = 56.2 (2OCH3), 61.0 (OCH3), 106.8  
(CHAr), 120 (q, JF,C = 320 Hz, CF3), 122.0, 128.5, 130.0, 130.4, 133.1, 133.3 (CHAr), 135.8, 136.7, 
137.7, 138.6, 149.0, 153.3 (CAr), 194.8 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.8 (CF3). IR 
(KBr): ~ = 3065, 2999, 2936 (w), 1660, 1609 (s),1584, 1514, 1488 (m), 1463, 1418, 1393, 1317, 
1291, 1278 (m), 1241 (s), 1170, 1104, 1063, 1001, 978 (m), 889, 831, 790, 745 (s), 675, 630, 598, 
569 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 496 (M+, 92), 363 (26), 332 (100), 317 (17), 255 (12), 
227 (07), 185 (05), 105 (57), 77 (19); HRMS (EI) calcd for C23H19F3O7S [M+]: 496.07981 found 
496.079887. 
 
4-Benzoyl-4'-tert-butylbiphenyl-2-yl trifluoromethanesulfonate (20e): Starting with 18 (200 
mg, 0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 mol%), 
4-tert-butylphenylboronic acid (94 mg, 0.53 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 20e was isolated as a colorless viscous oil, 
yield 145 mg, (70 %); 1H NMR (300 MHz, CDCl3):  = 1.19, 1.21 
(s, 6H, 2CH3), 1.28 (s, 3H, CH3), 6.97, 7.00 (dd, 1H, J = 1.80, 8.90 
Hz, ArH), 7.12, 7.15 (dd, 1H, J = 2.1, 8.4 Hz, ArH), 7.34, 7.45 (m, 3H, ArH), 7.48-7.54 (m, 4H, 
ArH), 7.72-7.80 (m, 4H, ArH). 13C NMR (75.47 MHz, CDCl3):  = 31.2 (2CH3), 31.3 (CH3), 34.7 
(C), 120 (q, JF,C = 320 Hz, CF3), 123.9, 124.8, 125.6, 128.3, 129.0, 129.4, 130.0, 131.9, 
132.3,133.0 (CHAr), 136.6, 137.9, 138.0, 139.4, 141.0, 146.6, 152.3 (CAr), 194.8 (C=O). 19F NMR 










1462, 1446 (w), 1392, 1317, 1278,1268, 1178, 1117, 1027, 1016, 1001, 973, 954, 854, 765, (m), 
734, 698, 605 (w), 565 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 462 (M+, 39), 447 (100), 299 (35), 
273 (07), 209 (05), 165 (06), 105 (30), 77 (15), 57 (09); HRMS (EI) calcd for C24H21F3O4S [M+]: 
462.11072 found 462.111104. 
 
4-Benzoyl-4'-fluorobiphenyl-2-yl trifluoromethanesulfonate (20f): Starting with 18 (200 mg, 
0.41 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 mol%), 4-
fluorophenylboronic acid (74 mg, 0.53 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 20f was isolated as a colorless solid, yield 88 
mg, (66 %) mp. = 158-160°C; 1H NMR (300 MHz, CDCl3):  = 7.00-
7.17 (m, 2H, ArH), 7.39-7.48 (m, 5H, ArH), 7.50-7.56 (m, 2H, ArH), 7.74-7.82 (m, 3H, ArH). 13C 
NMR (75.47 MHz, CDCl3):  = 115.7, 116.0 (CH), 120.0 (q, JF,C = 321 Hz, CF3), 123.8, 128.5, 
129.1, 129.4, 129.9, 130.0, 131.9, 133.1 (CHAr), 136.5, 138.3, 138.4, 146.4, 161.5, 164.8 (CAr), 
193.9 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.8 (CF3). IR (KBr): ~ = 3066, 2957, 2849 (w), 
1661, 1598 (s), 1552, 1486 (m), 1447, 1421, 1394, 1318, 1279, 1242 (m), 1205 (s), 1160, 1134, 
1096, 1028, 987 (m), 875, 818, 790, 763 (s), 694, 670, 572 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 
424 (M+, 53), 233 (04), 213 (08), 186 (04), 157 (14), 105 (100), 77 (33), 51 (04); HRMS (EI) calcd 
for C20H12O4F4S [M+]: 424.04376 found 424.37142. 
 
(3-Methoxy-4''-vinyl-[1,1';2',1'']terphenyl-4'-yl)-phenyl-methanone (21a): Starting with 20a 
(70 mg, 0.18 mmol), K3PO4 (114 mg, 0.54 mmol), Pd (PPh3)4 (3 
mol%), 4-vinylphenylboronic acid (89 mg, 1.60 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 21a was isolated as colorless 
viscous oil; yield 42 mg, (68 %); 1H NMR (300 MHz, CDCl3):  = 
3.53 (s, 3H, OCH3), 5.10 (dd, 1H, J = 1.4, 9.8 Hz, CH2), 5.58 (dd, 
1H, J = 1.2, 8.1 Hz, CH2), 6.52 (dd, 1H, J = 1.3, 8.2 Hz, CH), 6.52-6.72 (m, 3H, ArH), 7.00-7.20 
(m, 5H, ArH), 7.37-7.50 (m, 4H, ArH), 7.72-7.79 (m, 4H, ArH); 13C NMR (62.89 MHz, CDCl3):  
= 55.1 (OCH3), 113.2 (CHvinyl), 113.9 (CH2), 115.1, 122.1, 125.9, 128.3, 129.1, 129.2, 129.9, 
130.0, 132.1, 132.4, 136.3 (CHAr), 136.7, 137.6, 140.0, 140.1, 140.3, 141.8, 144.4, 159.2, (CAr), 
196.2 (C=O). IR (KBr): ~ = 3055, 3003, 2953, 2833 (w), 1655 (s), 1628 (w), 1595 (s), 1513 (w), 
1494, 1464, 1427, 1389, 1294 (m), 1248 (s), 1177, 1114, 1074, 1018, 989, 947 (m), 869, 842, 783, 








(15), 285 (04), 239 (09), 105 (33), 77 (16); HRMS (EI) calcd for C28H22O2 [M+]: 390.16143, found 
390.161704. 
 
(4-Methyl-4''-vinyl-[1,1';2',1'']terphenyl-4'-yl)-phenyl-methanone (21b): Starting with 20c (70 
mg, 0.18 mmol), K3PO4 (114 mg, 0.54 mmol), Pd (PPh3)4 (3 
mol%), 4-vinylphenylboronic acid (89 mg, 1.60 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 21b was isolated as colorless solid, 
mp= 148-150°C; yield 48 mg, (78 %); 1H NMR (300 MHz, 
CDCl3):  = 2.24 (s, 3H, CH3), 5.15 (d, 1H, J = 10.8 Hz, CH2), 5.66 (d, 1H, J = 9.6 Hz, CH2), 6.63 
(dd, 1H, J = 1.3, 8.2 Hz, CH), 6.96-7.00 (m, 2H, ArH), 7.16-7.21 (m, 3H, ArH), 7.41-7.51 (m, 6H, 
ArH), 7.72-7.80 (m, 5H, ArH); 13C NMR (62.90 MHz, CDCl3):  = 21.1 (CH3), 113.8 (CH2), 
125.9, 128.3, 128.8, 129.1, 129.5, 130.0, 130.6, 132.2, 132.4, 136.4 (CHAr), 136.9, 137.5, 137.8, 
140.1, 140.3, 144.6, 144.4, 159.2 (CAr), 196.2 (C=O). IR (KBr): ~ = 3052, 3002, 2952, 2830 (w), 
1654 (s), 1630 (w), 1596 (s), 1512 (w), 1496, 1462, 1428, 1390, 1296 (m), 1246 (s), 1178, 1116, 
1072, 1016, 987, 945 (m), 869, 842, 781, 765 (s), 696, 634, 564, 542 (m) cm-1; GC-MS (EI, 70 
eV): m/z (%): 374 (M+, 100), 359 (04), 297 (19), 253 (10), 148 (04), 105 (24), 77 (12); HRMS (EI) 
calcd for C28H22O1 [M+]: 374.16652, found 374.166329. 
 
Phenyl-(3,4,5-trimethoxy-4''-vinyl-[1,1';2',1'']terphenyl-4'-yl)-methanone (21c): Starting with 
20d (70 mg, 0.18 mmol), K3PO4 (114 mg, 0.54 mmol), Pd (PPh3)4 
(3 mol%), 4-vinylphenylboronic acid (89 mg, 1.60 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 21c was isolated as colorless 
viscous oil; yield 40 mg, (64 %); 1H NMR (300 MHz, CDCl3):  
= 3.54 (s, 6H, 2OCH3), 3.75 (s, 3H, OCH3), 5.19 (dd, 1H, J = 1.3, 
10.8 Hz, CH2), 5.69 (dd, 1H, J = 2.1, 9.6 Hz, CH2), 6.63 (dd, 1H, J = 1.3, 8.2 Hz, CH), 7.09 (d, 1H, 
J = 8.2 Hz, ArH), 7.24-7.36 (m, 4H, ArH), 7.40-7.48 (m, 3H, ArH), 7.50-7.65 (m, 3H, ArH), 7.71 
(dd, 1H, J = 1.8, 7.9 Hz, ArH), 7.80-7.86 (m, 3H, ArH); 13C NMR (62.90 MHz, CDCl3):  = 55.9 
(2OCH3), 60.9 (OCH3), 107.3 (CHvinyl), 114.2 (CH2), 125.9, 128.0, 128.3, 129.6, 130.0, 131.6, 
135.0, 135.8, 136.4 (CHAr), 136.9, 137.5, 137.8, 140.1, 140.3, 144.6, 144.4, 152.7 (CAr), 196.2 
(C=O). IR (KBr): ~ = 3054, 3002, 2952, 2830 (w), 1654 (s), 1630 (w), 1596 (s), 1512 (w), 1496, 
1462, 1428, 1390, 1296 (m), 1246 (s), 1178, 1116, 1072, 1016, 987, 945 (m), 869, 842, 781, 765 
(s), 696, 634, 564, 542 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 450 (M+, 100), 435 (20), 332 (05), 










(4-tert-Butyl-4''-vinyl-[1,1';2',1'']terphenyl-4'-yl)-phenyl-methanone (21d): Starting with 20e 
(70 mg, 0.18 mmol), K3PO4 (114 mg, 0.54 mmol), Pd (PPh3)4 (3 
mol%), 4-vinylphenylboronic acid (89 mg, 1.60 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 21d was isolated as colorless Solid, 
mp= 138-140°C; yield 39 mg, (62 %); 1H NMR (300 MHz, CDCl3): 
 = 1.21 (s, 3H, CH3), 1.22 (s, 6H, 2CH3), 5.13 (dd, 1H, J = 1.2, 
10.6 Hz, CH2), 5.61 (dd, 1H, J = 2.4, 9.5 Hz, CH2), 6.55 (dd, 1H, J = 1.3, 8.2 Hz, CH), 7.00-7.10 
(m, 4H, ArH), 7.15-7.23 (m, 4H, ArH), 7.40-7.54 (m, 4H, ArH), 7.72-7.81 (m, 4H, ArH); 13C 
NMR (62.90 MHz, CDCl3):  = 31.3 (2CH3), 34.5 (CH3), 113.8 (CH2), 125.0, 125.8, 128.3, 129.1, 
129.3, 129.6, 130.0, 130.7, 132.2, 132.3, 136.4 (CHAr), 136.9, 137.1, 137.3, 137.7, 140.1, 140.2, 
144.5, 150.2 (CAr), 196.2 (C=O). IR (KBr): ~ = 3052, 3006, 2956, 2832 (w), 1656 (s), 1632 (w), 
1598 (s), 1516 (w), 1496, 1464, 1432, 1392, 1298 (m), 1246 (s), 1178, 1118, 1072, 1014, 985, 943 
(m), 869, 842, 785, 765 (s), 694, 634, 562, 541 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 416 (M+, 
87), 401 (100), 252 (06), 105 (53), 77 (23); HRMS (EI) calcd for C31H28O [M+]: 416.21347, found 
416.213534. 
 
(3,4-bis((4-tert-butylphenyl)ethynyl) phenyl)(phenyl) methanone (22a): Starting with 18 
(238mg, 0.50 mmol), Pd (PPh3)4  (5 mol%), dry CuI (10 mol%), 
triethylamine (126 mg, 1.25 mmol), p-terbutylphenylacetylene 
(51mg, 0.55 mmol) was added  in DMF (5mL per 1 mmol of 2a),  
22a was isolated after chromatography (silica gel, n-
heptane/EtOAc) as a colourless oil (41mg, 78%). 1H NMR (250 
MHz, CDCl3):  = 1.26, 1.27 (s, 18H, 2 tBu), 7.16 (s, 1H, ArH), 
7.28-7.33 (m, 3H, ArH), 7.41-7.48 (m, 3H, ArH), 7.51-7.59 (m, 3H, ArH), 7.64-7.75 (m, 5H, ArH), 
7.88 (d, 1H, J = 1.65 Hz, ArH). 13C NMR (62.90 MHz, CDCl3):  = 30.9, 31.1 (6 CH3), 87.0, 87.4, 
94.6, 96.8, 119.8, 119.9 (C), 125.4, 125.5 (CHAr), 126.0 (CAr), 128.4, 128.9 (CHAr), 129.7 (CAr), 
129.9, 131.4, 131.6, 131.7, 132.6, 133.3 (CHAr), 136.4, 137.2, 152.0, 152.2 (CAr), 195.3 (C=O). IR 
(KBr): ~ = 3083, 3060, 2959, 2866, 2211 (w), 1714 (s), 1659 (s), 1591, 1506, 1462, 1406, 1363, 
1322 (m), 1268 (s), 1201, 1163, 1104, 1084, 982, 968, 882, 872, 792, 742, 651, 615, 528 (w) cm-1; 
GC-MS (EI, 70 eV): m/z (%): 494 (M+, 100), 479 (50), 262 (04), 232 (19), 204 (05), 105 (18), 77 






(3,4-Bis(phenylethynyl)phenyl)(phenyl)methanone (22b): Starting with 18 (238mg, 0.50 mmol), 
Pd (PPh3)4  (5 mol%), dry CuI (10 mol%), triethylamine (126 mg, 
1.25 mmol), phenylacetylene (56mg, 0.59 mmol) was added  in 
DMF (5mL per 1 mmol of 2a), 22b was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a colourless oil 
(24 mg, 54%). 1H NMR (250 MHz, CDCl3):  = 7.23-7.27 (m, 4H, 
ArH), 7.37 (s, 1H, ArH), 7.40-7.54 (m, 6H, ArH), 7.57 (s, 1H, 
ArH), 7.62 (d, 1H, J = 1.72 Hz, ArH), 7.66 (d, 1H, J = 1.72 Hz, ArH), 7.69-7.73 (m, 3H, ArH), 
7.88 (d, 1H, J = 1.62 Hz, ArH)). 13C NMR (62.90 MHz, CDCl3):  = 87.5, 87.9, 94.5, 96.6 (C), 
120.4, 122.8 (CAr), 125.3, 128.2, 128.4, 128.5, 128.7, 128.9, 129.1, 129.9, 131.7, 131.8, 132.7, 
133.3 (CHAr), 133.5, 136.7, 137.1 (CAr), 195.2 (C=O). IR (KBr): ~ = 3081, 3062, 2958, 2864, 2210 
(w), 1716 (s), 1658 (s), 1592, 1508, 1464, 1408, 1362, 1320 (m), 1266 (s), 1203, 1161, 1106, 1082, 
981, 967, 881, 873, 792, 741, 653, 613, 523 (w) cm-1; GC-MS (EI, 70 eV): m/z (%): 382 (M+, 100), 
352 (18), 305 (06), 276 (28), 250 (04), 176 (08), 77 (11); HRMS (EI) calcd for C29H18O [M+]: 
382.13522, found 382.134497. 
 
(3,4-Bis((3-methoxyphenyl)ethynyl)phenyl)(phenyl) methanone (22c): Starting with 18 (238mg, 
0.50 mmol), Pd (PPh3)4  (5 mol%), dry CuI (10 mol%), 
triethylamine (126 mg, 1.25 mmol), 3-methoxyphenylacetylene 
(48mg, 0.52 mmol) was added  in DMF (5mL per 1 mmol of 2a), 
22c was isolated after chromatography (silica gel, n-
heptane/EtOAc) as a colorless viscous oil (28mg, 64%). 1H NMR 
(300 MHz, CDCl3):  = 3.68, 3.69 (s, 6H, 2OCH3), 6.81-6.87 (m, 
2H, ArH), 7.00-7.06 (m, 2H, ArH), 7.08-7.20 (m, 4H, ArH), 7.41-
7.46 (m, 2H, ArH), 7.52-7.60 (m, 2H, ArH), 7.66, 7.69 (dd, 1H, J = 1.74, 8.07 Hz, ArH), 7.72-7.75 
(m, 2H, ArH), 7.90 (d, 1H, J = 1.71 Hz, ArH). 13C NMR (62.90 MHz, CDCl3):  = 55.2 (2OCH3), 
87.3, 87.6, 94.4, 96.5 (4 C), 115.6, 115.8, 116.2, 116.3 (CHAr), 123.7, 123.8 (CAr), 124.2, 124.3 
(CHAr), 126.0 (CAr), 128.4, 129.2, 129.4, 129.5, 129.9, 131.6, 132.7, 133.2 (CHAr), 136.7, 137.1, 
159.4 (CAr), 195.2 (C=O). IR (KBr): ~ = 3061 (w), 2998, 2832 (m), 2203 (w), 1656 (m), 1591 (s), 
1540, 1488, 1446, 1402, 1317 (m), 1279, 1219 (s), 1179, 1127, 1091, 985, 972, 869, 848 (m), 777, 
710, 681 (s), 603, 562 (w) cm-1; GC-MS (EI, 70 eV): m/z (%): 442 (M+, 100), 427 (05), 399 (12), 
365 (18), 337 (07), 250 (12), 105 (37), 77 (15), 57 (05), 44 (41); HRMS (EI) calcd for C31H22O3 







(3,4-Bis(p-tolylethynyl)phenyl)(phenyl) methanone (22d): Starting with 18 (238mg, 0.50 mmol), 
Pd (PPh3)4  (5 mol%), dry CuI (10 mol%), triethylamine (126 
mg, 1.25 mmol), p-methylphenylacetylene (56 mg, 0.61 
mmol) was added  in DMF (5mL per 1 mmol of 2a),  22d was 
isolated after chromatography (silica gel, n-heptane/EtOAc) as 
a reddish oil (32 mg, 66%). 1H NMR (300 MHz, CDCl3):  = 
2.28, 2.29 (s, 6H, 2CH3), 7.00-7.10 (m, 4H, ArH), 7.36-7.44 
(m, 6H, ArH), 7.50-7.57 (m, 2H, ArH), 7.63 (dd, 1H, J = 1.77 8.10 Hz, ArH), 7.70-7.74 (m, 2H, 
ArH), 7.87 (d, 1H, J = 1.71Hz, ArH). 13C NMR (62.90 MHz, CDCl3):  = 21.2, 21.5 (2CH3), 87.0, 
87.4, 94.7, 96.9 (CAr), 123.8, 125.2, 126.0, 126.6 (CAr), 128.4, 128.9, 129.2, 129.3, 129.5, 129.9, 
131.6, 131.7, 132.6, 133.2 (CHAr), 136.4, 137.2, 138.9, 139.2 (CAr), 195.3 (C=O). IR (KBr): ~ = 
3058, 3025, 2916, 2858, 2204 (w), 1651, 1587, 1514, 1444, 1404, 1317 (m), 1267, 1246 (m), 1177, 
1104, 1040 (w), 981, 913, 871, 834, 787, 664 (m), 612, 586, 560 (w) cm-1; GC-MS (EI, 70 eV): m/z 
(%):410 (M+, 100), 409 (33), 408 (15), 395 (29), 393 (12), 289 (16), 181 (10), 77 (10). HRMS (EI) 
calcd for C31H22O [M+]: 410.16652, found 410.166081. 
 
(3,4-Bis((4-fluorophenyl)ethynyl)phenyl)(phenyl)methanone (22e): Starting with 18 (238mg, 
0.50 mmol), Pd (PPh3)4  (5 mol%), dry CuI (10 mol%), 
triethylamine (126 mg, 1.25 mmol), p-flourophenylacetylene (58 
mg, 0.59 mmol) was added  in DMF (5mL per 1 mmol of 2a),  
22e was isolated after chromatography (silica gel, n-
heptane/EtOAc) as a colorless viscous oil (30 mg, 60%). 1H 
NMR (250 MHz, CDCl3):  = 6.99-7.04 (m, 2H, ArH), 7.14-7.23 
(m, 4H, ArH), 7.25-7.30 (m, 3H, ArH), 7.42-7.47 (m, 2H, ArH), 7.53-7.61 (m, 2H, ArH), 7.66 (d, 
1H, J = 1.47 Hz, ArH), 7.70-7.75 (m, 2H, ArH), 7.90 (d, 1H, J = 1.12 Hz, ArH)). 13C NMR (62.90 
MHz, CDCl3):  = 86.1, 86.9, 92.5, 96.9 (C), 120.4, 122.8 (CAr), 125.1, 127.2, 127.9, 128.2, 128.7, 
129.1, 129.9, 131.7, 132.7, 133.3 (CHAr), 134.0, 135.0, 136.7, 137.1 (CAr), 195.2 (C=O). IR (KBr): 
~ = 3066, 2918, 2859, 2207, 1681 (w), 1648 (s), 1589, 1547, 1486, 1434, 1405, 1278, 1210, 1138, 
1114, 1089, 1073, 937, 918, 867, 777, 695 (m), 605, 596, 546 (w) cm-1; GC-MS (EI, 70 eV): m/z 
(%): 418 (M+ 100), 389 (05), 341 (34), 312 (40), 293 (07), 216 (05), 187 (05), 147 (06), 105 (30), 










(3,4-Bis(m-tolylethynyl)phenyl)(phenyl)methanone (22f): Starting with 18 (238mg, 0.50 mmol), 
Pd (PPh3)4  (5 mol%), dry CuI (10 mol%), triethylamine (126 mg, 
1.25 mmol), 3-methylphenylacetylene (48mg, 0.52 mmol) was 
added  in DMF (5mL per 1 mmol of 2a),  22f was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a colourless oil 
(24mg, 58%). 1H NMR (300 MHz, CDCl3):  = 2.17, 2.18 (s, 6H, 
2CH3), 7.02-7.10 (m, 4H, ArH), 7.35-7.45 (m, 6H, ArH), 7.52-7.59 
(m, 2H, ArH), 7.62 (dd, 1H, J = 1.77 8.10 Hz, ArH), 7.68-7.72 (m, 
2H, ArH), 7.85 (d, 1H, J = 1.71Hz, ArH). 13C NMR (62.90 MHz, 
CDCl3):  = 21.2, 21.5 (2CH3), 87.1, 87.9, 94.8, 96.7 (CAr), 123.6, 125.3, 126.0, 126.8 (CAr), 128.3, 
128.4, 128.8, 128.9, 129.1, 129.7, 129.9, 131.5, 132.4, 132.5, 132.7, 133.1, 133.5 (CHAr), 136.2, 
137.6, 138.5, 139.6 (CAr), 195.1 (C=O). IR (KBr): ~ = 3056, 3021, 2914, 2857, 2206 (w), 1653, 
1585, 1513, 1441, 1402, 1315 (m), 1265, 1245 (m), 1177, 1104, 1040 (w), 981, 913, 871, 834, 787, 
664 (m), 612, 586, 560 (w) cm-1; GC-MS (EI, 70 eV): m/z (%): 410 (M+, 100), 333 (23), 305 (08), 
289 (34), 207 (07), 105 (15), 77 (15); HRMS (EI) calcd for C31H22O [M+]: 410.16652, found 
410.166081. 
 
3-Trifourosulphonolyxy-4-methylphenylaceylene-benzophenone (23): Starting with 18 (238mg, 
0.50 mmol), Pd (PPh3)4  (5 mol%), dry CuI (10 mol%), 
triethylamine (126 mg, 1.25 mmol), p-methylphenylacetylene 
(45mg, 0.50 mmol) was added  in DMF (5mL per 1 mmol of 
2a),  23 was isolated after chromatography (silica gel, n-
heptane/EtOAc) as a yellow oil (41mg, 51%). 1H NMR (300 
MHz, CDCl3):  = 2.31 (s, 3H, CH3), 7.12 (d, 2H, J = 7.92 Hz, ArH), 7.42-7.47 (m, 4H, ArH), 7.55 
(d, 1H, J = 7.13 Hz, ArH), 7.63-7.67 (m, 2H, ArH), 7.70-7.74 (m, 3H, ArH). 13C NMR (75.47 
MHz, CDCl3):  = 21.6 (CH3), 81.7, 99.9 (C), 118.6 (CAr), 122.6 (q, JC,F = 320.0 Hz, CF3), 123.1 
(CAr), 128.6, 129.3, 129.4, 129.9, 131.9, 133.1, 133.3 (CAr), 136.4, 138.0, 140.0, 149.3 (CAr), 193.7 
(C=O). IR (KBr): ~ = 3305, 3062, 2922, 2867, 1909 (w), 1659, 1599 (m), 1515, 1446 (w), 1423 
(s), 1319 (m), 1290, 1244 (m), 1171, 1076, 976 (m), 883, 844, 815 (s), 754, 733, 639, 532 (m) cm-
1; GC-MS (EI, 70 eV): m/z (%): 444 (M+, 100), 311 (46), 255 (22), 176 (08), 115 (05), 105 (39), 77 










(4'-Methyl-6-(p-tolylethynyl)biphenyl-3-yl)(phenyl)methanone (24): Starting with (23) (70 mg, 
0.18 mmol), K3PO4 (114 mg, 0.54 mmol), Pd (PPh3)4 (3 
mol%), 4-methylphenylboronic acid (89 mg, 1.60 mmol) and 
1,4-Dioxane (5ml/mmol of triflate), 24 was isolated as 
colorless crystalline solid; yield 40 mg, (64 %); 1H NMR (300 
MHz, CDCl3):  = 2.26, 2.33 (s, 6H, 2CH3), 7.05 (d, 2H, J = 
7.89 Hz, ArH), 7.16-7.20 (m, 4H, ArH), 7.40-7.52 (m, 5H, ArH), 7.60-7.64 (m, 2H, ArH), 7.73 (d, 
1H, J = 1.53 Hz, ArH), 7.76-7.80 (m, 2H, ArH). 13C NMR (62.90 MHz, CDCl3):  = 21.2, 21.5 
(2CH3), 88.4, 95.4 (2C), 125.9 (CAr), 128.2, 128.3, 128.7, 129.1, 129.2, 129.9, 130.9, 131.3, 131.4, 
132.4, 132.4 (CHAr), 132.7, 136.7, 136.8, 137.5, 137.6,138.8, 143.5 (CAr), 195.9 (C=O). IR (KBr): 
~ = 3078, 3057, 3028, 2916, 2858, 2209 (w), 1651, 1591 (s), 1512, 1442, 1412, 1394 (w), 1267, 
1245 (m), 1182, 1143, 1075, 1040, 1016, 999 (w), 951 (m), 909, 857, 838 (w), 748, 697 (m), 610, 
586 cm-1; GC-MS (EI, 70 eV): m/z (%): 386 (M+, 100), 371 (05), 309 (27), 281 (12), 266 (36), 239 
(05), 132 (05), 105 (39), 77 (22); HRMS (EI) calcd for C29H22O [M+]: 386.16652, found 
386.166115. 
 
Methyl 2,5-dihydroxybenzoate (25): 1H NMR (250 MHz, CDCl3):  = 3.86 (s, 3H, OCH3), 6.82 
(s, 1H, ArH), 6.92 (d, J = 2.9 Hz, 1H, ArH),  7.21 (d, 1H, J = 3.2 Hz, ArH), 
10.25 (s, 2H, 2OH); 13C NMR (62.89 MHz, CDCl3):  = 52.3 (OCH3), 112.1 
(CAr), 114.7, 118.5, 124.0 (CHAr), 147.7, 155.7 (2COH), 170.1 (C=O); IR 
(KBr): ~ = 3332, 3029, 2958 (w), 1682, 1615 (s), 1504, 1435, 1367, 1261 (m), 1211 (s), 1185, 
1076, 976 (m), 871, 779, 677 (s), 557 (m), cm-1; GC-MS (EI, 70 eV): m/z (%): 168 (M+, 38), 136 
(100), 108 (24), 80 (16), 69 (03), 63 (02), 53 (13), 44 (01), 39 (02). HRMS (EI) calcd for C8H8O4 
[M+]: 168.04231, found 168.14670. 
 
Methyl 2,5-bis(trifluoromethylsulfonyloxy)benzoate (26): Starting with 25 (168 mg, 1.0 mmol), 
pyridine (0.32 ml, 4.0 mmol) and  Tf2O (0.39 ml, 2.4 mmol), 26 was 
isolated as a colorless crystalline solid, (364 mg, 84 %), mp. = 152-154°C; 
1H NMR (300 MHz, CDCl3):  = 3.92 (s, 3H, OCH3), 7.36 (s, 1H, ArH), 
7.47 (d, 1H, J = 3.0 Hz, ArH),  7.92 (d, 1H, J = 3.2 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 
53.2 (OCH3), 116.5 (q, JC,F = 320.0 Hz, CF3), 120.2 (q, JC,F = 318.0 Hz, CF3), 125.0, 125.6, 127.0 
(CHAr), 147.1, 147.9, 148.0 (CAr), 162.3 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.3 (CF). IR 














1075, 977 (m), 875, 781, 759 (s), 698, 581, 543 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 432 (M+, 
70), 401 (40), 363 (06), 337 (02), 299 (32), 273 (13), 235 (98), 205 (27), 179 (24), 135 (62), 107 
(33), 79 (26), 69 (100), 53 (28); HRMS (EI) calcd for C10H6F6O8S2 [M+]: 431.94028 found 
431.940891. 
 
2,2''-Dimethoxy-[1,1';4',1'']terphenyl-2'-carboxylic acid methyl ester (27a): Starting with 26 
(200 mg, 0.46 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 mol%), 
2-methoxyphenylboronic acid (180 mg, 1.19 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 27a was isolated as colorless viscous oil; yield 
126 mg, (78 %); 1H NMR (300 MHz, CDCl3):  = 3.57 (s, 3H, OCH3), 
3.65 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 6.82 (d, 2H, J = 8.2 Hz, ArH), 
6.90-6.99 (m, 3H, ArH), 7.20-7.29 (m, 3H, ArH), 7.32 (d, 1H, J = 6.9 Hz, ArH), 7.64 (dd, 1H, J = 
1.9, 7.9 Hz, ArH), 7.95 (d, 1H, J = 1.7 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 51.6 (OCH3), 
55.2 (OCH3), 55.5 (OCH3), 110.0, 111.2, 120.7, 120.9, 128.7, 129.0 (CHAr), 129.4 (CAr), 130.0, 
130.4 (CHAr), 130.5 (CAr), 130.8, 130.9 (CHAr), 131.3 (CAr), 132.6 (CHAr), 137.1, 137.4, 156.1, 
156.5 (CAr), 168.7 (C=O). IR (KBr): ~ = 3055, 3024, 2945, 2834 (w), 1720 (m), 1597, 1508 (w), 
1492, 1479, 1433, 1311 (m), 1242 (s), 1179, 1120, 1086, 1053, 1003, 969, 910, 857, 789 (m), 748 
(s), 686, 672, 576 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 348 (M+, 72), 317 (100), 302 (16), 255 
(27), 231 (06), 215 (07), 166 (08), 101 (05); HRMS (EI) calcd for C22H20O4 [M+]: 348.13561, 
found 348.135865. 
 
4,4''-Di-tert-butyl-[1,1';4',1'']terphenyl-2'-carboxylic acid methyl ester (27b): Starting with 26 
(200 mg, 0.46 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 4-tert-butylphenylboronic acid (211 mg, 1.19 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 27b was isolated as a 
colorless crystalline solid; yield 140 mg, (75 %), mp. = 148-
150°C; 1H NMR (300 MHz, CDCl3):  = 1.28 (s, 18H, 6CH3), 
3.58 (s, 3H, OCH3), 7.15-7.25 (m, 4H, ArH), 7.28-7.42 (m, 4H, ArH), 7.49 (s, 1H, ArH), 7.63 (d, 
1H, J = 5.0 Hz, ArH), 7.94 (d, 1H, J = 6.9 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 31.3 
(6CH3), 34.5 (2CtBu), 51.9 (OCH3), 125.0, 125.8, 126.7, 127.0, 128.2, 129.2, 131.2 (CHAr), 131.7, 
132.0, 135.3, 136.8, 137.9, 140.8, 150.8 (CAr), 168.9 (C=O). IR (KBr): ~ = 3031, 2951, 2902 (w), 
1727, 1605, (s), 1483 (m), 1461, 1362, 1267 (m), 1234 (s), 1180, 1085, 959 (m), 895, 788, 765 (s), 









252 (02), 185 (14), 157 (09), 141 (04), 57 (06), 41 (03); HRMS (EI) calcd for C28H32O2 [M+]: 
400.23968, found 400.239581. 
 
3,4,3'',4''-Tetramethoxy-[1,1';4',1'']terphenyl-2'-carboxylic acid methyl ester (27c): Starting 
with 26 (200 mg, 0.46 mmol), K3PO4 (292 mg, 1.38 mmol), 
Pd(PPh3)4 (6 mol%), 3,4-dimethoxyphenylboronic acid (216 
mg, 1.19 mmol) and 1,4-dioxane (5ml/mmol of triflate), 27c 
was isolated as a reddish solid; yield 114 mg, (60 %), mp. = 
140-142°C; 1H NMR (300 MHz, CDCl3):  = 3.62 (s, 3H, 
OCH3), 3.82 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 6.81 (s, 
1H, ArH), 6.85 (s, 2H, ArH), 6.90 (d, 1H, J = 8.3 Hz, ArH), 7.07 (d, 1H, J = 6.2 Hz, ArH), 7.12 
(dd, 1H, J = 2.4, 8.6 Hz, ArH), 7.37 (d, 1H, J = 8.0 Hz, ArH), 7.63 (dd, 1H, J = 2.0, 8.0 Hz, ArH), 
7.87 (d, 1H, J = 1.9 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.1 (OCH3), 55.8 (OCH3), 
56.0 (OCH3), 110.2, 111.9, 111.5, 111.7, 119.4, 120.6, 127.7, 129.2, 130.9 (CHAr), 131.5, 132.6, 
133.5, 139.7, 140.1, 148.4, 148.6, 149.0, 149.6 (CAr), 169.7 (C=O). IR (KBr): ~ = 2922, 2848 (w), 
1724 (s), 1598, 1524, 1488, 1461, 1430, 1321, 1297 (m), 1240, 1215, 1174, 1137, 1090, 1020 (s), 
960, 901, 864, 855, 807, 746, 671, 630, 578 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 408 (M+, 100), 
393 (05), 333 (04), 204 (06), 145 (05); HRMS (EI) calcd for C24H24O6 [M+]: 408.15674, found 
408.157243. 
 
4,4''-Divinyl-[1,1';4',1'']terphenyl-2'-carboxylic acid methyl ester (27d): Starting with 26 (200 
mg, 0.46 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 4-vinylphenylboronic acid (176 mg, 1.19 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 27d was isolated as a yellow 
solid; yield 121 mg, (77 %), mp. = 156-158°C; 1H NMR (300 
MHz, CDCl3):  = 3.61 (s, 3H, OCH3), 5.9 (dd, 1H, J = 1.8, 6.2 Hz, CH2vinyl), 5.23 (dd, 1H, J = 1.6, 
6.9 Hz, CH2vinyl), 5.70 (dd, 1H, J = 1.9, 7.6 Hz, CH2vinyl), 5.76 (dd, 1H, J = 1.8, 6.9 Hz, CH2vinyl), 
6.66 (d, 1H, J = 10.8 Hz, CHvinyl), 6.72 (d, 1H, J = 10.2 Hz, CHvinyl), 7.17 (s, 1H, ArH), 7.35-7.47 
(m, 4H, ArH), 7.54 (d, 1H, J = 8.3 Hz, ArH), 7.66-7.72 (m, 4H, ArH), 7.98 (d, 1H, J = 1.8 Hz, 
ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.0 (OCH3), 114.4, 114.6 (2CH2vinyl), 126.0, 126.7, 
127.1, 128.2, 128.5, 129.5, 131.1, 136.2, 136.4 (CHAr), 136.6, 137.1, 138.9, 139.6, 140.3, 140.8, 
141.3 (CAr), 169.2 (C=O). IR (KBr): ~ = 3085, 3032, 2947, 2923 (w), 1719 (s), 1626, 1481, 1426, 











1; GC-MS (EI, 70 eV): m/z (%): 340 (M+, 100), 309 (09), 281 (04), 265 (12), 162 (08), 133 (05); 
HRMS (EI) calcd for C24H20O2 [M+]: 340.14578, found 340.146235. 
 
3,3''-Dichloro-[1,1';4',1'']terphenyl-2'-carboxylic acid methyl ester  (27e): Starting with 26 
(200 mg, 0.46 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 3-chlorophenylboronic acid (185 mg, 1.19 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 27e was isolated as a colorless 
viscous oil; yield 110 mg, (67 %); 1H NMR (300 MHz, CDCl3):  = 
3.61 (s, 3H, OCH3), 7.10-7.14 (m, 1H, ArH), 7.18-7.24 (m, 2H, 
ArH), 7.26 (s, 1H, ArH), 7.27-7.29 (m, 1H, ArH), 7.31 (d, 1H, J = 6.9 Hz, ArH), 7.42 (t, 1H, J = 
1.8 Hz, ArH), 7.44 (t, 1H, J = 1.6 Hz, ArH), 7.52-7.55 (m, 1H, ArH), 7.63 (dd, 1H, J = 2.0, 8.0 Hz, 
ArH), 7.96 (d, 1H, J = 1.95 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.0 (OCH3), 125.2, 
126.6, 127.2, 127.5, 128.4, 128.4, 129.2, 130.2, 131.2, 133.5, 133.8 (CHAr), 134.9, 135.2, 136.0 
139.2, 140.5, 141.3, 142.5 (CAr), 168.3 (C=O). IR (KBr): ~ = 3057, 2947, 2848 (w), 1719 (s), 
1594, 1566, 1463, 1435, 1311, 1294 (m), 1235 (s), 1192, 1146, 1092, 1054, 1022, 997, 970, 873 
(m), 779, 691 (s), 673, 618, 559 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 356 (M+, 100), 325 (71), 
290 (20), 262 (40), 200 (04), 160 (19), 131 (05), 113 (21), 75 (03); HRMS (EI) calcd for 
C20H14O2Cl2 [M+]: 356.03654, found 356.036229. 
 
[1,1';4',1'']Terphenyl-2'-carboxylic acid methyl ester (27f): Starting with 26 (200 mg, 0.46 
mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 mol%), phenylboronic 
acid (145 mg, 1.19 mmol) and 1,4-dioxane (5ml/mmol of triflate), 27f 
was isolated as a colorless viscous oil; yield 66 mg, (62 %); 1H NMR 
(300 MHz, CDCl3):  = 3.51 (s, 3H, OCH3), 7.22-7.25 (m, 4H, ArH), 
7.26 (s, 1H, ArH), 7.27-7.30 (m, 3H, ArH), 7.46-7.50 (m, 4H, ArH), 7.79 (dd, 1H, J = 1.7, 7.7 Hz, 
ArH); 13C NMR (62.89 MHz, CDCl3):  = 51.9 (OCH3), 125.7, 127.3, 127.4, 128.0, 128.1, 128.4, 
128.9 (CHAr), 129.3 (CAr), 129.6, 130.6 (CHAr), 139.8, 141.5, 143.3, 144.1 (CAr), 168.8 (C=O). IR 
(KBr): ~ = 3052, 2927, 2842 (w), 1716 (s), 1591, 1567, 1467, 1439, 1313, 1295 (m), 1231 (s), 
1191, 1143, 1091, 1051, 1027, 993, 970, 873 (m), 779, 691 (s), 673, 618, 559 (m) cm-1; GC-MS 
(EI, 70 eV): m/z (%): 288 (M+, 75), 257 (100), 228 (34), 202 (08), 152 (05), 128 (04), 113 (08); 










Methyl 3',5'-dimethyl-4-(trifluoromethylsulfonyloxy)biphenyl-3-carboxylate (28a): Starting 
with 26 (200 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd 
(PPh3)4 (3 mol%), 3,5-dimethylphenylboronic acid (88 mg, 0.59 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 28a was isolated as a 
colorless solid; yield 150 mg, (83 %), mp. = 160-162°C; 1H NMR 
(300 MHz, CDCl3):  = 2.27 (s, 6H, 2CH3), 3.61 (s, 3H, OCH3), 6.82 (s, 1H, ArH), 6.95 (s, 1H, 
ArH),  7.17 (s, 1H, ArH), 7.35 (d, 1H, J = 3.4 Hz, ArH), 7.36 (s, 1H, ArH), 7.63 (d, 1H, J = 3.4 Hz, 
ArH); 13C NMR (62.89 MHz, CDCl3):  = 21.2 (2CH3), 52.3 (OCH3), 120.0 (q, JF,C = 320 Hz, 
CF3), 122.4, 123.8, 126.1, 129.6, 132.6 (CHAr), 137.7, 139.2, 141.1, 143.0, 148.0 (CAr), 167.1 
(C=O). 19F NMR (282 MHz, CDCl3):  = -73.4 (CF). IR (KBr): ~ = 3018, 2951, 2920 (w), 1723, 
1601 (s), 1489 (m), 1467, 1328, 1271 (m), 1243 (s), 1137, 1099, 978 (m), 863, 785, 751 (s), 699, 
577, 540 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 388 (M+, 66), 357 (07), 255 (100), 227 (12), 152 
(15), 115 (03), 69 (08); HRMS (EI) calcd for C17H15F3O5S [M+]: 388.05868 found 388.05879. 
 
Methyl 2',5'-dimethoxy-4-(trifluoromethyl sulfonyloxy) biphenyl-3-carboxylate (28b): Starting 
with 26 (200 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 (3 
mol%), 2,5-dimethoxyphenylboronic acid (107 mg, 0.59 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 28b was isolated as a yellow solid; yield 
140 mg, (72 %), mp. = 148-150°C; 1H NMR (300 MHz, CDCl3):  = 3.69 
(s, 3H, OCH3), 3.74 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 6.81 (s, 1H, ArH), 6.83-6.86 (m, 2H, 
ArH),  7.24 (d, 1H, J = 8.5 Hz, ArH), 7.71 (dd, 1H, J = 2.4, 8.5 Hz, ArH), 8.14 (d, 1H, J = 2.3 Hz, 
ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.6 (OCH3), 55.8 (OCH3), 56.1 (OCH3), 112.6, 114.3, 
116.4 (CHAr), 120.0 (q, JF,C = 320.0 Hz, CF3), 122.2 (CHAr), 123.8, 128.3 (CAr), 133.5, 135.1 
(CHAr), 138.9, 147.0, 150.5, 153.8 (CAr), 164.2 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.5 
(CF). IR (KBr): ~ = 3001, 2953, 2837 (w), 1728 (m), 1681, 1606, 1582 (w), 1504, 1464 (m), 1422 
(s), 1307, 1248, 1171, 1074, 1051, 973, 905, 839, 804, 760, 693, 647, 572 (m) cm-1; GC-MS (EI, 
70 eV): m/z (%): 420 (M+, 100), 389 (08), 287 (46), 257 (19), 227 (14), 185 (12), 162 (06), 113 
(06), 69 (08); HRMS (EI) calcd for C17H15F3O7S [M+]: 420.04851 found 420.049146. 
 
Methyl 4'-methyl-4-(trifluoromethylsulfonyloxy)biphenyl-3-carboxylate (28c): Starting with 
26 (200 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd (PPh3)4 

















dioxane (5ml/mmol of triflate), 28c was isolated as a colorless solid; yield 108 mg, (62 %), mp. = 
152-154°C; 1H NMR (300 MHz, CDCl3):  = 2.26 (s, 3H, CH3), 3.61 (s, 3H, OMe), 6.45 (dd, 2H, J 
= 8.3, 18.5 Hz, ArH), 7.24 (d, 1H, J = 7.5 Hz, ArH), 7.27-7.31 (m, 1H, ArH), 7.47 (s, 1H, ArH), 
7.52 (dd, 1H, J = 1.4, 8.1 Hz, ArH), 8.00 (d, 1H, J = 8.1 Hz, ArH); 13C NMR (62.89 MHz, CDCl3): 
 = 21.2 (CH3), 52.3 (OCH3), 111.7 (CHAr), 120.0 (q, JF,C = 320.0 Hz, CF3), 123.0 (CAr), 124.1, 
129.3, 130.7 (CHAr), 131.0 (CAr), 132.5 (CHAr), 145.2, 147.9, 156.3 (CAr), 167.1 (C=O). 19F NMR 
(282 MHz, CDCl3):  = -73.4 (CF). IR (KBr): ~ = 3012, 2952, 2926 (w), 1714, 1602 (s), 1493 
(m), 1469, 1328, 1271 (m), 1243 (s), 1137, 1099, 978 (m), 863, 785, 751 (s), 699, 577, 540 (m) cm-
1; GC-MS (EI, 70 eV): m/z (%): 374 (M+, 66), 361 (07), 257 (100), 223 (12), 148 (15), 113 (03), 69 
(08); HRMS (EI) calcd for C16H13F3O5S [M+]: 374.04358 found 374.33163. 
 
Methyl 3',4'-dimethoxy-4-(trifluoromethylsulfonyloxy)biphenyl-3-carboxylate (28d): Starting 
with 26 (200 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd 
(PPh3)4 (3 mol%), 3,4-dimethoxyphenylboronic acid (107 mg, 
0.59 mmol) and 1,4-dioxane (5ml/mmol of triflate), 28d was 
isolated as a reddish solid; yield 125 mg, (64 %), mp. = 166-168°C; 1H NMR (300 MHz, CDCl3):  
= 3.59 (s, 3H, OCH3), 3.64 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 6.79 (s, 1H, ArH), 6.84-6.87 (m, 
2H, ArH),  7.26 (d, 1H, J = 8.2 Hz, ArH), 7.671 (dd, 1H, J = 2.6, 8.2 Hz, ArH), 8.16 (d, 1H, J = 2.3 
Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.4 (OCH3), 55.2 (OCH3), 56.4 (OCH3), 112.3, 
114.6, 116.8 (CHAr), 121.0 (q, JF,C = 320.2 Hz, CF3), 122.4 (CHAr), 123.4, 127.2 (CAr), 133.4, 
136.1 (CHAr), 137.9, 146.0, 150.1, 152.4 (CAr), 168.2 (C=O). 19F NMR (282 MHz, CDCl3):  = -
73.2 (CF). IR (KBr): ~ = 2999, 2952, 2849 (w), 1726 (m), 1603, 1588 (w), 1520, 1463 (m), 1421 
(s), 1325, 1289, 1171, 1080, 1052, 974, 905, 883, 827, 806, 755, 684, 664, 573 (m) cm-1; GC-MS 
(EI, 70 eV): m/z (%): 420 (M+, 51), 389 (04), 287 (100), 257 (15), 229 (17), 213 (04), 185 (05), 157 
(04), 114 (05), 69 (06); HRMS (EI) calcd for C17H15F3O7S [M+]: 420.04731 found 420.037247. 
 
Methyl 4'-bromo-4-(trifluoromethylsulfonyloxy)biphenyl-3-carboxylate (28e): Starting with 26 
(200 mg, 0.46 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 4-bromophenylboronic acid (118 mg, 0.59 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 28e was isolated as a colorless 
viscous oil; yield 136 mg, (67 %); 1H NMR (300 MHz, CDCl3):  = 
3.92 (s, 3H, OCH3), 7.33-7.41 (m, 2H, ArH), 7.44 (d, 1H, J = 6.2 Hz, ArH), 7.48-7.52 (m, 2H, 












(OCH3), 120.0 (q, JF,C = 320.0 Hz, CF3), 125.0, 125.6, 127.5, 128.6, 132.0 (CHAr), 133.0, 134.9, 
136.0, 147.1, 147.8 (CAr), 168.3 (C=O). IR (KBr): ~ = 3119, 2959, 2872 (w), 1725 (s), 1613, 1586, 
1479, 1461 (m), 1426 (s), 1300, 1278, 1244 (m), 1127 (s), 1076, 1001, 975, 921, 842, 782, 697, 
665, 542 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 439 (M+, 60), 383 (71), 353 (20), 307 (100), 215 
(43), 170 (08), 139 (16), 69 (05); HRMS (EI) calcd for C15H10BrF3O5S [M+]: 438.02642, found 
439.014672. 
 
Methyl 2',4'-dimethoxy-4-(trifluoromethyl sulfonyloxy) biphenyl-3-carboxylate (28f): Starting 
with 26 (200 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd 
(PPh3)4 (3 mol%), 2,4-dimethoxyphenylboronic acid (107 mg, 
0.59 mmol) and 1,4-dioxane (5ml/mmol of triflate), 28f was 
isolated as a colorless solid; yield 123 mg, (63 %), mp. = 168-170°C; 1H NMR (300 MHz, CDCl3): 
 = 3.73 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 6.48-6.52 (m, 2H, ArH), 7.15-
7.22 (m, 2H, ArH),  7.67 (dd, 1H, J = 2.4, 8.5 Hz, ArH), 8.1 (d, 1H, J = 2.3 Hz, ArH); 13C NMR 
(62.90 MHz, CDCl3):  = 52.5 (OCH3), 55.4 (OCH3), 55.5 (OCH3), 99.0, 104.9 (CHAr), 120.0 (q, 
JF,C = 320.0 Hz, CF3), 122.1 (CHAr), 123.7 (CAr), 131.1, 133.4 (CHAr), 134.9 (CAr), 135.0 (CHAr), 
139.0, 146.6, 157.4, 161.2 (CAr), 168.4 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.5 (CF). IR 
(KBr): ~ = 2921, 2871 (w), 1727 (m), 1677, 1609, 1578 (w), 1512, 1463 (m), 1422 (s), 1305, 
1281, 1160, 1074, 1053, 967, 905, 890, 835, 797, 761, 686, 638, 571 (m) cm-1; GC-MS (EI, 70 
eV): m/z (%): 420 (M+, 38), 389 (05), 287 (100), 257 (11), 229 (04), 185 (10), 128 (06), 69 (08); 
HRMS (EI) calcd for C17H15F3O7S [M+]: 420.04851 found 420.049176. 
 
Methyl 4'-chloro-4-(trifluoromethylsulfonyloxy)biphenyl-3-carboxylate (28g): Starting with 26 
(200 mg, 0.46 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (6 
mol%), 4-chlorophenylboronic acid (92 mg, 0.59 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 28g was isolated as a yellow solid; 
yield 134 mg, (73 %), mp. = 140-142°C; 1H NMR (300 MHz, CDCl3):  = 3.91 (s, 3H, OCH3), 
7.12-7.15 (m, 1H, ArH), 7.27-7.33 (m, 1H, ArH), 7.36 (s, 1H, ArH), 7.47 (dd, 1H, J = 3.1, 9.0 Hz, 
ArH), 7.61-7.71 (m, 1H, ArH), 7.92 (d, 1H, J = 3.0 Hz, ArH), 8.16 (d, 1H, J = 2.4 Hz, ArH); 13C 
NMR (62.90 MHz, CDCl3):  = 53.1 (OCH3), 120.0 (q, JF,C = 320.0 Hz, CF3), 124.1, 125.6, 127.0, 
128.3, 129.2 (CHAr), 133.0, 134.9, 136.0, 147.1, 147.8 (CAr), 168.4 (C=O). IR (KBr): ~ = 3119, 
2959, 2872 (w), 1725 (s), 1613, 1586, 1479, 1461 (m), 1426 (s), 1300, 1278, 1244 (m), 1127 (s), 












66), 363 (11), 261 (100), 233 (20), 198 (13), 175 (06), 155 (05), 139 (35), 113 (05), 69 (16), 63 
(05); HRMS (EI) calcd for C15H10ClF3O5S [M+]: 393.98841, found 393.987890. 
 
3'',5''-Dimethoxy-4-vinyl-(1,1';4',1'')terphenyl-2'-carboxylic acid methyl ester (29a): Starting 
with 28a (100 mg, 0.25 mmol), K3PO4 (114 mg, 0.54 mmol), Pd 
(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (47 mg, 0.32 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 29a was isolated 
as colorless solid; yield 64 mg, (72 %), mp. = 144-146°C; 1H 
NMR (300 MHz, CDCl3):  = 2.28 (s, 6H, 2CH3), 3.60 (s, 3H, 
OCH3), 5.20 (dd, 1H, J = 7.5, 3.2 Hz, CH2vinyl), 5.24 (dd, 1H, J = 7.3, 4.2 Hz, CH2vinyl), 5.71 (dd, 
1H, J = 6.48, 3.2 Hz, CHvinyl), 6.65 (d, 2H, J = 4.0 Hz, ArH) 6.90 (s, 1H, ArH), 7.18 (s, 1H, ArH), 
7.45 (s, 2H, ArH), 7.65 (d, 2H, J = 2.4 Hz, ArH), 7.68 (d, 1H, J = 2.4 Hz, ArH), 7.94 (d, 1H, J = 
2.4 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 21.3 (2CH3), 52.0 (OCH3), 113.9 (CH2vinyl), 
126.1, 126.7, 127.1, 127.9, 128.4, 129.3, 131.2, 130.1 (CHAr), 132.1, 133.6, 136.4, 137.0, 138.4, 
139.4, 140.7 (CAr), 169.4 (C=O). IR (KBr): ~ = 3029, 2947, 2900 (w), 1723, 1604, (s), 1479 (m), 
1459, 1361, 1264 (m), 1231 (s), 1179, 1081, 957 (m), 893, 785, 762 (s), 693, 571, 551 (m) cm-1; 
GC-MS (EI, 70 eV): m/z (%): 342 (M+, 100), 326 (01), 311 (22), 296 (06), 267 (08), 253 (07), 202 
(01), 163 (10), 133 (05); HRMS (EI) calcd for C24H22O2 [M+]: 342.16208, found 342.43081. 
 
2'',5''-Dimethoxy-4-vinyl-(1,1';4',1'')terphenyl-2'-carboxylic acid methyl ester (29b): Starting 
with 28b (100 mg, 0.23 mmol), K3PO4 (114 mg, 0.54 mmol), Pd 
(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (42 mg, 0.29 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 29b was isolated as colorless solid; 
yield 70 mg, (78 %), mp. = 156-158°C; 1H NMR (300 MHz, CDCl3): 
 = 3.59 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 5.52 
(dd, 1H, J = 1.5, 7.2 Hz, CH2vinyl), 5.62 (dd, 1H, J = 2.3, 6.2 Hz, CH2vinyl), 5.72 (dd, 1H, J = 1.8, 6.2 
Hz, CHvinyl), 6.82-6.88 (m, 2H, ArH), 7.24 (d, 1H, J = 8.2 Hz, ArH), 7.30-7.40 (m, 4H, ArH), 7.60-
7.66 (m, 2H, ArH), 7.92 (d, 1H, J = 1.8 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 51.9 
(OCH3), 55.8 (OCH3), 56.3 (OCH3), 113.7 (CH), 113.8 (CH2vinyl), 116.5, 125.9, 128.0, 128.5, 
130.4, 132.3, 133.0, 134.9 (CHAr), 135.0, 135.1, 136.4, 136.5, 137.4, 140.6, 150.8, 153.8 (CAr), 
169.1 (C=O). IR (KBr): ~ = 2922, 2850 (w), 1715, 1604, 1462, 1391, 1275 (m), 1227 (s), 1176, 











374 (M+, 100), 327 (07), 300 (19), 285 (07), 257 (07), 228 (04), 202 (06), 150 (06), 101 (04), 59 
(06); HRMS (EI) calcd for C24H22O4 [M+]: 374.15126, found 374.150994. 
 
4''-Methyl-4-vinyl-(1,1';4',1'')terphenyl-2'-carboxylic acid methyl ester (29c): Starting with 
28c (100 mg, 0.26 mmol), K3PO4 (114 mg, 0.54 mmol), Pd 
(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (50 mg, 0.33 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 29e was isolated 
as colorless solid; yield 60 mg, (68 %), mp. = 132-134°C; 1H 
NMR (300 MHz, CDCl3):  = 2.31 (s, 3H, CH3), 3.60 (s, 3H, OCH3), 5.19 (dd, 1H, J = 2.4, 9.4 Hz, 
CH2vinyl), 5.71 (dd, 1H, J = 3.8, 8.6 Hz, CH2vinyl), 6.67 (dd, 1H, J = 10.8, 17.6 Hz, CHvinyl), 7.15 (d, 
2H, J = 6.2 Hz, ArH), 7.24 (s, 1H, ArH), 7.35-7.40 (m, 3H, ArH), 7.54-7.66 (m, 4H, ArH), 7.95 (d, 
1H, J = 1.9 Hz, ArH); 13C NMR (75.47 MHz, CDCl3):  = 21.2 (CH3), 52.0 (OCH3), 113.9 
(CH2Vinyl), 126.0, 126.8, 127.1, 128.1, 128.5, 129.5, 131.1, 136.2 (CHAr), 136.3, 136.5, 137.1, 
137.9, 139.0, 139.4, 140.8 (CAr), 169.3 (C=O). IR (KBr): ~ = 3052, 2946, 2920 (w), 1722, 1604, 
(s), 1482 (m), 1434, 1308, 1254 (m), 1234 (s), 1164, 1072, 971 (m), 854, 783, 750 (s), 694, 567 
(m) cm-1; GC-MS (EI, 70 eV): m/z (%): 328 (M+, 100), 297 (24), 282 (05), 253 (11), 157 (11), 126 
(06); HRMS (EI) calcd for C23H20O2 [M+]: 328.14578, found 328.146151. 
 
3'',4''-Dimethoxy-4-vinyl-(1,1';4',1'')terphenyl-2'-carboxylic acid methyl ester (29d): Starting 
with 28d (100 mg, 0.23 mmol), K3PO4 (114 mg, 0.54 mmol), 
Pd (PPh3)4 (3 mol%), 4-vinylphenylboronic acid (42 mg, 0.29 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 29d was 
isolated as yellow solid; yield 57 mg, (64 %), mp. = 138-
140°C; 1H NMR (250 MHz, CDCl3):  = 3.58 (s, 3H, OCH3), 3.69 (s, 3H, OCH3), 3.72 (s, 3H, 
OCH3), 5.50 (dd, 1H, J = 2.6, 6.4 Hz, CH2vinyl), 5.60 (dd, 1H, J = 2.4, 7.2 Hz, CH2vinyl), 5.70 (dd, 
1H, J = 1.4, 7.8 Hz, CHvinyl), 6.80-6.86 (m, 2H, ArH), 7.22 (d, 1H, J = 6.2 Hz, ArH), 7.28-7.38 (m, 
4H, ArH), 7.58-7.64 (m, 2H, ArH), 7.88 (d, 1H, J = 4.6 Hz, ArH); 13C NMR (62.90 MHz, CDCl3): 
 = 52.1 (OCH3), 53.3 (OCH3), 55.8 (OCH3), 111.6, 113.4 (CHAr), 114.6 (CH2vinyl), 126.7, 127.1, 
128.0, 130.5, 134.6, 135.0, 135.1 (CHAr), 136.0, 136.1, 137.4, 138.5, 139.4, 140.6, 149.1, 151.4 
(CAr), 168.1 (C=O). IR (KBr): ~ = 3050, 2922, 2851 (w), 1721, 1602 (s), 1461, 1433, 1390, 1240, 
1215, 1171, 1093, 967, 888, 788, 722 (s), 665, 539 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 374 
(M+, 100), 325 (03), 301 (16), 281 (05), 253 (04), 226 (06), 207 (05), 153 (08), 121 (05), 57 (10); 










4''-Bromo-4-vinyl-(1,1';4',1'')terphenyl-2'-carboxylic acid methyl ester (29e): Starting with 
28e (100 mg, 0.22 mmol), K3PO4 (114 mg, 0.54 mmol), Pd 
(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (42 mg, 0.29 mmol) 
and 1,4-dioxane (5ml/mmol of triflate), 29e was isolated as a 
colorless viscous oil; yield 56 mg, (62 %); 1H NMR (250 MHz, 
CDCl3):  = 3.61 (s, 3H, OCH3), 5.22 (dd, 1H, J = 2.4, 8.4 Hz, CH2vinyl), 5.70 (dd, 1H, J = 2.8, 7.6 
Hz, CH2vinyl), 5.77 (dd, 1H, J = 2.4, 8.6 Hz, CHvinyl), 7.24 (d, 2H, J = 6.2 Hz, ArH), 7.36-7.42 (m, 
4H, ArH), 7.45 (s, 1H, ArH), 7.56 (d, 2H, J = 6.8 Hz, ArH), 7.66-7.70 (dd, 1H, J = 2.4, 9.6 Hz, 
ArH), 7.98 (d, 1H, J = 2.3 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.0 (OCH3), 113.9 
(CH2vinyl), 126.0, 126.7, 127.1, 128.2, 128.5, 129.5, 131.1, 136.2 (CHAr), 136.4, 136.6, 137.1, 
138.9, 139.6, 140.3, 140.8 (CAr), 169.1 (C=O). IR (KBr): ~ = 3084, 2946, 2921 (w), 1716 (s), 1604 
(m), 1481 (m), 1455, 1389, 1256 (m), 1235 (s), 1185, 1090, 973 (m), 857, 781, 743 (s), 694, 653, 
539 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 392 (M+, 100), 319 (03), 279 (10), 231 (05), 201 (04), 
173 (06), 126 (11), 107 (08), 77 (05), 57 (10); HRMS (EI) calcd for C22H17BrO2 [M+]: 392.04119, 
found 393.27318. 
 
2'',4''-Dimethoxy-4-vinyl-(1,1';4',1'')terphenyl-2'-carboxylic acid methyl ester (29f): Starting 
with 28f (100 mg, 0.23 mmol), K3PO4 (114 mg, 0.54 mmol), Pd 
(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (42 mg, 0.29 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 29f was isolated 
as a colorless viscous oil; yield 67 mg, (67 %); 1H NMR (300 
MHz, CDCl3):  = 3.59 (s, 3H, OCH3), 3.75 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 5.20 (dd, 1H, J = 
2.4, 10.8 Hz, CH2vinyl), 5.72 (dd, 1H, J = 2.4, 9.6 Hz, CH2vinyl), 6.69 (dd, 1H, J = 2.4, 10.6 Hz, 
CHvinyl), 7.21-7.24 (m, 3H, ArH), 7.26 (s, 1H, ArH), 7.30-7.39 (m, 4H, ArH), 7.60 (dd, 1H, J = 1.9, 
7.9 Hz, ArH), 7.88 (d, 1H, J = 1.6 Hz, ArH); 13C NMR (75.47 MHz, CDCl3):  = 51.9 (OCH3), 
55.4 (OCH3), 55.6 (OCH3), 99.0, 104.8 (CHAr), 113.8 (CH2vinyl), 125.9, 128.6, 130.3 (CHAr), 130.4 
(CAr), 130.7, 131.2, 132.0, 136.5 (CHAr), 136.6, 137.5, 138.9, 139.6, 140.0, 141.6, 142.0 (CAr), 
169.1 (C=O). IR (KBr): ~ = 3052, 2921, 2848 (w), 1716, 1608 (s), 1463, 1435, 1391 (m), 1242, 
1217 (s), 1173, 1095, 965, 887, 783, 721, 663, 537(m) cm-1; GC-MS (EI, 70 eV): m/z (%): 374 
(M+, 100), 343 (04), 285 (06), 257 (05), 179 (06), 120 (04); HRMS (EI) calcd for C24H22O4 [M+]: 











4''-Chloro-4-vinyl-(1,1';4',1'')terphenyl-2'-carboxylic acid methyl ester (29g): Starting with 
28g (100 mg, 0.25 mmol), K3PO4 (114 mg, 0.54 mmol), Pd 
(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (47 mg, 0.32 mmol) 
and 1,4-dioxane (5ml/mmol of triflate), 29g was isolated as 
reddish solid; yield 65 mg, (74 %), mp. = 152-154°C; 1H NMR 
(300 MHz, CDCl3):  = 3.61 (s, 3H, OCH3), 5.22 (dd, 1H, J = 4.6, 10.8 Hz, CH2vinyl), 5.72 (dd, 1H, 
J = 4.3, 17.6 Hz, CH2vinyl), 6.69 (dd, 1H, J = 10.8, 17.5 Hz, CHvinyl), 7.21-7.25 (m, 2H, ArH), 7.35-
7.41 (m, 2H, ArH), 7.44 (s, 1H, ArH), 7.54 (d, 2H, J = 8.2 Hz, ArH), 7.58-7.62 (m, 2H, ArH), 7.68 
(dd, 1H, J = 1.9, 8.6 Hz, ArH), 7.98 (d, 1H, J = 1.9 Hz, ArH); 13C NMR (75.47 MHz, CDCl3):  = 
52.1 (OCH3), 114.0 (CH2vinyl), 126.0, 126.8, 127.1, 128.2, 129.5, 130.0, 131.1, 136.2 (CHAr), 136.5, 
137.1, 138.9, 139.7, 140.3, 140.8, 141.0 (CAr), 169.1 (C=O). IR (KBr): ~ = 3054, 2922, 2852 (w), 
1715, 1604 (m), 1501, 1462, 1391, 1306, 1275, 1241 (m), 1227 (s), 1176, 11181092, 1024, 998, 
907, 877, 800, 788, 722, 639, 540 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 348 (M+, 100), 317 (13), 
282 (31), 254 (18), 226 (07), 156 (16), 126 (10); HRMS (EI) calcd for C22H17O2Cl [M+]: 
348.09116, found 348.091376. 
 
Methyl 2,4-bis(trifluoromethylsulfonyloxy)benzoate (32): Starting with 31 (168 mg, 1.0 mmol), 
pyridine (0.32 ml, 4.0 mmol) and  Tf2O (0.39 ml, 2.4 mmol), 32 was 
isolated as colorless oil (382 mg, 88 %); 1H NMR (300 MHz, CDCl3):  = 
3.92 (s, 3H, OCH3), 7.19 (s, 1H, ArH), 7.35 (d, 1H, J = 8.2 Hz, ArH),  8.17 
(d, 1H, J = 8.6 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 53.1 (OCH3), 116.1 (CHAr), 116.8 
(q, JF,C = 320.2 Hz, CF3), 120.8 (CHAr), 121.4 (q, JF,C = 321.2 Hz, CF3), 124.7 (CAr), 133.8 (CHAr), 
148.6, 151.8, (CAr), 162.7 (C=O). 19F NMR (282 MHz, CDCl3):  = -72.4, -73.1 (2CF3). IR (KBr): 
~= 3117, 3085, 2960 (w), 1733, 1617 (s), 1583 (m), 1481, 1302, 1277 (m), 1241 (s), 1123, 1073, 
975 (m), 873, 780, 758 (s), 697, 580, 541 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 432 (M+, 61), 
401 (61), 363 (06), 337 (52), 273 (77), 207 (53), 179 (15), 138 (10), 107 (34), 95 (06), 79 (22), 69 
(100), 51 (16), 39 (03); HRMS (EI) calcd for C10H6F6O8S2 [M+]: 431.94028 found 431.941432. 
 
4,4''-Dichloro-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (33a): Starting with 32 (300 
mg, 0.69 mmol), K3PO4 (440 mg, 2.07 mmol), Pd(PPh3)4 (6 mol%), 
4-chlorophenylboronic acid (280 mg, 1.80 mmol) and 1,4-dioxane 












mg, (76 %); 1H NMR (300 MHz, CDCl3):  = 3.56 (s, 3H, OCH3), 7.06-7.09 (m, 1H, ArH), 7.19-
7.23 (m, 4H, ArH), 7.32-7.34 (m, 2H, ArH), 7.37 (d, 1H, J = 3.2 Hz, ArH), 7.44 (d, 1H, J = 1.9 Hz, 
ArH), 7.45-7.47 (m, 1H, ArH), 7.82 (d, 1H, J = 8.1 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 
52.2 (OCH3), 125.4, 126.7, 127.5, 128.2, 129.3 (CHAr), 129.6 (CAr), 130.2, 130.9 (CHAr), 133.9, 
134.9, 141.3, 142.0, 142.8, 143.0 (CAr), 168.0 (C=O). IR (KBr): ~= 3053, 2945, 2847 (w), 1716 
(s), 1593, 1567, 1461, 1432, 1317, 1291 (m), 1231 (s), 1193, 1147, 1091, 1053, 1021, 996, 971, 
875 (m), 773, 693 (s), 671, 617, 541 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 356 (M+, 73), 325 
(100), 290 (11), 262 (38), 226 (36), 200 (04), 161 (22), 131 (05), 113 (19); HRMS (EI) calcd for 
C20H14O2Cl2 [M+]: 356.03654, found 356.036629. 
 
2,5,2'',5''-Tetramethoxy-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (33b): Starting 
with 32 (300 mg, 0.69 mmol), K3PO4 (440 mg, 2.07 mmol), 
Pd(PPh3)4 (6 mol%), 2,5-dimethoxyphenylboronic acid (327 mg, 
1.80 mmol) and 1,4-dioxane (5ml/mmol of triflate), 33b was 
isolated as colorless solid; yield 234 mg, (82 %), mp. = 148-150°C; 
1H NMR (300 MHz, CDCl3):  = 3.59 (s, 6H, 2OCH3), 3.66 (s, 3H, 
OCH3), 3.70 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 6.74 (d, 1H, J = 2.3 Hz, ArH), 6.76 (s, 1H, ArH), 
6.78 (d, 1H, J = 2.9 Hz, ArH), 6.82-6.83 (m, 2H, ArH), 6.85 (d, 1H, J = 2.8 Hz, ArH), 7.43 (d, 1H, 
J = 1.6 Hz, ArH), 7.50 (dd, 1H, J = 1.8, 8.0 Hz, ArH), 7.82 (d, 1H, J = 7.9 Hz, ArH); 13C NMR 
(62.90 MHz, CDCl3):  = 51.6 (OCH3), 55.7 (OCH3), 55.8 (OCH3), 56.3 (OCH3), 111.1, 112.7, 
113.0, 113.8, 116.1, 116.5, 128.3, 129.1 (CHAr), 130.0, 130.3, 131.5 (CAr), 132.2 (CHAr), 138.2, 
141.7, 150.4, 150.8, 153.6, 153.8 (CAr), 168.4 (C=O). IR (KBr): ~= 2928, 2831 (w), 1721, 1601, 
1585, 1498, 1461, 1378,1250 (m), 1213 (s), 1175, 1092, 1040, 964, 904, 860, 821, 789 (m), 723 
(s), 694, 605, 539 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 408 (M+, 100), 393 (05), 377 (71), 346 
(20), 204 (08); HRMS (EI) calcd for C24H24O6 [M+]: 408.15674, found 408.156969. 
 
[1,1';3',1'']Terphenyl-4'-carboxylic acid methyl ester (33c): Starting with 32 (300 mg, 0.69 
mmol), K3PO4 (440 mg, 2.07 mmol), Pd(PPh3)4 (6 mol%), phenylboronic 
acid (219 mg, 1.80 mmol) and 1,4-dioxane (5ml/mmol of triflate), 33c 
was isolated as a reddish solid; yield 148 mg, (74 %), mp. = 150-152°C; 
1H NMR (300 MHz, CDCl3):  = 3.51 (s, 3H, OCH3), 7.22-7.25 (m, 4H, 
ArH), 7.26 (s, 1H, ArH), 7.27-7.30 (m, 3H, ArH), 7.46-7.50 (m, 4H, ArH), 7.79 (dd, 1H, J = 1.7, 










128.4, 128.9 (CHAr), 129.3 (CAr), 129.6, 130.6 (CHAr), 139.8, 141.5, 143.3, 144.1 (CAr), 168.8 
(C=O). IR (KBr): ~= 3052, 2927, 2842 (w), 1716 (s), 1591, 1567, 1467, 1439, 1313, 1295 (m), 
1231 (s), 1191, 1143, 1091, 1051, 1027, 993, 970, 873 (m), 779, 691 (s), 673, 618, 559 (m) cm-1; 
GC-MS (EI, 70 eV): m/z (%): 288 (M+, 75), 257 (100), 228 (34), 202 (08), 152 (05), 128 (04), 113 
(08); HRMS (EI) calcd for C20H16O2 [M+]: 228.11448, found 228.114296. 
 
4,4''-Di-tert-butyl-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (33d): Starting with 32 
(300 mg, 0.69 mmol), K3PO4 (440 mg, 2.07 mmol), Pd(PPh3)4 (6 
mol%), 4-ter-butylphenylboronic acid (320 mg, 1.80 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 33d was isolated as a 
colorless solid; yield 86 mg, (72 %), mp. = 168-170°C; 1H NMR 
(300 MHz, CDCl3):  = 1.48 (s, 9H, 3CH3), 1.50 (s, 9H, 3CH3), 
3.78 (s, 3H, OCH3), 7.44 (d, 1H, J = 8.3 Hz, ArH), 7.55-7.60 (m, 4H, ArH), 7.68 (s, 1H, ArH), 
7.70-7.75 (m, 4H, ArH), 8.00 (d, 1H, J = 8.1 Hz, ArH); 13C NMR (75.46 MHz, CDCl3):  = 31.4 
(3CH3), 31.5 (3CH3), 34.5 (2CtBu), 51.9 (OCH3), 125.0, 125.4, 125.9, 127.0, 128.2, 129.5, 130.6 
(CHAr), 133.9, 137.0, 138.5, 143.2, 143.9, 150.1, 151.2 (CAr), 169.0 (C=O). IR (KBr): ~= 3031, 
2951, 2902 (w), 1727, 1605, (s), 1483 (m), 1461, 1362, 1267 (m), 1234 (s), 1180, 1085, 959 (m), 
895, 788, 765 (s), 698, 572, 554 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 400 (M+, 36), 385 (100), 
357 (05), 313 (03), 252 (04), 185 (11), 157 (07), 141 (04), 57 (04); HRMS (EI) calcd for C28H32O2 
[M+]: 400.23968, found 400.2399954. 
 
3,3''-Dihydroxy-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (33e): Starting with 32 
(300 mg, 0.69 mmol), K3PO4 (440 mg, 2.07 mmol), Pd(PPh3)4 (6 
mol%), 3-hydroxyphenylboronic acid (248 mg, 1.80 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 33e was isolated as a colorless 
viscous oil; yield 138 mg, (62 %); 1H NMR (300 MHz, CDCl3):  = 
3.56 (s, 3H, OCH3), 6.02 (s, 2H, 2OH), 6.68 (s, 1H, ArH), 6.70.6.75 
(m, 3H, ArH), 6.90 (t, 1H, J = 1.8 Hz, ArH), 6.98 (d, 1H, J = 7.9 Hz, ArH), 7.08 (d, 1H, J = 7.5 Hz, 
ArH), 7.11 (m, 1H, ArH), 7.34 (s, 1H, ArH), 7.37 (d, 1H, J = 1.7 Hz, ArH), 7.68 (d, 1H, J = 7.9 
Hz, ArH); 13C NMR (75.47 MHz, CDCl3):  = 52.3 (OCH3), 114.2, 114.5, 115.2, 115.4, 119.6, 
120.8, 125.7, 129.2, 129.3, 130.1, 130.3 (CHAr), 139.0, 141.2, 142.5, 142.6, 143.7, 155.4, 156.0 
(CAr), 169.9 (C=O). IR (KBr): ~= 3058, 2941, 2927 (w), 1721, 1607, (s), 1481 (m), 1462, 1357, 









70 eV): m/z (%): 320 (M+, 100), 289 (75), 260 (13), 231 (08), 215 (09), 202 (08), 189 (05), 152 
(06), 101 (05); HRMS (EI) calcd for C20H16O4 [M+]: 320.10431, found 320.104231. 
 
2,2''-Dibromo-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (33f): Starting with 32 (300 
mg, 0.69 mmol), K3PO4 (440 mg, 2.07 mmol), Pd(PPh3)4 (6 mol%), 2-
bromophenylboronic acid (360 mg, 1.80 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 33f was isolated as a yellow solid; yield 219 mg, 
(70 %), mp. = 138-140°C; 1H NMR (300 MHz, CDCl3):  = 3.60 (s, 3H, 
OCH3), 7.10-7.15 (m, 2H, ArH), 7.22 (d, 1H, J = 1.9 Hz, ArH), 7.24 (d, 1H, J = 1.5 Hz, ArH), 
7.26-7.30 (m, 2H, ArH), 7.43 (dd, 1H, J = 1.8, 8.1 Hz, ArH), 7.52-7.59 (m, 3H, ArH), 8.00 (d, 1H, 
J = 8.0 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.0 (OCH3), 122.3, 122.9 (CAr), 127.0, 
127.5, 128.7, 128.8 (CHAr), 129.0 (CAr), 129.3, 130.0, 130.1, 131.1, 132.1, 132.6, 133.3 (CHAr), 
141.1, 141.9, 142.4, 144.4 (CAr), 167.0 (C=O). IR (KBr): ~= 3052, 2946, 2839 (w), 1716 (s), 
1605, 1562, 1474, 1430, 1387 (m), 1286 (s), 1189, 1118, 1060, 1004, 962, 904, 827, 788 (m), 749 
(s), 697, 660, 587 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 446 (M+, 69), 370 (12), 289 (10), 257 
(100), 231 (30), 202 (08), 148 (05), 128 (04), 113 (08); HRMS (EI) calcd for C20H14Br2O2 [M+]: 
446.93605, found 446.13196. 
 
2,2''-Diflouro-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (33g): Starting with 32 (300 
mg, 0.69 mmol), K3PO4 (440 mg, 2.07 mmol), Pd(PPh3)4 (6 mol%), 1-
flourophenylboronic acid (252 mg, 1.80 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 33g was isolated as a reddish solid; yield 150 mg, 
(66 %), mp. = 144-146°C; 1H NMR (300 MHz, CDCl3):  = 3.60 (s, 3H, 
OCH3), 6.95-7.10 (m, 4H, ArH), 7.18-7.26 (m, 3H, ArH), 7.35 (dt, 1H, J = 1.8, 7.7 Hz, ArH), 7.43 
(t, 1H, J = 1.5 Hz, ArH), 7.53 (dt, 1H, J = 1.7, 8.1 Hz, ArH), 7.95 (d, 1H, J = 8.1 Hz, ArH); 13C 
NMR (62.90 MHz, CDCl3):  = 52.0 (OCH3), 115.0 (d, 2JC,F = 22.2 Hz, CHAr), 116.2 (d, 2JC,F = 
22.5 Hz, CHAr), 124.0 (d, 4JC,F = 3.5 Hz, CHAr), 124.5 (d, 4JC,F = 3.7 Hz, CHAr), 127.5 (d, 2JC,F = 
13.0 Hz, CF), 128.4 (d, 4JC,F = 3.3 Hz, CHAr), 128.9 (CAr), 129.1 (CAr), 129.3 (d, 3JC,F = 8.1 Hz, 
CHAr), 129.9 (d, 3JC,F = 8.3 Hz, CHAr), 130.4 (CHAr), 130.5 (d, 4JC,F = 3.3 Hz, CHAr), 130.6 (d, 4JC,F 
= 3.1 Hz, CHAr), 132.0 (d, 4JC,F = 2.9 Hz, CHAr), 136.3 (CAr), 139.4 (d, 4JC,F = 1.0 Hz, CF), 157.7 
(d, 2JC,F = 11.5 Hz, CF), 161.6 (d, 2JC,F = 14.3 Hz, CF), 167.5 (C=O). IR (KBr): ~= 3030, 2950, 
2850 (w), 1722 (s), 1614, 1604, 1579, 1494, 1433, 1392, 1284, 1220, 1190, 1109, 1049, 1011, 960, 











293 (100), 264 (17), 244 (35), 170 (04), 146 (05), 122 (12); HRMS (EI) calcd for C20H14O2F2 [M+]: 
324.09564, found 324.095647. 
 
4,4''-Diflouro-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (33h): Starting with 32 (300 
mg, 0.69 mmol), K3PO4 (440 mg, 2.07 mmol), Pd(PPh3)4 (6 mol%), 
4-flourophenylboronic acid (252 mg, 1.80 mmol) and 1,4-dioxane 
(5ml/mmol of triflate), 33h was isolated as a colorless solid; yield 
168 mg, (74 %), mp. = 156-158°C; 1H NMR (300 MHz, CDCl3):  = 
3.58 (s, 3H, OCH3), 6.97-7.06 (m, 4H, ArH), 7.19-7.23 (m, 2H, ArH), 7.40 (d, 1H, J = 1.8 Hz, 
ArH), 7.46-7.51 (m, 3H, ArH), 7.84 (d, 1H, J = 8.1 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 
51.9 (OCH3), 114.9 (d, 2JC,F = 21.5 Hz, CHAr), 115.8 (d, 2JC,F = 21.5 Hz, CHAr), 125.7 (CHAr), 
128.9 (d, 3JC,F = 8.2 Hz, CHAr), 129.1 (CAr), 129.4 (CHAr), 129.9 (d, 3JC,F = 8.1 Hz, CHAr), 130.8 
(CHAr), 135.7 (d, 4JC,F = 3.2 Hz, CF), 137.2 (d, 4JC,F = 3.3 Hz, CF), 142.4 (CAr), 143.1 (CAr), 162.3 
(d, 1JC,F = 246.4 Hz, CF), 162.9 (d, 1JC,F = 247.9 Hz, CF), 168.3 (C=O). IR (KBr): ~= 3043, 2927, 
2843 (w), 1721 (s), 1617, 1603, 1573, 1497, 1431, 1389, 1277, 1221, 1189, 1117, 1051, 1011, 957, 
923, 839 (m), 817, 757 (s), 689, 638, 543 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 324 (M+, 81), 
293 (100), 264 (20), 244 (25), 170 (04), 122 (08); HRMS (EI) calcd for C20H14O2F2 [M+]: 
324.09564, found 324.09544. 
 
3,3''-Bis-trifluoromethyl-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (33i): Starting 
with 32 (300 mg, 0.69 mmol), K3PO4 (440 mg, 2.07 mmol), 
Pd(PPh3)4 (6 mol%), 3-triflouromethylphenylboronic acid (342 mg, 
1.80 mmol) and 1,4-dioxane (5ml/mmol of triflate), 33i was isolated 
as a colorless viscous oil; yield 203 mg, (69 %); 1H NMR (300 
MHz, CDCl3):  = 3.59 (s, 3H, OCH3), 7.44-7.48 (m, 4H, ArH), 
7.54 (d, 2H, J = 7.6 Hz, ArH), 7.59 (dd, 2H, J = 1.8, 8.1 Hz, ArH), 7.72 (d, 1H, J = 7.6 Hz, ArH), 
7.77 (s, 1H, ArH), 7.94 (d, 1H, J = 8.1 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.0 (OCH3), 
121.9 (q, JF,C = 320.0 Hz, CF3), 122.0 (q, JF,C = 321.0 Hz, CF3), 124.0 (dq, JC,F = 3.8 Hz, CHAr), 
124.2 (dq, JF,C = 3.9 Hz, CHAr), 124.9 (q, JC,F = 3.7 Hz, CHAr), 125.3 (q, JC,F = 3.7 Hz, CHAr), 
126.5, 128.4, 129.5 (CHAr), 129.8, 130.2 (CAr), 130.6 (CHAr), 130.7 (CAr), 131.2, 131.7, 132.0 
(CHAr), 140.3, 141.9, 142.1, 142.9 (CAr), 167.8 (C=O). IR (KBr): ~= 3075, 2952, 2843 (w), 1725 
(s), 1606, 1564, 1583, 1428, 1341, 1298 (m), 1244 (s), 1157 (m), 1125, 1071, 1035 (s), 965, 903, 










393 (100), 373 (10), 345 (13), 325 (07), 296 (13), 275 (05), 226 (05); HRMS (EI) calcd for 
C22H14O2F6 [M+]: 424.08925, found 424.088866. 
 
4,4''-Bis-trifluoromethyl-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (33j): Starting 
with 32 (300 mg, 0.69 mmol), K3PO4 (440 mg, 2.07 mmol), 
Pd(PPh3)4 (6 mol%), 4-triflouromethylphenylboronic acid (342 
mg, 1.80 mmol) and 1,4-dioxane (5ml/mmol of triflate), 33j was 
isolated as a yellow solid; yield 172 mg, (76 %), mp. = 142-
144°C; 1H NMR (300 MHz, CDCl3):  = 3.61 (s, 3H, OCH3), 7.38 (d, 2H, J = 7.9 Hz, ArH), 7.46 
(d, 1H, J = 1.7 Hz, ArH), 7.58 (d, 1H, J = 1.7 Hz, ArH), 7.62 (d, 2H, J = 1.8 Hz, ArH), 7.64 (m, 
4H, ArH), 7.95 (d, 1H, J = 8.1 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.0 (OCH3), 121.9 
(q, JF,C = 320.0 Hz, CF3), 122.0 (q, JF,C = 321.0 Hz, CF3), 124.0 (q, JC,F = 250.2 Hz, CF3), 124.9 (q, 
JC,F = 3.8 Hz, CHAr), 125.9 (q, JF,C = 3.8 Hz, CHAr), 126.6, 127.6, 128.7, 129.6 (CHAr), 129.7, 
129.8, 130.6 (CAr), 131.1 (CHAr), 142.3, 142.9, 143.0, 144.8 (CAr), 167.8 (C=O). IR (KBr): ~= 
3071, 2947, 2841 (w), 1717 (s), 1607, 1563, 1579, 1421, 1343, 1293 (m), 1241 (s), 1161 (m), 1131, 
1077, 1031 (s), 967, 907, 844 (m), 805, 703 (s), 661, 613 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 
424 (M+, 56), 405 (10), 393 (100), 373 (07), 345 (11), 325 (07), 296 (20), 275 (05), 226 (05); 
HRMS (EI) calcd for C22H14O2F6 [M+]: 424.08925, found 424.089297. 
 
2',5'-Dimethoxy-3-trifluoromethanesulfonyloxy-biphenyl-4-carboxylic acid methyl ester 
(34a): Starting with 32 (300 mg, 0.69 mmol), K3PO4 (219 mg, 1.03 
mmol), Pd(PPh3)4 (6 mol%), 2,5-dimethoxyphenylboronic acid (163 mg, 
0.90 mmol) and 1,4-dioxane (5ml/mmol of triflate), 34a was isolated as a 
colorless viscous oil; yield 199 mg, (68 %); 1H NMR (300 MHz, CDCl3): 
 = 3.67 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 6.80-
6.84 (m, 3H, ArH), 7.47 (s, 1H, ArH),  7.52 (dd, 1H, J = 1.6, 8.3 Hz, ArH), 8.00 (d, 1H, J = 8.1 Hz, 
ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.5 (OCH3), 55.8 (OCH3), 56.0 (OCH3), 112.8, 114.8, 
116.3 (CHAr), 121.3 (q, JF,C = 320.0 Hz, CF3), 122.2 (CAr), 123.8 (CHAr), 127.9 (CAr), 129.0, 132.2 
(CHAr), 145.0, 147.9, 150.6, 153.8 (CAr), 164.1 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.4 
(CF). IR (KBr): ~= 3001, 2953, 2837 (w), 1725, 1614, 1553, 1510, 1464 (m), 1421 (s), 1387, 
1270, 1246 (m), 1202, 1135, 1072 (s), 1022, 893, 824, 778, 730, 664, 571 (m) cm-1; GC-MS (EI, 
70 eV): m/z (%): 420 (M+, 100), 389 (06), 255 (11), 240 (15), 187 (17), 162 (05), 114 (04), 69 (05); 











3',4'-Dimethoxy-3-trifluoromethanesulfonyloxy-biphenyl-4-carboxylic acid methyl ester 
(34b): Starting with 32 (300 mg, 0.69 mmol), K3PO4 (219 mg, 
1.03 mmol), Pd(PPh3)4 (6 mol%), 3,4-dimethoxyphenylboronic 
acid (163 mg, 0.90 mmol) and 1,4-dioxane (5ml/mmol of triflate), 
34b was isolated as a colorless solid; yield 210 mg, (72 %); mp. = 
148-150°C; 1H NMR (300 MHz, CDCl3):  = 3.82 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 3.86 (s, 3H, 
OCH3), 6.97 (d, 1H, J = 2.1 Hz, ArH), 7.05 (dd, 1H, J = 2.1, 8.3 Hz, ArH),  7.20 (s, 1H, ArH), 7.33 
(d, 1H, J = 1.3 Hz, ArH), 7.52 (d, 1H, J = 1.7, 8.1 Hz, ArH), 8.00 (d, 1H, J = 8.2 Hz, ArH); 13C 
NMR (62.90 MHz, CDCl3):  = 52.4 (OCH3), 55.2 (OCH3), 56.4 (OCH3), 110.1, 111.6, 119.9 
(CHAr), 120.2 (q, JF,C = 320.2 Hz, CF3), 120.6, 126.1 (CHAr), 127.7, 131.6 (CAr), 133.0 (CHAr), 
147.5, 148.6, 149.5, 150.2 (CAr), 168.2 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.2 (CF). IR 
(KBr): ~= 2999, 2952, 2849 (w), 1726 (m), 1603, 1588 (w), 1520, 1463 (m), 1421 (s), 1325, 1289, 
1171, 1080, 1052, 974, 905, 883, 827, 806, 755, 684, 664, 573 (m) cm-1; GC-MS (EI, 70 eV): m/z 
(%): 420 (M+, 100), 389 (07), 259 (62), 228 (09), 185 (05), 157 (04), 114 (06), 69 (06); HRMS (EI) 
calcd for C17H15F3O7S [M+]: 420.04731 found 420.037247. 
 
2'-Methoxy-3-trifluoromethanesulfonyloxy-biphenyl-4-carboxylic acid methyl ester (34c): 
Starting with 32 (300 mg, 0.69 mmol), K3PO4 (219 mg, 1.03 mmol), 
Pd(PPh3)4 (6 mol%), 2-methoxyphenylboronic acid (136 mg, 0.90 mmol) 
and 1,4-dioxane (5ml/mmol of triflate), 34c was isolated as a colorless 
crystalline solid; yield 190 mg, (70 %); mp. = 150-152°C; 1H NMR (300 
MHz, CDCl3):  = 3.74 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 6.91-7.00 (m, 2H, ArH), 7.22-7.32 (m, 
2H, ArH),  7.47 (s, 1H, ArH), 7.53 (dd, 1H, J = 1.6, 8.7 Hz, ArH), 8.03 (d, 1H, J = 8.1 Hz, ArH); 
13C NMR (62.89 MHz, CDCl3):  = 52.5 (OCH3), 55.4 (OCH3), 111.4, 121.1 (CHAr), 122.0 (q, JF,C 
= 321.0 Hz, CF3), 123.8, 129.0 (CHAr), 127.1 (CAr), 130.4, 130.6, 132.2 (CHAr), 145.2, 146.1, 
147.9, 156.3 (CAr), 164.2 (C=O). 19F NMR (282 MHz, CDCl3):  = -73.5 (CF3). IR (KBr): ~= 
3072, 2954, 2918 (w), 1726 (s), 1687 (w), 1615 (m), 1582 (w), 1483 (m), 1422 (s), 1397, 1292 (m), 
1245 (s), 1136, 1073 (s), 969 (w), 914 (s), 858 (w), 826 (s), 783 (m), 752 (s), 695, 568 (m) cm-1; 
GC-MS (EI, 70 eV): m/z (%): 390 (M+, 100), 359 (19), 225 (27), 197 (11), 169 (21), 155 (10), 69 













2',4'-Dimethoxy-3-trifluoromethanesulfonyloxy-biphenyl-4-carboxylic acid methyl ester 
(34d): Starting with 32 (300 mg, 0.69 mmol), K3PO4 (219 mg, 
1.03 mmol), Pd(PPh3)4 (6 mol%), 2,4-dmethoxyphenylboronic 
acid (136 mg, 0.90 mmol) and 1,4-dioxane (5ml/mmol of triflate), 
34d was isolated as a colorless crystalline solid; yield 190 mg, (70 
%); mp. = 150-152°C; 1H NMR (300 MHz, CDCl3):  = 3.73 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 
3.89 (s, 3H, OCH3), 6.48-6.52 (m, 2H, ArH), 7.15-7.22 (m, 2H, ArH),  7.67 (dd, 1H, J = 2.4, 8.5 
Hz, ArH), 8.1 (d, 1H, J = 2.3 Hz, ArH); 13C NMR (62.90 MHz, CDCl3):  = 52.5 (OCH3), 55.4 
(OCH3), 55.5 (OCH3), 99.0, 104.9 (CHAr), 120.0 (q, JF,C = 320.0 Hz, CF3), 122.1 (CHAr), 123.7 
(CAr), 131.1, 133.4 (CHAr), 134.9 (CAr), 135.0 (CHAr), 139.0, 146.6, 157.4, 161.2 (CAr), 168.4 
(C=O). 19F NMR (282 MHz, CDCl3):  = -73.5 (CF). IR (KBr): ~= 2921, 2871 (w), 1727 (m), 
1677, 1609, 1578 (w), 1512, 1463 (m), 1422 (s), 1305, 1281, 1160, 1074, 1053, 967, 905, 890, 835, 
797, 761, 686, 638, 571 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 420 (M+, 38), 389 (05), 287 (100), 
257 (11), 229 (04), 185 (10), 128 (06), 69 (08); HRMS (EI) calcd for C17H15F3O7S [M+]: 
420.04851 found 420.049176. 
 
Methyl 3',5'-dimethyl-3-(trifluoromethylsulfonyloxy)biphenyl-4-carboxylate (34e): Starting 
with 32 (200 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd 
(PPh3)4 (3 mol%), 3,5-dimethylphenylboronic acid (88 mg, 0.59 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 34e was isolated as 
colorless oil; yield 150 mg, (83 %); 1H NMR (300 MHz, CDCl3):  
= 2.25 (s, 6H, 2CH3), 3.59 (s, 3H, OCH3), 6.81 (s, 1H, ArH), 6.92 
(s, 1H, ArH),  7.15 (s, 1H, ArH), 7.34 (d, 1H, J = 3.4 Hz, ArH), 7.36 (s, 1H, ArH), 7.61 (d, 1H, J = 
3.4 Hz, ArH); 13C NMR (62.89 MHz, CDCl3):  = 21.1 (2CH3), 52.4 (OCH3), 120.0 (q, JF,C = 320 
Hz, CF3), 122.6, 123.4, 126.0, 129.3, 132.4 (CHAr), 137.7, 139.2, 141.1, 143.0, 148.0 (CAr), 167.1 
(C=O). 19F NMR (282 MHz, CDCl3):  = -73.4 (CF). IR (KBr): ~ = 3016, 2948, 2920 (w), 1723, 
1600 (s), 1485 (m), 1462, 1324, 1268 (m), 1241 (s), 1136, 1099, 975 (m), 861, 785, 753 (s), 699, 
577, 540 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 388 (M+, 66), 357 (07), 255 (100), 227 (12), 152 














2,5-Dimethoxy-4''-vinyl-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (35a): Starting 
with 34a (150 mg, 0.36 mmol), K3PO4 (114 mg, 0.54 mmol), Pd 
(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (69 mg, 0.47 mmol) and 
1,4-dioxane (5ml/mmol of triflate), 35a was isolated as yellow solid; 
yield 83 mg, (62 %), mp. = 156-158°C; 1H NMR (300 MHz, CDCl3): 
 = 3.59 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 5.19 
(d, 1H, J = 10.8 Hz, CH2vinyl), 5.71 (d, 1H, J = 17.5 Hz, CH2vinyl), 6.67 (d, 1H, J = 6.3 Hz, CHvinyl), 
6.82 (d, 3H, J = 6.4 Hz, ArH), 7.24 (d, 2H, J = 7.3 Hz, ArH), 7.36 (d, 2H, J = 7.3 Hz, ArH), 7.46 
(s, 1H, ArH), 7.50 (d, 1H, J = 7.8 Hz, ArH), 7.80 (d, 1H, J = 7.7 Hz, ArH); 13C NMR (62.90 MHz, 
CDCl3):  = 51.9 (OCH3), 55.8 (OCH3), 56.3 (OCH3), 112.7 (CH), 113.8 (CH2vinyl), 113.9, 116.5, 
125.8, 128.3, 128.6, 129.7 (CHAr), 130.2 (CAr), 131.7 (CHAr), 136.4 (CAr), 136.5 (CHAr), 135.0, 
140.9, 141.6, 142.0, 150.7, 153.8 (CAr), 168.9 (C=O). IR (KBr): ~= 2996, 2832 (w), 1716 (s), 
1600, 1553, 1483, 1431, 1379 (m), 1266, 1211 (s), 1138 (m), 1095, 1021, 1012 (s), 989, 906, 877 
(m), 843 (s), 827, 752, 688, 631, 542 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 374 (M+, 100), 343 
(04), 327 (06), 300 (15), 285 (10), 257 (06), 227 (04), 202 (07), 180 (04), 150 (06), 101 (04), 59 
(06); HRMS (EI) calcd for C24H22O4 [M+]: 374.15126, found 374.151271. 
 
3,4-Dimethoxy-4''-vinyl-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (35b): Starting 
with 34b (150 mg, 0.36 mmol), K3PO4 (114 mg, 0.54 mmol), 
Pd (PPh3)4 (3 mol%), 4-vinylphenylboronic acid (69 mg, 0.47 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 35b was 
isolated as yellow solid; yield 88 mg, (66 %), mp. = 142-
144°C; 1H NMR (300 MHz, CDCl3):  = 3.57 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 3.83 (s, 3H, 
OCH3), 5.17 (d, 1H, J = 11.1 Hz, CH2vinyl), 5.69 (d, 1H, J = 17.5 Hz, CH2vinyl), 6.66 (dd, 1H, J = 
10.9, 17.6 Hz, CHvinyl), 6.84 (d, 1H, J = 8.3 Hz, ArH), 7.03 (d, 1H, J = 1.8 Hz, ArH), 7.10 (dd, 1H, 
J = 2.0, 8.3 Hz, ArH), 7.22 (d, 2H, J = 8.1 Hz, ArH), 7.36 (d, 1H, J = 8.1 Hz, ArH), 7.44 (d, 2H, J 
= 1.5 Hz, ArH), 7.48 (dd, 1H, J = 1.7, 8.0 Hz, ArH), 7.82 (d, 1H, J = 8.0 Hz, ArH); 13C NMR 
(62.90 MHz, CDCl3):  = 52.1 (OCH3), 55.9 (OCH3), 56.0 (OCH3), 111.3, 111.5 (CHAr), 113.9 
(CH2vinyl), 119.7, 125.4, 125.9, 128.6, 129.0, 130.7 (CHAr), 132.6 (CAr), 136.4 (CHAr), 136.6, 137.0, 
138.2, 141.0, 142.9, 143.9, 149.3 (CAr), 168.6 (C=O). IR (KBr): ~= 2998, 2835 (w), 1715 (s), 
1600, 1518, 1485, 1462, 1432, 1379, 1283 (m), 1246 (s), 1212, 1170, 1097, 1041, 990, 905, 843, 











(07), 301 (12), 281 (06), 253 (08), 226 (06), 207 (05), 153 (08), 121 (05), 57 (10); HRMS (EI) 
calcd for C24H22O4 [M+]: 374.15126, found 374.151281. 
 
2-Methoxy-4''-vinyl-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (35c): Starting with 
34c (150 mg, 0.36 mmol), K3PO4 (114 mg, 0.54 mmol), Pd (PPh3)4 (3 
mol%), 4-vinylphenylboronic acid (69 mg, 0.47 mmol) and 1,4-
dioxane (5ml/mmol of triflate), 35c was isolated as white solid; yield 
85 mg, (64 %), mp. = 160-162°C. 1H NMR (250 MHz, CDCl3):  = 
3.58 (s, 3H, OCH3), 3.72 (s, 3H, OCH3), 5.17 (d, 1H, J = 10.9 Hz, CH2vinyl), 5.68 (d, 1H, J = 17.6 
Hz, CH2vinyl), 6.67 (dd, 1H, J = 10.9, 17.6 Hz, CHvinyl), 6.94 (dd, 2H, J = 7.9, 14.0 Hz, ArH), 7.22-
7.29 (m, 4H, ArH), 7.36 (d, 1H, J = 8.1 Hz, ArH), 7.46 (d, 1H, J = 1.2 Hz, ArH), 7.50 (dd, 1H, J = 
1.6, 8.0 Hz, ArH), 7.42 (s, 1H, ArH), 7.80 (d, 1H, J = 8.0 Hz, ArH); 13C NMR (62.90 MHz, 
CDCl3):  = 51.9 (OCH3), 55.5 (OCH3), 111.3 (CHAr), 113.8 (CH2vinyl), 120.9, 125.8, 128.3, 128.6 
(CHAr), 128.8 (CAr), 129.4, 129.7, 130.7, 131.8 (CHAr), 136.4 (CAr), 136.5 (CHAr), 141.0, 141.8, 
141.9, 142.6, 156.4 (CAr), 168.9 (C=O). IR (KBr): ~= 3002, 2947, 2835 (w), 1716 (s), 1627, 1580, 
1513, 1498, 1461, 1386 (m), 1243 (s), 1180, 1137, 1120, 1055, 1024, 1005, 904, 786 (m), 750 (s), 
715, 637, 574, 541 (m) cm-1; GC-MS (EI, 70 eV): m/z (%): 344 (M+, 100), 313 (24), 285 (06), 270 
(10), 239 (10), 164 (06), 119 (04); HRMS (EI) calcd for C23H20O3 [M+]: 344.14070, found 
344.140881. 
 
2,4-Dimethoxy-4''-vinyl-[1,1';3',1'']terphenyl-4'-carboxylic acid methyl ester (35d): Starting 
with 34d (150 mg, 0.36 mmol), K3PO4 (114 mg, 0.54 mmol), 
Pd (PPh3)4 (3 mol%), 4-vinylphenylboronic acid (69 mg, 0.47 
mmol) and 1,4-dioxane (5ml/mmol of triflate), 35d was 
isolated as a colorless solid; yield 80 mg, (60 %), mp. = 160-
162°C. 1H NMR (300 MHz, CDCl3):  = 3.59 (s, 3H, OCH3), 3.75 (s, 3H, OCH3), 3.79 (s, 3H, 
OCH3), 5.20 (dd, 1H, J = 2.4, 10.8 Hz, CH2vinyl), 5.72 (dd, 1H, J = 2.4, 9.6 Hz, CH2vinyl), 6.69 (dd, 
1H, J = 2.4, 10.6 Hz, CHvinyl), 7.21-7.24 (m, 3H, ArH), 7.26 (s, 1H, ArH), 7.30-7.39 (m, 4H, ArH), 
7.60 (dd, 1H, J = 1.9, 7.9 Hz, ArH), 7.88 (d, 1H, J = 1.6 Hz, ArH); 13C NMR (75.47 MHz, CDCl3): 
 = 51.9 (OCH3), 55.4 (OCH3), 55.6 (OCH3), 99.0, 104.8 (CHAr), 113.8 (CH2vinyl), 125.9, 128.6, 
130.3 (CHAr), 130.4 (CAr), 130.7, 131.2, 132.0, 136.5 (CHAr), 136.6, 137.5, 138.9, 139.6, 140.0, 
141.6, 142.0 (CAr), 169.1 (C=O). IR (KBr): ~= 3052, 2921, 2848 (w), 1716, 1608 (s), 1463, 1435, 










m/z (%): 374 (M+, 100), 343 (04), 285 (06), 257 (05), 179 (06), 120 (04); HRMS (EI) calcd for 
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X-Ray Crystals Data 
Data for Compound 4 Chapter 2: 
Identification code  av_mn41 
Empirical formula  C17H10F6O9S2 
Formula weight  Mr = 536.37 
Temperature  T = 173 K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  'P 21 21 21'  
Space group (Hall)  'P 2ac 2ab' 
Unit cell dimensions a = 7.3168 (5) Å = 90.00° 
 b = 11.9492 (5) Å = 90.00° 
 c = 23.5888 (14) Å  = 90.00° 
Volume 2062.4 (2) Å3 
Z 4 
Crystal Density (Calculated) 1.727 Mg m−3 
Absorption coefficient 0.36 mm−1 
F(000) 1080 
Crystal size 0.40 × 0.19 × 0.06 mm 
 range for data collection 4.4°–27.5° 
Reflections collected 10600 
Independent reflections 4696 [R(int) = 0.035] 
Completeness to  = 29.00° 98.7%  
Absorption correction multi-scan 
Max. and min. transmission 0.869 and 0.979 
Refinement method phi and psi scans 
Data / restraints / parameters 3761 / 0 / 309 
Goodness-of-fit on F2 1.07 
Final R indices [I>2(I)] R1 = 0.0798, wR2 = 0.1533 
R indices (all data) R1 = 0.0617, wR2 = 0.1455 
Largest diff. peak and hole 0.782 and -0.317 e.Å-3 
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Data for Compound 6a Chapter 2: 
Identification code  av_mn42 
Empirical formula  C29H24O3 
Formula weight  420.48 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 13.7757 (10) Å = 90.00° 
 b = 14.2815 (9) Å = 116.716 (2)° 
 c = 12.4993 (9) Å = 90.00° 
Volume 2196.6 (3) Å3 
Z 4 
Density (calculated) 1.271 Mg m−3 
Absorption coefficient 0.08 mm−1 
F(000) 888 
Crystal size 0.70 × 0.47 × 0.29 mm 
 range for data collection 1.7° to 29.0°. 
Reflections collected 22988 
Independent reflections 5817  [R(int) = 0.027] 
Completeness to  = 29.00° 99.6% 
Absorption correction multi-scan 
Max. and min. transmission 0.9453 and 0.9768 
Refinement method phi and psi scans 
Data / restraints / parameters 4737 / 0 / 292 
Goodness-of-fit on F2 1.10 
Final R indices [I>2(I)] R1 = 0.0567, wR2 = 0.1388 
R indices (all data) R1 = 0.0459, wR2 = 0.1317 
Largest diff. peak and hole 0.376 and -0.290 e.Å-3 
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Data for Compound 7g Chapter 2: 
 
Identification code  av_mn70b 
Empirical formula  C25H21F3O9S 
Formula weight  554.49 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 13.8684 (11) Å = 90.00° 
 b = 15.6453 (12) Å = 98.288 (2)° 
 c = 12.9560 (8) Å = 90.00° 
Volume 2781.8 (4) Å3 
Z 4 
Density (calculated) 1.527 Mg m−3 
Absorption coefficient 0.381 mm−1 
F(000) 1312 
Crystal size 0.47 × 0.22 × 0.10 mm 
 range for data collection 3.4° to 27.8°. 
Reflections collected 24192 
Independent reflections 6561 [R(int) = 0.027] 
Completeness to  = 29.00° 99.4% 
Absorption correction multi-scan 
Max. and min. transmission 0.8413 and 0.9629 
Refinement method phi and psi scans 
Data / restraints / parameters 5043 / 0 / 374 
Goodness-of-fit on F2 1.090 
Final R indices [I>2(I)] R1 = 0.0615, wR2 = 0.1279 
R indices (all data) R1 = 0.0441, wR2 = 0.1205 
Largest diff. peak and hole 0.491 and -0.667 e.Å-3 
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Data for Compound 14b Chapter 2: 
 
Identification code  av_mn214 
Empirical formula  C25H16F2O 
Formula weight  370.38 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  C2/c 
Space group (Hall)  -C 2yc 
Unit cell dimensions a = 25.4358 (6) Å = 90.0° 
 b =11.8456 (3) Å = 126.439 (1)° 
 c = 15.2452 (4) Å = 90.0° 
Volume 3695.35 (16) Å3 
Z 8 
Density (calculated) 1.331 Mg m−3 
Absorption coefficient 0.09 mm−1 
Crystal size 0.50 × 0.28 × 0.24 mm 
 range for data collection 2.7° to 27.5°. 
Reflections collected 22802 
Independent reflections 4241 [R(int) = 0.025] 
Completeness to  = 29.00° 97.7 % 
Absorption correction multi-scan 
Max. and min. transmission 0.955 and 0.978 
Refinement method phi and psi scans  
Data / restraints / parameters 3323 / 0 / 253 
Goodness-of-fit on F2 1.09 
Final R indices [I>2(I)] R1 = 0.046, wR2 = 0.1421 
R indices (all data) R1 = 0.062, wR2 = 0.1331 




Data for Compound 15f Chapter 2: 
 
Identification code  av_mn215b 
Empirical formula  C24H21F3O4S 
Formula weight  462.47 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c 
Space group (Hall)  P 2ybc 
Unit cell dimensions a = 18.5491 (11) Å = 90.0° 
 b =10.8383 (5) Å = 100.602 (2)° 
 c = 11.2417 (7) Å = 90.0° 
Volume 2221.5 (2) Å3 
Z 4 
Density (calculated) 1.383 Mg m−3 
Absorption coefficient 0.21 mm−1 
Crystal size 0.80 × 0.14 × 0.06 mm 
 range for data collection 2.6° to 29.0°. 
Reflections collected 22333 
Independent reflections 5906 [R(int) = 0.042] 
Completeness to  = 29.00° 99.6 % 
Absorption correction multi-scan 
Max. and min. transmission 0.857 and 0.988 
Refinement method phi and psi scans 
Data / restraints / parameters 3674 / 0 / 292 
Goodness-of-fit on F2 1.01 
Final R indices [I>2(I)] R1 = 0.087, wR2 = 0.1096 
R indices (all data) R1 = 0.043, wR2 = 0.0987 




Data for Compound 15h Chapter 2: 
 
Identification code  av_mn218 
Empirical formula  C22H17F3O4S 
Formula weight  434.42 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 17.7277 (7) Å = 90.0° 
 b =8.9214 (5) Å = 97.313 (3)° 
 c = 12.6395 (6) Å = 90.0° 
Volume 1982.75 (17) Å3 
Z 4 
Density (calculated) 1.455 Mg m−3 
Absorption coefficient 0.22 mm−1 
Crystal size 0.93 × 0.73 × 0.07 mm 
 range for data collection 2.6° to 30.0°. 
Reflections collected 19639 
Independent reflections 5772 [R(int) = 0.043] 
Completeness to  = 29.00° 99.7 % 
Absorption correction multi-scan 
Max. and min. transmission 0.823 and 0.985 
Refinement method phi and psi scans 
Data / restraints / parameters 3587 / 0 / 272 
Goodness-of-fit on F2 1.01 
Final R indices [I>2(I)] R1 = 0.0931, wR2 = 0.1273 
R indices (all data) R1 = 0.0464, wR2 = 0.1150 




Data for Compound 19c Chapter 2: 
 
Identification code  av_mn152 
Empirical formula  C29H26O2 
Formula weight  390.50 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 18.055 (4) Å = 90.00° 
 b =8.1746 (16) Å = 111.43 (3)° 
 c = 16.069 (3) Å = 90.00° 
Volume 2207.7 (8) Å3 
Z 4 
Density (calculated) 1.175 Mg m−3 
Absorption coefficient 0.07 mm−1 
F(000) 832 
Crystal size 1.21 × 0.29 × 0.13 mm 
 range for data collection 4.2° to 28.5°. 
Reflections collected 4435 
Independent reflections 5560 [R(int) = 0.045] 
Completeness to  = 29.00° 99.5%  
Absorption correction multi-scan 
Max. and min. transmission 0.921 and 0.991 
Refinement method phi and ω scans 
Data / restraints / parameters 4435 / 0 / 341 
Goodness-of-fit on F2 1.08 
Final R indices [I>2(I)] R1 = 0.064, wR2 = 0.1458 
R indices (all data) R1 = 0.049, wR2 = 0.1370 
Largest diff. peak and hole 0.327 and -0.331 e.Å-3 
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Data for Compound 24 Chapter 2: 
 
Identification code  av_rk231 
Empirical formula  C29H22O 
Formula weight  386.47 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P  
Space group (Hall)  -P 1 
Unit cell dimensions a = 8.612 (7) Å = 91.992 (16)° 
 b =10.015 (6) Å = 107.669 (16)° 
 c = 13.765 (8) Å = 111.33 (3)° 
Volume 1039.5 (12) Å3 
Z 2 
Density (calculated) 1.235 Mg m−3 
Absorption coefficient 0.07 mm−1 
Crystal size 0.99 × 0.57 × 0.21 mm 
 range for data collection 1.6° to 27.5°. 
Reflections collected 13753 
Independent reflections 4732 [R(int) = 0.037] 
Completeness to  = 29.00° 99.2 % 
Absorption correction multi-scan 
Max. and min. transmission 0.931 and 0.985 
Refinement method phi and ω scans  
Data / restraints / parameters 4071 / 0 / 275 
Goodness-of-fit on F2 1.12 
Final R indices [I>2(I)] R1 = 0.0600, wR2 = 0.1520 
R indices (all data) R1 = 0.0525, wR2 = 0.1435 




Data for Compound 25 Chapter 3: 
 
Identification code  av_mn100b 
Empirical formula  C8H8O4 
Formula weight  168.14 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/n 
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 4.869 (5) Å = 90.00° 
 b =12.833 (12) Å = 96.23 (4)° 
 c = 12.255 (13) Å = 90.00° 
Volume 761.2 (13) Å3 
Z 4 
Density (calculated) 1.467 Mg m−3 
Absorption coefficient 0.12  mm−1 
F(000) 352 
Crystal size 0.51 × 0.32 × 0.08 mm 
 range for data collection 4.4° to 30.0°. 
Reflections collected 8723 
Independent reflections 2201 [R(int) = 0.026] 
Completeness to  = 29.00° 99.4%  
Absorption correction multi-scan 
Max. and min. transmission 0.942 and 0.991 
Refinement method phi and psi scans 
Data / restraints / parameters 1824 / 0 / 118 
Goodness-of-fit on F2 1.07 
Final R indices [I>2(I)] R1 = 0.049, wR2 = 0.1231 
R indices (all data) R1 = 0.041, wR2 = 0.1157 
Largest diff. peak and hole 0.451 and -0.235 e.Å-3 
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Data for Compound 26 Chapter 3: 
 
Identification code  av_mn101 
Empirical formula  C10H6F6O8S2 
Formula weight  432.27 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  C2/c 
Space group (Hall)  -C 2yc 
Unit cell dimensions a = 33.116 (2) Å = 90.00° 
 b =5.5154 (3) Å = 118.757 (2)° 
 c = 19.1402 (13) Å = 90.00° 
Volume 3064.8 (3) Å3 
Z 8 
Density (calculated) 1.874 Mg m−3 
Absorption coefficient 0.46 mm−1 
F(000) 1728 
Crystal size 0.65 × 0.26 × 0.07 mm 
 range for data collection 4.2° to 28.0°. 
Reflections collected 2908 
Independent reflections 3693 [R(int) = 0.035] 
Completeness to  = 29.00° 99.5%  
Absorption correction multi-scan 
Max. and min. transmission 0.755 and 0.969 
Refinement method phi and ω scans 
Data / restraints / parameters 2908 / 0 / 236 
Goodness-of-fit on F2 1.05 
Final R indices [I>2(I)] R1 = 0.050, wR2 = 0.0916 
R indices (all data) R1 = 0.035, wR2 = 1.050 
Largest diff. peak and hole 0.417 and -0.312 e.Å-3 
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Data for Compound 27b Chapter 3: 
 
Identification code  av_mn104 
Empirical formula  C28H32O2 
Formula weight  400.54 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 8.7751 (6) Å = 90.00° 
 b =26.497 (2) Å = 101.856 (3)° 
 c = 10.1463 (7) Å  = 90.00° 
Volume 2308.9 (3) Å3 
Z 4 
Density (calculated) 1.152 Mg m−3 
Absorption coefficient 0.07 mm−1 
F(000) 864 
Crystal size 0.65 × 0.25 × 0.14 mm 
 range for data collection 4.1° to 27.5°. 
Reflections collected 20313 
Independent reflections 5292 [R(int) = 0.040] 
Completeness to  = 29.00° 99.6% 
Absorption correction multi-scan 
Max. and min. transmission 0.956 and 0.990 
Refinement method phi and ω scans 
Data / restraints / parameters 3557 / 0 / 341 
Goodness-of-fit on F2 1.05 
Final R indices [I>2(I)] R1 = 0.0917, wR2 = 0.1575 
R indices (all data) R1 = 0.0555, wR2 = 0.1433 
Largest diff. peak and hole 0.367 and -0.244 e.Å-3 
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Data for Compound 27d Chapter 3: 
 
Identification code  av_mn108a 
Empirical formula  C24H20O2 
Formula weight  340.40 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 12.712 (5) Å = 90.00° 
 b =21.899 (7) Å = 105.43 (3)° 
 c = 6.783 (2) Å  = 90.00° 
Volume 1820.1 (11) Å3 
Z 4 
Density (calculated) 1.242 Mg m−3 
Absorption coefficient 0.08 mm−1 
F(000) 720 
Crystal size 0.67 × 0.18 × 0.16 mm 
 range for data collection 3.3° to 28.0°. 
Reflections collected 18253 
Independent reflections 4351 [R(int) = 0.049] 
Completeness to  = 29.00° 99.3% 
Absorption correction multi-scan 
Max. and min. transmission 0.950 and 0.988 
Refinement method phi and ω scans 
Data / restraints / parameters 2595 / 0 / 237 
Goodness-of-fit on F2 1.04 
Final R indices [I>2(I)] R1 = 0.098, wR2 = 0.1387 
R indices (all data) R1 = 0.047, wR2 = 0.1208 
Largest diff. peak and hole 0.261 and -0.232 e.Å-3 
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Data for Compound 34c Chapter 3: 
 
Identification code  av_mn133 
Empirical formula  C16H13F3O6S 
Formula weight  390.32 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P   
Space group (Hall)  -P 1 
Unit cell dimensions a = 7.6106 (6) Å = 113.815 (4)° 
 b =11.2409 (9) Å = 102.495 (4)° 
 c = 11.9009 (10) Å  = 106.407 (3)° 
Volume 827.76 (12) Å3 
Z 2 
Density (calculated) 1.566 Mg m−3 
Absorption coefficient 0.26 mm−1 
Crystal size 0.88 × 0.24 × 0.13 mm 
 range for data collection 3.0° to 27.5°. 
Reflections collected 14195 
Independent reflections 3723 [R(int) = 0.033] 
Completeness to  = 29.00° 97.7 % 
Absorption correction multi-scan 
Max. and min. transmission 0.804 and 0.967 
Refinement method phi and psi scans  
Data / restraints / parameters 3341 / 0 / 237 
Goodness-of-fit on F2 1.09 
Final R indices [I>2(I)] R1 = 0.042, wR2 = 0.1176 
R indices (all data) R1 = 0.038, wR2 = 0.1143 
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